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PREFACE 
A tandem SN2-Michael addition sequence has been developed for the preparation 
of 5- and 6-ring nitrogen and sulfur heterocycles from ethyl m-halo-2-alkenoates. The 
preparation of nitrogen heterocycles involves reaction of the haloester with a primary amine 
and triethylamine in methanol or ethanol solvent This initially affords a secondary amine 
intermediate which then cyclizes onto the acrylate acceptor to form the heterocyclic product 
The formation of sulfur heterocycles involves reaction of the haloester with thiourea to 
initally yield the isothiuronium halide adduct which is then hydrolyzed in aqueous base to 
afford the sulfur heterocyclic product proceeding through a thiolate intermediate. The 
process is useful for the preparation of mono-, fused- and spirocyclic rings having an 
acetate residue at C-2 relative to the heteroatom. The reactions proceed in 60-80% yields 
and can be carried out in a single reaction flask. The mechanism, stereochemistry, and 
scope of these reactions are discussed. 
A one-pot tandem decarboxylation-Michael addition sequence has also been 
developed for the construction of functionalized spiranes. Starting substrates were readily 
prepared by alkylation of methyl2-oxocycloalkanecarboxylates with a side chain group 
incorporating a terminal acrylate Michael acceptor. The process is initiated by nucleophilic 
ester cleavage-decarboxylation of the cyclic P-ketoester with lithium chloride in 
hexamethylphosphoramide (HMPA) solvent at 95-130oC and the resulting anion is trapped 
by subsequent Michael addition to the side-chain acrylate acceptor. Both 5- and 6-rings 
can be prepared by this procedure. Yields range from 50-70% and closure occurs such that 
the two carbonyl groups are oriented trans to one another in the major product. 
ill 
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CHAPTER I 
HISTORICAL BACKGROUND: THE UTILITY 




This chapter presents a brief overview of the use of the Michael addition in tandem 
reaction sequences. Attention has been focused on several strategies that have been devised 
involving the integration of the Michael addition reaction into tandem sequences that allow 
for the efficient preparation of a number of different types of organic compounds having 
both synthetic and practical utility. Specific examples have been included to illustrate these 
applications. 
Preparation of Carbocyclic Compounds 
The Michael addition has been utilized extensively as a component step in tandem 
reaction sequences for the preparation of many useful carbocyclic systems.l-26 One of the 
advantages of the use of the Michael reaction in such sequences is that one is able to 
efficiently construct ring systems of moderate to high structural complexity bearing useful 
functionality. For example, in an intramolecular Michael addition reported by Haynes and 
Katsifis, 1 treatment of the allyl phenyl sulfone 1 with potassium tert-butoxide in tetra-
hydrofuran cleanly afforded the bicyclo[2.2.l]heptanone derivative 3 (65%) proceeding 




In a total synthesis of atisine, a diterpene alkaloid, Kametani and co-workers2,3 
utilized a tandem intramolecular Michael-Michael reaction to prepare the pentacyclic 
intermediate 7 from precursor 4. Reaction of 4 with lithium bis(trimethylsilyl)amide in 
ether at -78°C smoothly generated kinetic enolate 5 which cyclized intramolecularly onto 
the methoxycarbonylethenyl moiety in Michael fashion to afford intermediate enolate 6. 
Subsequent Michael addition of the ester enolate portion of 6 to the cyclohexenone 














In a method involving a tandem intermolecular Michael addition-Michael addition 
sequence for the preparation of functionalized 1- and 2-ring carbocycles, Bunce and 
co-workers4 utilized triester precursor 8 incorporating both a Michael donor and a Michael 
acceptor grouping. Reaction of 8 with an a.,(}-unsaturated ketone (9 or 11) in the 
presence of sodium methoxide generated products 10 and 12. The reaction involves 
conjugate addition of the deprotoned malonate portion of 8 to ketone 9 (or 11) to afford a 
carbanion intermediate which then undergoes an intramolecular Michael addition to the 
acceptor portion of 8 to yield the observed product (10 or 12) after workup. The method 
























In efforts relating to the preparation of 13a.-methyl14a.-hydroxy steroid 
derivatives, Lavallee and Deslongchamps5 reported a preparation of tetracyclic intermediate 
16 which involved a tandem Michael-Michael-aldol reaction. The reaction of 13 and 14 in 
the presence of cesium carbonate in chloroform initially yielded intermediate 15 resulting 
from the Michael addition of the carbanion of 14 to 13. This was followed by a second 
intramolecular Michael addition of the resulting ~-ketoester carbanion moiety of 13 to the 
a,~-unsaturated ketone portion of 14. Subsequent intramolecular aldol addition of the 
resulting enolate (15) to one of the two ketone functionalities of the neighboring 1,3-





An example of an intermolecular Michael-Michael-aldol reaction sequence involving 
a very efficient and general, 2+2+2 synthesis of poly-functionalized cyclohexanols (19) 
was reported by Posner and co-workers. 6 The approach entailed reaction of piperidone 17 
with 2.2 equivalents of methyl a-bromoacrylate and 1.0 equivalent of lithium 
diisopropylamide (LDA) in tetrahydrofuran at -78"C. The reaction proceeds along a 
pathway involving two sequential Michael additions and an aldol reaction as shown in 18 
to afford cyclohexanol19 (66% overall yield) after workup and purification. 
17 
LDA, THF, -78"C 
0 
BrvJI. 




In an approach to the preparation of the bicyclo[3.2.1 ]octane ring system, a basic 
structural unit in a number of natural products, Alexakis and co-workers? utilized a tandem 
Michael-aldol route to prepare tricyclic product 22. Reaction of 20 with sodium hydroxide 
afforded Michael addition product 21 which subsequently underwent an intramolecular 
aldol addition to yield 22. 
20 
3 eg. Naou..,. 




In a facile one-flask preparation of 8-methoxy-1-tetralones (27), Tarnachompoo 
and co-workers8 described an efficient tandem Michael addition-Dieckmann condensation 
route involving the reaction of the methoxy toluate 23 and methyl acrylate (24). Reaction 
of 23 with lithium diisopropylamide in tetrahydrofuran at -7s·c in the presence of 24 
initially generated enolate 25 which then underwent Michael addition to 24 to afford 
intermediate 26. Subsequent intramolecular Dieckmann condensation of 26 then yielded 









~ OMe THF, -78°~ 
24 
~C~e 
MeO 0 \..:; 
26 
~~ 
~~Me + ~~OMe 
MeO o- 0 
25 
6 
In another example illustrating a tandem Michael-Dieckmann approach to 
carbocycles, Stetter and co-workers9 reported a method for the synthesis of bicyclo-
[3.2.l]octane derivative 31 from diester 28. Reaction of 28 with cyanide ion in 
dimethylsulfoxide at 800C initially yielded enolate 29 resulting from the Michael addition 
of cyanide to one of the acrylate moieties. This was followed by intramolecular Michael 
addition, enolate equilibration (29~30) and Dieckmann condensation to afford 31 in an 










Yamaguchi and co-workerslO illustrated the use of chiral reagents for the 
stereocontrolled construction of tertiary carbon centers using a tandem Michael-Dieckmann 
8 
scheme. Reaction of the dilithium derivative of (S)-(+)-N-methyl-N-propionylvalinol with 
diester 32 in ether-tetrahydrofuran at -78oC afforded chiral intermediate 33 by an 
intermolecular enantioselective Michael addition to the ene diester which subsequently 
cyclized through a Dieckmann condensation to give chiral 34 in 71% yield. The authors 





~N? "' Me 
OH 
34 
Another sequence utilizing the Michael addition in a tandem reaction scheme was 
reported by Nokami and co-workers.12 In this work, the reaction of 2-allyloxycarbonyl-
cyclopentanone 35 with palladium(II) acetate in the presence of triphenylphosphine in 
acetonitrile at 40°C initially generated the (1t-allyl) palladium enolate 36 through 
decarboxylation of 35. Subsequent formation of the (1t-allyl) palladium enolate 37 from 
36 through an intramolecular 1 ,4-addition of the palladium enolate moiety of 36 to the 
terminal enone functionality (and hydrolytic workup) smoothly afforded spiro adduct 38 















In a scheme devised for the preparation of functionalized diquinanes utilizing a 
[3+2] annulation route, Marino and co-workersl3 reported a process involving a tandem 
desilylation-Michael addition-Wittig reaction sequence that allowed for the facile 
preparation of diquinane 43 from cyclopropane 39. Reaction of 2-(silyloxy)cyclopropane 
ester 39 with potassium fluoride in refluxing acetonitrile in the presence of 1-thiovinyl-
phosphonium bromide (41) initially afforded y-oxo ester enolate 40 through a fluoride-
induced desilylation-cyclopropyl ring-opening sequence. Subsequent Michael addition of 
40 to 41 yielded ylide 42 which then underwent an intramolecular Wittig olefination to 
afford the diquinane product 43 in an overall yield of 80%. In the same citation, the 
authors also illustrated the preparation of a series of functionalized triquinanes using this 













R t . Jlr eac aon 
10 
Lastly, d'Angelo and coworkers14 described a route for an efficient asymmetric 
synthesis of spirane 46 from 2-substituted cyclohexanes (44) proceeding through a 
tandem imine formation-Michael addition sequence. Reaction of 44 with (R)-1-phenyl-
ethylamine in refluxing toluene intially yielded the chiral imine. This species, which is in 
equilibrium with the thermodynamic enamine 45, underwent an intramolecular Michael 
addition to the terminal enoate ester to afford spiro product 46 (85% conversion) following 
hydrolytic workup. According to the authors, this process allowed for the synthesis of 46 
with a high level of stereochemical homogeneity as verified by lH-NMR and single 










Preparation of Heterocyclic Compounds 
C~Me 
In 1975, Mcintosh and co-workers15,16 reported a procedure for the efficient 
preparation of 2,5-dihydrothiophenes (i.e. 51) from a-mercaptoketone 48 and 
11 
phosphonate 47. Reaction of 48 with sodium hydride in the presence of 47 in benzene 
solvent initially yielded thiolate 49. Subsequent Michael addition of 49 to 47 then 
afforded the phosphonate anion 50 which underwent an intramolecular Wadsworth-
Emmons olefination to yield thioether 51 (72% overall conversion from 48). The 
preparation of dihydrothiophenes has received much attention because of their facile 
conversion to substituted butadienes17 through an oxidation-thermal decomposition route. 
0 
II 












During the preparation of substrates for ring expansion studies of sulfur 
heterocycles, V edejs and co-workers18 described a facile synthesis of tetrahydrothiopyran 
derivative 54 from 52 involving a tandem thioacetate methanolysis-Michael addition 
reaction sequence. Reaction of thioacetate 52 with sodium methoxide in methanol at 
23oC resulted in acetate cleavage to form thiolate 53 which subsequently underwent an 





As part of a total synthesis of lycorine, Boeckmann and co-workers19 reported an 
efficient one-flask preparation of dihydroisoindole 57 from phthalimide derivative 55. 
13 
Treatment of 55 with hydrazine in refluxing methanol solvent resulted in mild hydra-
zinolysis of 55 to afford primary amine 56 which subsequently underwent intramolecular 
Michael addition to the ortho acrylate moiety to give 57 in an overall yield of 70% from 
55. 
57 




A TANDEM SN2-MICHAEL ADDITION ROUTE 
TO S- AND 6-RING NITROGEN AND 
SULFUR HETEROCYCLES 
Introduction 
Heterocylic ring systems are an important structural component of many natural 
products27-30 and compounds used as medicinal agents.31-35 Consequently, this class of 
organic structures has and continues to receive much attention in contemporary organic 
research. Work by Boeckman and co-workers19 has illustrated the use of a tandem Gabriel 
amine synthesis-Michael addition sequence for the preparation of the dihydroisoindole 
ring portion (4) of the natural product lycorine. This approach is shown in Figure 1. This 
process involved the mild hydrazinolysis of phthalimide derivative 2 to yield primary amine 
3 which then cyclized by a Michael addition process to afford the dihydroisoindole product 
4 in a yield of 70%. This product (4) proved to be a key intermediate in a total synthesis 
of the natural product lycorine and several related compounds. 
In view of these results, it was thought that a similar approach involving a tandem 
SN2-Michael addition sequence resulting from the reaction of ro-halo-2-alkenoates S with a 
primary amine could potentially be used to prepare 5- and 6-ring nitrogen heterocycles 6 
bearing useful functionality at C-2 on the heterocyclic ring as shown in Figure 2. In this 
study, several topics were of interest: 1) the design and optimization of reaction conditions 
for the process, 2) the elucidation of ring size effects in the closure step, 3) the structural 
variations possible in the closure products, and 4) the stereochemical selectivity in 
substrates where a chiral center would be introduced in the ring closure. 
14 
15 







NH2NH2 · nH20 
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Figure 1. The Approach of Boeckman and Co-workers for the 








Figure 2. A Tandem SN2-Michael Addition Approach for 
Preparing Nitrogen Heterocycles. 
Previous work by Vedejs and co-workers18 also demonstrated the use of a tandem 
thioacetate methanolysis-Michael addition sequence for the preparation of tetrahydro-
thiopyran product 8 from thioacetate derivative 7 (see Figure 3). This method involved 
the treatment of 7 with methanolic sodium methoxide to yield the expected thiolate 
intermediate which then cyclized onto the acrylate moiety by a Michael addition process 
to afford product 8. 
NaOMe Qco,Me s . MeOH 
7 8 
Figure 3. The Method of Vedejs and Co-workers for the 
Preparation of Sulfur Product 8. 
16 
In view of these observations, it was envisioned that a similiar approach involving 
a tandem SN2-Michael addition sequence resulting from the reaction of haloester 9 with 
some organic or inorganic source of sulfur could be developed to prepare 5- and 6-ring 
sulfur heterocycles 10 bearing useful functionality (see Figure 4). In this portion of the 
"S" 
9 
en. ~COzR s 
10 
Figure 4. A Tandem SN2-Michael Addition Approach for 
the Preparation of Sulfur Heterocycles. 
17 
study as well, several goals were set: 1) the determination of the best source of sulfur for 
the process, 2) the design of a set of optimized reaction conditions that would allow for the 
process to proceed smoothly, 3) the study of ring size effects in the closure step, 4) the 
structural variations possible in the closure products, and 5) the stereochemical selectivity 
in substrates where a chiral center would be introduced by such a process. 
Results 
Synthesis of the Starting Materials. A number of different starting 
substrates were prepared for use in our heterocyclization study. Compounds were selected 
for evaluation in the synthesis of simple, fused, and spiro ring systems. The synthesis of 
the starting substrates 11 for the preparation of a series of monocytic 5- and 6-ring 
nitrogen and sulfur heterocycles 12 (see Figure 5) is shown in Figure 6. Reaction of 
> 
11 n=l, 2 12 n=l, 2 
Y=N-R', S 
Figure 5. Preparation ofMonocyclic Heterocycles 12 
from Haloesters 11. 
tetrahydrofuran (13) and tetrahydropyran (14) with refluxing 48% hydrobromic acid36 
afforded 4-bromo-1-butanol (15) in 12% and 5-bromo-1-pentanol (16) in 15% yield 
respectively. Chloro alcohols 17 and 18 were available from commercial sources. 
Buffered oxidation of the 4- or 5-halo-1-alkanols 15-18 with pyridium chlorochromate37 
18 
to the corresponding halo aldehydes 19-22 followed by Wittig olefination using ethyl 
(triphenylphosphoranylidene)acetate in refluxing benzene smoothly afforded the ethyl 
(E)-6 or (E)-7-halo-2-alkenoates 23-26 in overall yields ranging from 52-57% (for 23 and 
25, respectively) from the starting halo alcohols 15 and 17. Finally, treatment of 25 and 
26 with sodium iodide in refluxing acetone cleanly afforded ethyl (E)-6-iodo-2-hexenoate 
(27) and ethyl (E)-7-iodo-2-heptenoate (28), respectively. 
48% aq. HBr, !!.. 
13 n=1 
14 n=2 
15 n=1, X=Br 
16 n=2, X=Br 
17 n=1, X=CI 
18 n=2, X=CI 
23 n=1, X=Br 
24 n=2, X=Br 
25 n=l, X=CI 










19 n=1, X=Br 
20 n=2, X=Br 
21 n=1, X=CI 








Figure 6. Synthesis of Haloester Precursors to Monocyclic 
Nitrogen and Sulfur Heterocycles. 
The preparation of precursors 29 (see Figure 7) for the synthesis of several 
dihydroisoindoles (30, n=1, Y=N), tetrahydroisoquinolines (30, n=2, Y=N), 1,3-
dihydrobenzo[c]thiophenes (30, n=1, Y=S), and 3,4-dihydro-1H-2-benzothiopyrans 
(30, n=2, Y=S) is shown in Figure 8. Wittig reaction of 2-methylbenzaldehyde (31) 
29 n=l, 2 30 n=l, 2 
Y=N-R', s 
Figure 7. Preparation of Aromatic Nitrogen and Sulfur 
Heterocycles 30 from Haloesters 29. 
19 
with methyl (triphenylphosphoranylidene)acetate, followed by benzylic bromination with 
N-bromosuccinimide38 in carbon tetrachloride, smoothly afforded substrate 33 in an 
overall yield of 61%. The reaction of 2-phenylethanol (34) with paraformaldehyde and 
gaseous hydrochloric acid yielded isochroman39 (35) which, upon sequential treatment 
with bromine and then 48% hydrobromic acid, afforded 2-(2-bromoethyl)benzaldehyde39 
(36) in an overall yield of 54% from 34. Wittig olefination of 36 with ethyl (triphenyl-
phosphoranylidene)acetate, followed by Finkelstein halide exchange with sodium iodide in 
acetone, yielded iodoester 38. 
The synthesis of substrate 39 allowing access to cis 6-5 fused-ring nitrogen and 
sulfur heterocycles 40 (see Figure 9) is illustrated Figure 10. Reduction of cis-1,2-cyclo-
hexanedicarboxylic acid anhydride (41) with lithium aluminum hydride40 in 
dOzMe NBS c{01Me C(HO Ph3P=CHC02Me 
~ 
~ C6H6, A Bz20 












1) Br2, CC4 
2) HBr, 64% 
36 
c{~Et ce:1Et 
Ph3P=CHC02Et ~ Nal ~ 
C6H6, A acetone 
75% Br 97% I 
37 38 
Figure 8. Synthesis of Starting Substrates 33 and 38. 
39 40 Y=N-R', S 
Figure 9. Preparation of cis 6-5 Fused-Ring Nitrogen and Sulfur 
Heterocycles 40 from Haloester 39. 
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tetrahydrofuran, followed by oxidation of the cis diol intermediate 42 with manganese 
dioxide41 in methylene chloride, afforded cis 6-5 fused-ring lactol product 43 in an overall 
yield of 81% from 41. Wittig olefination of 43 with ethyl (triphenylphosphoranylidene)-
acetate yielded hydroxyester 44. Sequential treatment of 44 with methanesulfonyl 
chloride/triethylamine42 in methylene chloride at ooc and lithium bromide43 in ether-
HMPA afforded cis bromoester 46 in an overall yield of 90% from 44. 
ex? LiAIH4 cc: 10 Mn02 oS THF CH2CI2, 20"C 94% 86% 
41 42 43 
c{~Et c{~ru 
Ph3P=CHC02Et . MsCI, Et3N 
C6H6,1l CH2CI2, O"C 
48% OH 91% OMs 





Figure 10. Synthesis of Substrate 46. 
The synthesis of substrate 47 allowing access to trans 6-5 fused-ring nitrogen and 
sulfur heterocycles 48 (see Figure 11) is illustrated in Figure 12. Reaction of 41 with 
ethanol and sulfuric acid44 yielded cis diester product 49 in a yield of 90%. Base-induced 
22 
epimerization-hydrolysis44 of 49 with ethanolic and then aqueous potassium hydroxide 
smoothly afforded the trans diacid 50 which was subsequently reduced with lithium 
aluminum hydride in tetrahydrofuran to yield trans-1,2-bis(hydroxymethyl)cyclohexane 
(51). The employment of the same reaction sequence described previously and shown in 
Figure 10 for the preparation of 46 from 42 allowed for the preparation of the trans 
bromoester 55 from 51 in an overall yield of 32%. 
47 48 Y=N-R', S 
Figure 11. Preparation of trans 6-5 Fused-Ring Nitrogen and Sulfur 
Heterocycles 48 from Haloester 47. 
The preparation of substrates 56 (see Figure 13) for the attempted syntheses of 3-
substituted-2-(aza or thia)-spiro[4.4]nonanes (57, n=1, Y=N or S) and 3-substituted-2-
(aza or thia)-spiro[4.5]decanes (57, n=2, Y=N or S) is illustrated in Figure 14. Fischer 
esterification45 of cyclopentanecarboxylic acid (58) yielded ester 60 which was then 
alkylated with allyl bromide and lithium diisopropylamide46 in tetrahydrofuran to afford 
62. Reduction of 62 with lithium aluminum hydride, followed by treatment of the alcohol 
intermediate 64 with triphenylphosphine in refluxing carbon tetrachloride,47 yielded 
chloride 66 in an overall yield of 45% from 58. Ozonolysis of 66, followed by Wittig 
olefmation with ethyl (triphenylphosphoranylidene)acetate in refluxing benzene, 
23 
afforded chloro ester 70. The implementation of the same sequence of reactions allowed 
for the preparation of 71, the 6-ri.ng analog of 70, from cyclohexane carboxylic acid (59). 











90% 3) u3o+, 91% 
49 
















Attempts to prepare the iodides of 70 and 71 using Finkelstein methodology, however, 
proved unsuccessful in both cases, probably due to the sterically-hindered nature of the 
chloromethyl moiety which inhibited approach of the iodide ion for displacement of the 
24 
chlorine atom. The corresponding bromide of 70 also exhibited a similiar lack of reactivity 
with regard to halogen exchange.48 
X 
~0~ 
56 n=l, 2 57 n=l, 2 
Y=N-R', S 
Figure 13. Preparation of Spiroheterocycles 57 from Haloesters 56. 
QC02H EtOH, HzS04 40,Et 1) LDA, THF ~ c,u,, A 2) ~Br 
80% 78-85% 
58 n=1 60 n=l 62 n=1 
59 n=2 61 n=2 63 n=2 
n=1 
LiAIH4 ~ Ph3P ~ 62 CCI4, A 63 n=2 THF, A 76% 74% 
64 n=l 66 n=1 
65 n=2 67 n=2 
CI Cl I 
1) 03, MeOH (j:cuo Ph3P:CHC02Et ~01Et 2) (CH3)zS, c6u6,A 
HOAc, 99% 73% 
68 n=1 70 n=1 
69 n=2 71 n=2 
Figure 14. Synthesis of Substrates 70 and 71. 
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Lastly, the synthesis of substrate 72 (see Figure 15) for the preparation of 2-
substituted-3-azaspiro[ 4.5]decanes (73, Y =N) and 2-substituted-3-thiaspiro[ 4.5]decanes 
(73, Y=S) is illustrated in Figure 16. Reaction of cyclohexanone (74) with trimethyl 
phosphonoacetate and sodiwn hydride49 in benzene afforded ethyl cyclopentylideneacetate 
(75) which was then reduced with lithium aluminum hydride50 at ooc to yield allylic 
alcohol 76 (79% overall yield from 74). Treatment of 76 with triethyl orthoacetate 
containing a catalytic amount of propanoic acid at 140-145"C, followed by base hydrolysis, 
gave 1-vinylcyclohexaneacetic acid (77) in 72% yield. Reduction of77 with lithiwn 
aluminum hydride, followed by mesylation42 and treatment with LiB~3, afforded bromide 
~~R > qso,R 
72 73 Y=N-R', S 
Figure 15. Preparation of Spiroheterocycles 73 from Haloester 72. 
80 in an overall yield of 63%. Ozonolysis of 80, followed by Wittig olefmation of the 
resulting aldehyde 81 with ethyl (triphenylphosphoranylidene)acetate in benzene, afforded 
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Figure 16. Synthesis of Starting Material 82. 
Preparation of 5- and 6-Ring Nitrogen Heterocycles. Our results on the 
use of the tandem SN2-Michael addition sequence for the synthesis of nitrogen heterocycles 
are shown in Tables I and IT. Reaction of the haloester with an equimolar amount of a 
primary amine in the presence of triethylamine in methanol or ethanol solvent afforded the 
5- and 6-ring nitrogen heterocycles in yields ranging from 59-7 6% by a one-pot procedure. 
In the case of substrate 33, the reaction conditions for formation of dihydroisoindole 
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products 83-85 did not require either heating or an extended reaction time as shown in 
Table I. This obsetvation was probably due to both the enhanced reactivity of the benzylic 
bromide and the large degree of rigidity in substrate 33 which facilitated the ring closure 
by holding the nitrogen atom and the acrylate moiety in close proximity. Another 
interesting obsetvation regarding the reactivity of 33 was that the reaction proceeded even 
when cyclohexylamine was used as the nitrogen donor although the obsetved yield was 
slightly lower. This presumably resulted from the increased steric hindrance surrounding 
the reacting amino group. 
TABLE I 
THE PREPARATION OF DIHYDROISOINDOLES BY 
A TANDEM SN2-MICHAEL ADDffiON 
REACfiON SEQUENCE. 
~O,Me ce:co,Me 
1 eq. RNH~ .. -R 
Br 1.1 eq. Et3N .& 
MeOH, RT, 24 h 
33 83-85 
Product R % Yielda 
83 -CH2CH2Ph 71 
84 -CH2Ph 69 
85 -c-C6HII 62 
























cr:~Et 8 ,-co2Et 




d=):co,Et H ,-C02Et 






~. 36 h 
~. 36 h 
~. 48 h 
~. 120 h 
~. 96 h 
8Yields refer to isolated, purified products. 
bAll reactions were run using 1 eq of PhCH2NH2 and 1.1 eq Et3N for the 
indicated time in MeOH or EtOH solvent 
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As shown in Table II, the method can be used to prepare a number of moriocyclic 
and bicyclic ring systems with the only difference in conditions being the required time of 
reaction. The reaction time required may reflect the relative amount of steric hindrance 
about the halomethyl portion of the substrate. The lack of reactivity shown by substrates 
70 and 71 using this methodology is probably explained by the fact that the halides in 
each of these substrates are essentially neopentyl and, thus, inhibit the initial SN2 reaction. 
The bromide analog of 70 also showed a similar lack of reactivity with a >80% recovery 
of starting material at the end of the heterocyclization attempt using the same conditions 
(see page 71) as cited for 70 and 71. 
c{1Et ~01Et 
~ 1 eq. PhCHzNHz 
I 
1.1 eq. Et3N u 
EtOH, .:1, 36 h 
38 91% 93 
0 
o:e~· cQ·K• dC1Et ~ 
~ 
0 





1.4 eq NHzNHz ~ 
,H 
N 
EtOH, .:1, 6 h .& 
72% NH 2 
95 96 
Figure 17. The Preparation of Tetrahydroisoquinoline 96. 
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Application of this method to substrate 38 is shown in Figure 17. Reaction of 
iodoester 38 with benzylamine in the presence of triethylamine using the standard 
conditions afforded a 90% yield of elimination product 93; none of the desired 
tetrahydroisoquinoline was obseiVed. Elimination also predominated over alkylation 
when the bromoester 37 was subjected to these reaction conditions. It was obseiVed, 
however, that the application of Boeckman's approach19 allowed for the desired 
annulation to proceed. Reaction of 37 with potassium phthalimide in dimethyl-
fonnamide,51 followed by hydrazinolysis ofphthalimide derivative 94 in ethanol, cleanly 
afforded tetrahydroisoquinoline product 96 (72%) presumably through formation of 
intermediate primary amine 95 which underwent subsequent ring closure. 
Structure Elucidation of Products 89, 90, 91, and 92. The 
stereochemical structures of products 89, 90, 91, and 92 were assigned on the basis of 
the analysis of a series of comparative lH-n.O.e. and lH-NMR coupling constant 
studies52,53,54,55 that were carried out on each pair of products. The results of these 
studies on products 89 and 90 are shown in Tables III and IV. Following the aquisition 
of additional! H selective decoupling experiments to verify the initial proton assignments, 
the COSY and HETCOR 20 spectra on each of these products were recorded. 
Comparison of the H7a-Ht coupling constants of 89 and 90 seemed to indicate that the 
acetate residue moiety in 89 was most likely cis to the ring junction (or exo) because of the 
larger H7a-Ht coupling constant in 89 (protons trans) relative to 90 (protons cis). 
Comparative lH-n.O.e. determinations55,56 on 89 and 90 supported the results obseiVed 
in the above studies. For use in these determinations, degassed and evacuated samples of 
89 and 90 (0.024 Min CDCl3) were prepared using the freeze-thaw cycle as described by 
Neuhaus and Williamson. 55 Three identical sealed samples of both 89 and 90 were 
prepared in this manner. Each sample was then submitted to three separate lH-n.O.e. 
determinations. For all three of the samples studied for both 89 and 90 (a total of nine 
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determinations for each compound), the lH-n.O.e. results observed were reproducible to 
within ±0.1% enhancement. In the case of 90, an lH-n.O.e. of 7% was observed 
between protons H1 and H7a and a 3% enhancement was observed between protons H1 
and H32 thus suggesting that H1, H7a. and H32 were all on the same face of the 5-ring. 
In the case of 89, however, an lH-n.O.e. of 3% was observed between protons H1 and 
H31 indicating their proximity to each other; no enhancement between H7a and H 1 was 
observed. The structural assignments shown in Tables ill and N are those that best 
support the results obtained in these comparative lH-NMR experiments. 
TABLE ill 
SELEcrED PROTON ASSIGNMENTS AND OBSERVED 
COUPLING CONSTANTS FOR BICYCLIC 
















OBSERVED lH-N. 0. E. INTERACITONS FOR 
SELECfED PROTON PAIRS OF NITROOEN 
PRODUCfS 89 AND 90. 
I I 
H3a H H32 
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Proton lnteractiona 89 
CH2- H7a 3% 
H1- H7a 0% 
H1- H3a 0% 
H7a- H3a 6% 
H1- H31 3% 









The same structural assignment strategy was carried out on 91 and 92. The 
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results of these studies are shown in Tables V and VI. The smaller magnitude of the H7a-
Ht coupling constant in 91 relative to 92 indicated that the protons H7a and Ht of 91 were 
most probably on the same face of the 5-ring; this observation was further substantiated 
by an observed lH-n.O.e. of 5% between protons H7a and Ht and a 3% enhancement 
between protons Ht and H31 in 91. Conversely, in product 92 no enhancement between 
33 
protons H7a and HI or protons HI and H3I was observed; in addition, a IH-n.O.e. of 4% 
was observed between protons HI and H3a as well as a 4% enhancement between protons 
TABLEV 
SELECfED PROTON ASSIGNMENTS AND OBSERVED 
COUPLING CONSTANTS FOR BICYCLIC 















HI and H32 thus implying that HI, H3a, and H32 are all on the same face of the 5-ring. 
The structural assignments for 91 and 92 shown in Tables V and VI are those that best 
support the data obtained in these comparative IH-NMR experiments. 
TABLE VI 
OBSERVED lH-N. o.·E. INTERACTIONS FOR 
SELECfED PROTON PAIRS OF NITROOEN 
PRODUCfS 91 AND 92. 
91 92 
Product 
Proton Interactiona 91 
CH2- H7a 0% 
H1- H7a 5% 
H1- H3a 0% 
H7a- H3a 0% 
H1 - H31 3% 









Mechanistic Description of the Nitrogen Heterocyclic Ring 
Formation Process. Two mechanistic scenarios are possible to describe the nitrogen 
34 
heterocyclization process. In the formation of cyclic amines, it is conceivable that the SN2 
process occurs first followed by the Michael addition reaction but it is also possible that the 
reverse sequence with the Michael addition being the initial step in the reaction pathway 
may be operating. To determine which of these processes is responsible for product 
formation, an equimolar mixture of 1-iodohexane and ethyl crotonate was treated with 
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benzylamine and triethylamine according to the standard procedure. The reaction was 
monitored by GC for the selective disappearance of reactants. Mter 12 h, the benzylamine 
and 1-iodohexane were totally consumed. The ethyl crotonate was also consumed but to a 
much lesser extent. The results of this experiment suggest that the SN2 displacement 
process is the initial step in the reaction mechanism. 
In view of these observations, one can envision the mechanism as shown in Figure 
18 to be operating. The reaction of the haloester 97 with the primary amine proceeds 
97 
RHN~o2Et 
On V . 
99 
Figure 18. Mechanism of the Formation of Nitrogen Heterocycles by 
a Tandem SN2-Michael Addition Sequence. 
through an SN2 displacement of the halogen by the lone electron pair of the primary 
nitrogen atom to yield a secondary aminium halide salt 98 which then reacts with 
triethylamine to afford the secondary amine 99. The intermediate amine 99 then initiates 
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an intramolecular Michael addition process onto the acrylate acceptor to afford the cyclic 
amine product 100. In cases where the alcohol solvent is different than the alkyloxy 
group of the ester functionality, for example in substrates 27 and 28, transesterification of 
the acrylate ester moiety may also occur. 
Preparation of 5- and 6-Ring Sulfur Heterocycles. Several routes to the 
analogous sulfur heterocycles were also evaluated. An initial attempt involved the reaction 
of the haloester substrate 97 with Na2S in ethanol. 57 The approach that was employed is 
illustrated in Figure 19. It was thought a priori that the sulfide ion would assume a role 
similar to that shown by nitrogen, i.e. displacing the halide by an SN2 process to generate 
a thiolate intermediate 101 which would undergo a subsequent intramolecular Michael 
addition reaction to form the sulfur product 102. Attempts using substrate 33 as a test 
case, however, produced a complex mixture of products. 
-~ S ~C02Et 
On U 
101 
Figure 19. An Attempted Formation of Sulfur Heterocycles 
Using Sodium Sulfide. 
A successful method was developed for the generation of 5- and 6-ring sulfur 
heterocycles and is shown in Figure 20 for substrate 33. The method proceeded by a 
two-step process involving reaction of the halo ester 33 with thiourea in ethanol solvent 
to afford the isothiuronium salt58 103 which was then hydrolyzed in aqueous base58 to 
afford the sulfur product 110 in the form of its carboxylic acid. 
EtOH, li 
33 103 
1) 22% aq. KOH, li 
110 
Figure 20. The Preparation of Sulfur Heterocycle 110 by a Tandem 
SN2-Michael Addition Reaction Sequence. 
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The results of this study on the tandem SN2-hydrolysis-Michael addition approach 
to sulfur heterocycles are shown in Table VII. The bromoester was first converted to its 
isothiuronium salt by reaction with thiourea in ethanol solvent Although it proved 
possible to effect the entire reaction sequence in a single operation, the isothiuronium salts 
were generally isolated and characterized. Treatment of the isolated salt with 22% aqueous 
potassium hydroxide at reflux for 8 h resulted in hydrolysis of the isothiuronium moiety to 
form the thiolate intermediate which then underwent an intramolecular Michael addition to 
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method, the sulfur products were isolated as the carboxylic acid derivatives because of 
base hydrolysis of the starting ester functionality during the course of the reaction. The 
method as devised proceeds smoothly to afford essentially pure products with yields in the 
range of 59-76%. With the exception of 111, all of the sulfur products were isolated as 
white solids that were easily purified by recrystallization. 
Structure Elucidation of Products 114 and 115. Following the same 
structural assignment strategy as that used for nitrogen products 89-92, evaluations of 
lH-n.O.e. and lH-NMR coupling constants were carried out on sulfur product 115 as 
well. The results are shown in Tables vm and IX. In the lH-n.O.e. studies, a 4% 
TABLE VIII 
SELECIED PROTON ASSIGNMENTS AND OBSERVED 
COUPLING COUPLING CONSTANTS FOR 












enhancement was observed to occur between protons H7a and H1 and a 3% enhancement 
was observed for protons H1 and H31 thus implying that H7a, Ht. and H31 are all on the 
same face of the 5-ring. The structural assignment for 115 shown in Tables VITI and IX 
is the one which best supports the data obtained in these lH-NMR experiments. 
TABLE IX 
OBSERVED lH-N. 0. E. INTERACfiONS FOR 
SELECI'ED PROTON PAIRS IN SULFUR 
HETEROCYCLE 115. 
















The exo stereochemistry of the acetate residue of sulfur product 114 was assigned 
from a single crystal X-ray structure obtained on crystals of 114 grown in aqueous 
41 
ethanol. The CHEM3D diagram of 114 is illustrated in Figure 21. 
Figure 21. The CHEM3D Diagram for Sulfur Heterocycle 114. 
Mechanistic Description of the Sulfur Heterocyclic Ring Formation 
Process. Since the isothiuronium salts were isolated as intermediates in the sulfur 
heterocyclization process, the initial stages of the reaction are less ambiguous. There exist, 
however, two reaction pathways that the second hydrolysis step in the sequence could 
potentially follow to afford the obsexved cyclized products. The strong base required for 
the second stage of the method performs three functions: 1) neutralization of the 
isothiuronium halide salt, 2) hydrolysis of the ester functionality and 3) cleavage of the 
amidine group to afford the free thiolate that closes onto the Michael acceptor moiety. To 
determine the sequence of steps leading to the obsexved cyclic products, a control 
experiment was conducted where equimolar amounts of benzylisothiuronium bromide 
(117) and ethyl cinnamate (118) were exposed to 22% aqueous potassium hydroxide at 
42 
23·c using the same concentrations as described in the method devised (see Figure 22). 
Periodic monitoring of the reaction mixture by TLC indicated that ester 118 was 
saponified (to afford carboxylate 119) more readily under these conditions than 117 was 
hydrolyzed (to afford thiolate 120). This observation suggests that the Michael addition 
process most likely occurs onto the acrylic acid moiety after the base hydrolysis of the 
ester group. This appears to be one of a very few reported additions to monoactivated 
acrylic acids. 59 
22% aq. KOH 
117 119 
0 "'C02Me 
22% aq. KOH 
118 120 
Figure 22. Reaction of 117 and 118 with Potassium Hydroxide. 
In view of these observations, one can envision the mechanism shown in Figure 23 
to be operating in the formation of sulfur heterocycles. The acid-base reaction of 
isothiuronium halide salt 121 with hydroxide ion initially yields the neutral arnidine 
intermediate 122 which then undergoes base hydrolysis of the ester functionality to afford 
carboxylate 123. Subsequent base hydrolysis of the arnidine group generates dianion 124 
which then cyclizes by Michael addition of the thiolate to the acrylic acid moiety to yield the 
carboxylate dianion 125.60 Protonation of 125 by water then affords the carboxylate 















Figure 23. Mechanism of the Formation of Sulfur Heterocycles by a 




All solvents were distilled prior to use; other reagents were used as received from 
the vendors. All reactions were run under an atmosphere of dry nitrogen. Ozonolyses 
were performed using a Welbash T-23laboratory ozonizer. Reactions were monitored by 
one of the following methods: 1) TLC on hard layer silica gel GF plates (Analtech No. 
21521) with UV or phosphomolybdic acid detection or 2) capillary GC (Varian 3400) with 
FI detection on a 0.1 mm x 6 m SE-30 column programmed between 40-150°C. 
Preparative separations were performed using one of the following methods: 1) PTLC on 
20 em x 20 em silica gel GF plates (Analtech No. 02015) or 2) flash chromatography61 on 
silica gel (Grace, grade 62, 60-200 mesh) containing UV active phosphor (Sylvania no. 
2282); in each case, band elution was monitored by a hand-held UV lamp. Melting points 
were obtained on a Fisher-Johns melting point apparatus and are uncorrected. IR spectra 
were recorded with a PE-681 instrument and are referenced to polystyrene. lH-NMR and 
13C-NMR spectra were measured as solutions in deuterated solvents at 300 MHz or 400 
MHz and 75 MHz or 100 MHz, respectively, on a Varian XL-300 or a Varian XLA-400 
superconducting Ff instrument; chemical shifts are reported in B units relative to internal 
Me4Si. Mass spectra (MS) were obtained using a VG TS-250 instrument; high resolution 
mass spectra (HRMS) were obtained using a VG ZAB-2SE. Elemental analyses(± 0.4%) 
were performed by Galbraith Laboratories, Knoxville, TN. 
General Procedure for the Preparation of co-Bromo-n-alkanols from 
Cyclic Ethers Using Hydrobromic Acid (15 and 16). The procedure of Vedejs 
and co-workers36 was followed. To 4.15 mol of refluxing tetrahydrofuran (in the 
preparation of 15) or tetrahydropyran (in the preparation of 16) was added 152 mL of 
48% aqueous hydrobromic acid (226.5 g, 108.7 g HBr, 1.34 mol HBr) dropwise over the 
course of 3 h with vigorous stirring. Following the addition, the mixture was refluxed 
with continued stirring for 2 hand cooled to 25°C. The mixture was neutralized with solid 
NaHC03, partitioned with water, washed with water and saturated aqueous NaCl, dried 
over anhydrous MgS04 and concentrated in vacuo to afford the bromoalkanol as a clear 
light yellow oil that was purified by vacuum distillation. The physical and spectral 
properties of the products were the following: 
4-Bromo-1-butanol (15): 23.2 g (0.161 mol, 12%); bp 62-64·c (0.5 mm 
Hg); IR (thin film) 3540-3100 cm-1; 1H NMR (CDC13) 8 3.79 (s, 1 H), 3.69 (m, 2 H), 
3.46 (m, 2 H), 1.96 (m, 2 H), 1.72 (m, 2 H); 13C NMR (CDCl3) 8 61.8, 33.6, 30.9, 
29.1; HRMS, mle for C4H9079Br: calcd, 143.9211; found, 143.9208; mle for 
C4H9Q81Br: calcd, 145.9190; found, 145.9188. 
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5-Bromo-1-pentanol (16): 31.7 g (0 201 mol, 15%); bp 73-75·c (0.5 mm 
Hg); IR (thin film) 3540-3100 cm-1; 1H NMR (CDC13) 8 3.66 (m, 2 H), 3.43 (m, 2 H), 
1.98 (m, 3 H), 1.58 (m, 4 H); 13C NMR (CDC13) 8 62.5, 33.7, 32.4, 31.7, 24.4; HRMS, 
mle for C5H11079Br: calcd, 157.9367; found, 157.9364; mle for C5H11081Br: calcd, 
159.9347; found, 159.9342. 
General PCC Oxidation Procedure for the Preparation of co-Halo-n-
alkanals from co-Halo-n-alkanols (19, 20, 21, and 22). The general procedure 
of Corey and Suggs37 was followed. To a stirred and cooled (0-5.C) slurry of 105.0 g 
(487 mmol) ofpyridinium chlorochromate and 6.97 g (85 mmol) of sodium acetate in 325 
mL of methylene chloride was added a solution of 250 mmol of the haloalkanol in 325 mL 
of methylene chloride dropwise over the course of 2 h with stirring. After 2.5 h of 
continued stirring at 25•c, 700 mL of petroleum ether was added in one portion and the 
resulting mixture was stirred for 30 min. The mixture was suction filtered through a 
20 em x 12 em plug of Celite® in a large frit and the collected filtrate was concentrated 
in vacuo to yield the haloalkanal product as a clear light brown oil that was used without 
further purification. The physical and spectral properties of the products were the 
following: 
4-Chloro-1-butanal (21): 21.3 g (250.0 mmol, 80%); IR (thin film) 2720, 
1725 cm-1; 1H NMR (CDC13) 8 9.81 (bs, 1 H), 3.60 (t, 2 H, J = 6.3 Hz), 2.68 (t, 2 H, 
J = 6.9 Hz), 2.11 (tt, 2 H, J = 6.9, 6.3 Hz); 13C NMR (CDCI3) o 200.8, 43.9, 40.6, 
24.6; HRMS, mle for C4H7035Cl: calcd, 106.0185; found, 106.0184; mle for 
C4H7037CI: calcd, 108.0156; found, 108.0152. 
5-Chloro-1-pentanal (22): 22.9 g (190.0 mmol, 76%); IR (thin film) 2725, 
1720 cm-1; 1H NMR (CDC13) o 9.72 (bs, 1 H), 3.62 (m, 2 H), 2.52 (m, 2 H), 1.98 (m, 
2 H), 1.82 (m, 2 H); 13C NMR (CDC13) o 200.5, 43.9, 33.2, 31.7, 20.3; HRMS, mle 
for C5H9Q35CI: calcd, 120.0342; found, 120.0339; mle for C5H9Q37Cl: calcd, 
122.0312; found 122.0310. 
4-Bromo-1-butanal (19): 27.6 g (183.0 mmol, 73%); IR (thin fllm) 2730, 
1725 cm-1; 1H NMR (CDC13) o 9.82 (bs, 1 H), 3.47 (t, 2 H, J = 6.3 Hz), 2.69 (t, 2 H, 
J = 6.9 Hz), 2.19 (tt, 2 H, J = 6.9, 6.3 Hz); 13C NMR (CDC13) o 200.7, 42.0, 32.7, 
24.9; HRMS, mle for C4H7079Br: calcd, 149.9680; found, 149.9684; mle for 
C4H7081Br: calcd, 151.9660; found, 151.9661. 
5-Bromo-1-pentanal (20): 32.7 g (198.0 mmol, 79%); IR (thin fllm) 2720, 
1725 cm-1; lH NMR (CDC13) o 9.78 (bs, 1 H), 3.42 (m, 2 H), 2.50 (m, 2 H), 1.90 (m, 
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2 H), 1.80 (m, 2 H); 13C NMR (CDC13) o 201.7, 42.7, 32.9, 31.8, 20.5; HRMS, mle for 
C5H9079Br: calcd, 163.9837; found, 163.9834; m/e for C5H9081Br: calcd, 165.9816; 
found, 165.9815. 
General Wittig Olefination Procedure for the Preparation of Ethyl 
(E)-ro-Halo-2-alkenoates from ro-Halo-n-alkanals (23, 24, 25, and 26). A 
150-mL benzene solution of79.0 mmol of the haloalkanal and 27.5 g (79.0 mmol) of 
ethyl (triphenylphosphoranylidene)acetate was refluxed for 14 h with stirring. The mixture 
was cooled to 25oC and concentrated in vacuo to afford a light brown solid residue. The 
residue was subjected to flash vacuum chromatography62 through a 20 em x 12 em plug of 
silica gel in a large frit using 90:10 hexane/ether. Concentration of the collected eluent 
afforded the crude chloro enoate ester product as a clear light yellow oil that was purified 
by vacuum distillation. The physical and spectral properties of the products were the 
following: 
Ethyl (E)-6-Chloro-2-hexenoate (25): 9.90 g (56.1 mmol, 71 %); bp 68-
72oe (1.0 mm Hg); IR (thin fllm) 1735, 1660 cm-1; 1H NMR (eDel3) o 6.93 (dt, 1 H, 
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J = 15.9, 6.7 Hz), 5.88 (d, 1 H, J = 15.9 Hz), 4.19 (q, 2 H, J = 7.2 Hz), 3.56 (m, 2 H), 
2.38 (m, 2 H), 1.95 (m, 2 H), 1.29 (t, 3 H, J = 7.2 Hz); 13e NMR (eDel3) o 166.4, 
146.9, 122.5, 60.3, 44.0, 30.7, 29.2, 14.3; HRMS, mle for esHBQ235el: calcd, 
176.0604; found, 176.0607; mle for e 8H B0237el: calcd, 178.0574; found, 178.0572. 
Ethyl (E)-7-Chloro-2-heptenoate (26): 10.98 g (57.7 mmol, 73%); bp 74-
76oe (1.0 mm Hg); IR (thin film) 1725, 1650 cm-1; 1H NMR (eDel3) o 6.95 (dt, 1 H, 
J = 15.8, 6.4 Hz), 5.85 (d, 1 H, J = 15.8 Hz), 4.19 (q, 2 H, J = 7.2 Hz), 3.55 (m, 2 H), 
2.26 (m, 2 H), 1.81 (m, 2 H), 1.63 (m, 2 H), 1.27 (t, 3 H, J = 7.2 Hz); Be NMR 
(eDel3) o 166.1, 147.9, 121.6, 59.9, 44.3, 31.6, 31.0, 25.0, 14.0; HRMS, mle for 
~H15o23Sel: calcd, 190.0760; found, 190.0762; mle for ~H15o237el: calcd, 
192.0731; found, 192.0728. 
Ethyl (E)-6-Bromo-2-hexenoate (23): 12.39 g (56.1 mmol, 71 %); bp 75-
7Te (1.0 mm Hg); IR (thin film) 1725, 1660 cm-1; 1H NMR (eDel3) o 6.93 (dt, 1 H, 
J = 15.8, 6.7 Hz), 5.89 (d, 1 H, J = 15.8 Hz), 4.20 (q, 2 H, J = 6.9 Hz), 3.42 (m, 2 H), 
2.39 (m, 2 H), 2.04 (m, 2 H), 1.28 (t, 3 H, J = 6.9 Hz); Be NMR (eDel3) o 166.7, 
147.0, 122.1, 61.0, 32.5, 30.7, 30.4, 14.1; HRMS, mle for egH 13o279Br: calcd, 
220.0099; found, 220.0093; mle for esHB0281Br: calcd, 222.0078; found, 222.0072. 
Ethyl (E)-7-Bromo-2-heptenoate (24): 11.89 g (50.6 mmol, 64%); bp 85-
8Te (1.0 mm Hg); IR (thin film) 1730, 1655 cm-1; 1H NMR (eDel3) o 6.94 (dt, 1 H, 
J = 15.6, 6.8 Hz), 5.84 (d, 1 H, J = 15.6 Hz), 4.19 (q, 2 H, J = 7.2 Hz), 3.42 (m, 2 H), 
2.24 (m, 2 H), 1.89 (m, 2 H), 1.63 (m, 2 H), 1.29 (t, 3 H, J = 7.2 Hz); Be NMR 
(eDel3) o 166.4, 148.0, 121.8, 60.1, 33.2, 31.9, 31.1, 26.4, 14.2; HRMS, mle for 
~H15o279Br: calcd, 234.0255; found, 234.0255; mle for ~H15o281Br: calcd, 
236.0235; found, 236.0236. 
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General Finkelstein Halogen Exchange Procedure for the Formation 
of Alkyl Iodides (27 and 28). A 375-mL acetone solution of 57.0 mmol of the 
chloro enoate ester and 84.9 g (570 mmol) of sodium iodide was stirred at reflux for 18 h. 
The reaction mixture was cooled to 25•c and concentrated in vacuo to afford a solid 
yellow residue. The residue was dissolved in 200 mL of water and extracted twice with 
ether. The combined ether extracts were washed with water, 5% aqueous sodium 
thiosulfate and saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in 
vacuo to yield the iodo enoate ester as a clear light yellow oil that was used without further 
purification. The physical and spectral properties of the products were the following: 
Ethyl (E)-6-Iodo-2-hexenoate (27): 15.10 g (56.3 mmol, 99%); IR (thin 
film) 1730, 1650 cm-1; lH NMR (CDCl3) o 6.90 (dt, 1 H, J = 15.6, 7.2 Hz), 5.88 (d, 1 
H, J = 15.6 Hz), 4.19 (q, 2 H, J = 7.5 Hz), 3.19 (m, 2 H), 2.35 (m, 2 H), 1.98 (m, 
2 H), 1.29 (t, 3 H, J = 7.5 Hz); 13C NMR (CDCl3) o 166.3, 146.5, 122.6, 60.2, 32.7, 
31.4, 14.3, 5.5; HRMS, mle for C8H130 2I: calcd, 267.9960; found, 267.9961. 
Ethyl (E)-7-Iodo-2-heptenoate (28): 15.93 g (56.5 mmol, 99%); IR (thin 
film) 1720, 1650 cm-1; lH NMR (CDCI3) o 6.94 (dt, 1 H, J = 15.6, 7.5 Hz), 5.83 (d, 1 
H, J = 15.6 Hz), 4.18 (q, 2 H, J = 7.2 Hz), 3.19 (m, 2 H), 2.23 (m, 2 H), 1.86 (m, 
2 H), 1.59 (m, 2 H), 1.29 (t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) o 166.4, 148.0, 
121.8, 60.2, 32.7, 30.9, 28.8, 14.2, 6.1; HRMS, mle for ~H1502I: calcd, 282.0117; 
found, 282.0114. 
Methyl (E)-2-(Methyl)cinnamate (32). A 200-mL benzene solution of 12.0 
g (100 mmol) of 2-methylbenzaldehyde (31) and 33.4 g (100 mmol) of methyl (triphenyl-
phosphoranylidene)acetate was refluxed for 14 h with stirring. The mixture was cooled to 
25·c and concentrated in vacuo to afford a white solid residue. The residue was subjected 
to flash vacuum chromatography62 through a 20 em x 12 em plug of silica gel in a large 
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frit using 90:10 hexane/ether. Concentration of the collected eluent afforded a light yellow 
thin oil that was purified by vacuum distillation to afford 15.66 g (89.0 mmol, 89%) of 32 
as a clear colorless liquid, bp 99-1oo·c (0.5 mm Hg). The spectral data for 32 were: IR 
(thin film) 1725, 1640, 1600, 1575,760 cm-1; 1H NMR (CDCI3) a 7.97 (d, 1 H, J = 15.9 
Hz), 7.52 (d, 1 H), 7.23 (m, 3 H), 6.35 (d, 1 H, J = 15.9 Hz), 3.79 (s, 3 H), 2.41 (s, 3 
H); 13C NMR (CDC13) a 167 .3, 142.4, 137 .5, 133.2, 130.6, 129.9, 126.3, 126.2, 
118.7, 51.5, 19.6; HRMS, mle for C11H1202: calcd,176.0837; found, 176.0837. 
Methyl (E)-2-(Bromomethyl)cinnamate (33). The procedure of 
Greenwood and co-workers 38 was followed. A mixture of 8.80 g (50.0 mmol) of 32, 
8.90 g (50.0 mmol) of N-bromosuccinimide and 50 mg of benzoyl peroxide in 60 mL of 
carbon tetrachloride was irradiated to reflux with a spotlamp (Westinghouse 150w reflector 
spotlight) with stirring for 2.5 h. The mixture was then cooled to 25•c and 60 mL of 
pentane was added in one portion. The resulting succinimide by-product was removed by 
suction filtration and washed with two 50 mL portions of pentane. The collected washings 
were concentrated in vacuo to afford the crude bromide as a light-yellow solid which was 
purified by recystallization from methanol to yield 8.79 g (34.5 mmol, 69%) of 33 as a 
white solid, mp 86-87·c. The spectral data for 33 were: IR (CHCl3) 1715, 1630, 1600, 
1565 cm-1; 1H NMR (CDC13) a 8.07 (d, 1 H, J = 15.9 Hz), 7.59 (m, 1 H), 7.36 (m, 
3 H), 6.45 (d, 1 H, J = 15.9 Hz), 4.60 (s, 2 H), 3.84 (s, 3 H); 13C NMR (CDCl3) a 
167.0, 140.7, 136.6, 133.7, 130.7, 130.3, 129.3, 127.2, 120.6, 51.8, 30.5; HRMS, 
mle for C11H11o279Br: calcd, 253.9942; fo~nd, 253.9939; mle for C11H11o281Br: 
calcd, 255.9922; found, 255.9921. 
Isochroman (35). The procedure of Rieche and Schmitz39 was used. A stirred 
and cooled (0-5.C) mixture of 24.4 g (200 mmol) of 2-phenylethanol (34) and 7.5 g (250 
mmol) of dry paraformaldehyde was treated with a strong stream (90 bubbles/min) of HCl 
gas until the paraformaldehyde dissolved and two layers were observed to form (ca. 2 h). 
The resulting mixture was allowed to warm to 25•c and was then treated with a thin stream 
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(30 bubbles/min) of HCl gas for 6 h with continued stirring. The mixture was cooled to 0-
5"C and a solution of 10 g of NaOH in 50 mL of water was cautiously added. The mixture 
was then refluxed for 2 h with stirring. After cooling to 25·c, the resulting aqueous 
mixture was extracted twice with ether. The combined ether extracts were washed with 
saturated aqueous NaHC03 and saturated aqueous NaCl, dried over anhydrous Na2S04, 
and concentrated in vacuo to afford a yellow oil which was purified by vacuum distillation 
to yield 22.8 g (170 mmol, 85%) of 35 as a clear colorless liquid, bp 69-70"C (1.0 mm 
Hg). The spectral data for 35 were: IR (thin film) 3060, 3020, 1600, 1560, 1490 cm-1; 
lH NMR (CDCI3) o 7.12 (m, 3 H), 6.95 (m, 1 H), 4.75 (s, 2 H), 3.95 (t, 2 H, J = 
5.7 Hz), 2.83 (t, 2 H, J = 5.7 Hz); 13C NMR (CDCl3) o 135.0, 133.3, 129.0, 126.4, 
126.0, 124.5, 68.0, 65.5, 28.4; HRMS, mle for C9H 100: calcd, 134.0731; found, 
134.0729. 
2-(2-Bromoethyl)benzaldehyde (36). The procedure of Rieche and 
Schmitz39 was used. A stirred solution of 10.0 g (74.6 mmol) of 35 in 50 mL of carbon 
tetrachloride at 25•c was treated with 12.0 g (74.6 mmol, 3.86 mL) of bromine over the 
course of 1 h. Following the addition, the resulting mixture was refluxed with stirring for 
1 h. The mixture was concentrated in vacuo and the isolated residue was treated with 15 
mL of 48% aqueous hydrobromic acid. The resulting slurry was heated to reflux for 5 
min with vigorous stirring. The mixture was then cooled to 25•c and extracted twice with 
ether. The combined ether extracts were washed with saturated aqueous NaHC03, 5% 
aqueous sodium thiosulfate and saturated aqueous NaCl, dried over anhydrous Na2S04 
and concentrated in vacuo to afford a brown oil. Vacuum distillation using a Kugelrohr 
apparatus yielded 10.2 g (48.0 mmol, 64%) of36 as a clear colorless oil, bp 120-123•c 
(0.5 mm Hg). The spectral data for 36 were: IR (thin film) 2735, 1695 cm·l; lH NMR 
(CDCl3) o 10.14 (bs, 1 H), 7.82 (m, 1 H), 7.56 (m, 1 H), 7.48 (m, 1 H), 7.33 (m, 1 H), 
3.59 (m, 4 H); 13C NMR (CDC13) o 193.0, 140.5, 134.5, 133.8, 132.1, 130.2, 127.7, 
36.3, 32.9; HRMS, mle for ~H9Q79Br: calcd, 211.9837; found, 211.9834; mle for 
c 9H9Q81Br: calcd, 213.9816; found, 213.9814. 
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Ethyl (E)-2-(2-Bromoethyl)cinnamate (37). A 100-mL benzene solution 
of 8.25 g (38.8 mmol) of 36 and 13.5 g (38.8 mmol) of ethyl (triphenylphosphoranyl-
idene)acetate was refluxed for 16 h with stirring. The mixture was cooled to 25·c and 
concentrated in vacuo to afford a light tan solid residue. The solid was subjected to flash 
vacuum chromatography62 through a 20 em x 12 em plug of silica gel in a large frit using 
90:10 hexane/ether. Concentration of the collected eluent afforded a yellow oil which was 
purified by column chromatography on a 80 em x 2.5 em slurry packed silica gel column 
eluted with increasing the concentrations of ether in hexane. The first and largest band, 
eluted with 4% ether in hexane, afforded 7.46 g (26.4 mmol, 68%) of 37 as a clear 
colorless oil after concentration. The spectral data for 37 were: IR (thin film) 3050, 1710, 
1630 cm-1; 1H NMR (CDCl3) o 7.95 (d, 1 H, J = 15.6 Hz), 7.58 (m, 1 H), 7.29 (m, 3 
H), 6.39 (d, 1 H, J =: 15.6 Hz), 4.28 (q, 2 H, J = 7.2 Hz), 3.51 (t, 2 H, J = 7.5 Hz), 3.31 
(t, 2 H, J = 7.5 Hz), 1.35 (t, 3 H, J = 7.2 Hz); 13C NMR (CDCl3) o 166.7, 141.1, 138.2, 
133.3, 130.6, 130.2, 127.7, 127.0, 120.7, 60.7, 36.5, 32.1, 14.4; HRMS, mle for 
C13H15o279Br: calcd, 282.0255; found, 282.0249; mle for C13H15o281Br: calcd, 
284.0235; found, 284.0237. 
Ethyl (E)-2-(2-Iodoethyl)cinnamate (38). A 75-mL acetone solution of 
2.83 g (10.0 mmol) of 37 and 15.0 g (100 mmol) of sodium iodide was stirred at reflux 
for 14 h. The reaction mixture was cooled to 25·c and concentrated in vacuo to afford a 
solid yellow residue. The residue was dissolved in 7 5 mL of water and extracted twice 
with ether. The combined ether extracts were washed with water, 5% aqueous sodium 
thiosulfate and saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in 
vacuo to yield 3.02 g (9.20 mmol, 92%) of 38 as a clear light yellow oil that was used 
without further purification. The spectral data for 38 were: IR (thin film) 3050, 1710, 
1635, 1600 cm-1; 1H NMR (CDC13) o 7.91 (d, 1 H, J = 15.9 Hz), 7.56 (m, 1 H), 7.31 
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(m, 2 H), 7.21 (m, 1 H), 6.38 (d, 1 H, J = 15.9 Hz), 4.27 (q, 2 H, J = 7.2 Hz), 3.28 (m, 
4 H), 1.34 (t, 3 H, J = 7.2 Hz); 13C NMR (CDCl3) o 166.7, 141.1, 139.9, 133.0, 130.2 
(2), 127.6, 127 .0, 120.6, 60.7, 37.5, 14.4, 4.5; HRMS, mle for C13Hts02I: calcd, 
330.0117; found, 330.0116. 
(1R* ,2S*)-(±)-1,2-Cyclohexanedimethanol (42). The procedure of 
Photis and Paquette40 was used. To a stirred slurry of 1.48 g (39 mmol) of lithium 
aluminum hydride (LiAIH4) in 150 mL of dry tetrahydrofuran (THF) was added a solution 
of 5.00 g (32.5 mmol) of cis-1,2-cyclohexanedicarboxylic anhydride (41) in 30 mL of 
dry TIIF over the course of 15 min and the resulting mixture was maintained at reflux for 
3 h. The reaction mixture was cooled (0-5GC) and 20 mL of a freshly prepared solution of 
saturated aqueous Na2so4 was cautiously added dropwise with continued stirring and 
cooling. The insoluable aluminum salts were removed by suction filtration through a 20 
em x 12 em plug of Celite® and were washed with several portions of hot THF. The 
collected filtrate was dried over anhydrous Na2S04 and concentrated in vacuo to yield 4.40 
g (31 mmol, 94%) of 42 as a clear colorless thick oil which was used without further 
purification. The spectral data for 42 were: IR (thin film) 3600-3000, 1030 cm-1; lH 
NMR (CDC13) o 4.16 (bs, 2 H), 3.69 (m, 2 H), 3.53 (m, 2 H), 1.92 (m, 2 H), 1.62-1.30 
(complex, 8 H); 13C NMR (CDC13) o 63.9, 39.8, 27.1, 23.9; HRMS, m/e for CgH1602: 
calcd, 144.1150; found, 144.1149. 
(1S*,2R*)-(±)-Diethyl 1,2-Cyclohexanedicarboxylate (49). The 
general procedure of Price and Schwartz44 was followed. A 100-mL ethanol solution of 
15.4 g (100 mmol) of 41 and 5 mL of concentrated sulfuric acid was refluxed for 18 h 
with stirring. The mixture was cooled to 25GC and 50 mL of saturated aqueous NaHC03 
was cautiously added in small portions. The ethanol was then removed by rotary 
evaporation under vacuum and the resulting aqueous mixture was extracted twice with 
ether. The combined ether extracts were washed with water, saturated aqueous NaHC03 
and saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in vacuo to 
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yield a light yellow oil which was purified by vacuum distillation to afford 20.3 g (89.0 
mmol, 89%) of 49 as a clear colorless liquid, bp 95-96·c (0.5 mm Hg). The spectral data 
for 49 were: IR (thin film) 1735 cm-1; lH NMR (CDCl3) a 4.14 (q, 4 H, J = 7.2 Hz), 
2.81 (m, 2 H), 2.00 (m, 2 H), 1.78 (m, 2 H), 1.52 (m, 2 H), 1.41 (m, 2 H), 1.24 
(t, 6 H, J = 7.2 Hz); 13C NMR (CDCI3) a 173.6, 60.2, 42.5, 26.2, 23.7, 14.1; MS 
(EI!DP): mle (%) 228 (6), 184 (12), 183 (100), 182 (41), 155 (24), 154 (85), 109 (27), 
108 (30), 82 (10), 81 (62), 80 (19), 67 (10); HRMS, m/e for C12H2o04: calcd, 
228.1362; found, 228.1370. 
(lR* ,2R*)-(±)-Hexahydrophthalic Acid (50). The general procedure of 
Price and Schwartz44 was followed. A solution of 10.0 g (43.9 mmol) of 49 in 50 mL of 
10% ethanolic KOH was refluxed for 1 h with stirring. After this period of reflux, a 
20 em Vigreux distillation apparatus was affixed to the reaction flask and the ethanol was 
removed by distillation at atmospheric pressure while water (20 mL) was added to the 
resulting residue in small portions during the course of the process to control the distillation 
rate. Mter the ethanol had been removed, a solution of 5.0 g of KOH in 20 mL of water 
was added and the resulting mixture was refluxed for 12 h with stirring. The mixture was 
cooled to 25·c and acidified to a pH of ca. 2 by the dropwise addition of 6 M HCl at 
0-5·c. The resulting precipitate was removed by filtration and recrystallized twice from 
acetone to yield 6.87 g (39.9 mmol, 91 %) of 50 as a fine white solid, mp 218-219·c. 
The spectral data for 50 were: IR (CHC13) 3630-2780, 1715 cm-1; lH NMR (DMSO-<\)) 
a 12.20 (bs, 2 H), 2.35 (m, 2 H), 1.93 (m, 2 H), 1.69 (m, 2 H), 1.24 (m, 2 H); 
13C NMR (DMSO-<\)) a 176.2, 44.4, 28.6, 25.0; MS (CI, isobutane): mle (%) 173 
(M+ 1, 47), 155 (100), 128 (23), 109 (12), 99 (8), 81 (47), 67 (15); HRMS, m/e for 
CgH1204: calcd, 172.0736; found, 172.0734. 
(1S*,2S*)·(±)-1,2-Cyclohexanedimethanol (51). The procedure of 
Photis and Paquette40 was followed. To a stirred slurry of 1.66 g (43.9 mmol) of LiAIH4 
in 150 mL of dry THF was added a solution of 4.20 g (24.4 mmol) of 50 in 100 mL of 
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dry TI:IF over the course of 15 min. and the resulting mixture was maintained at reflux for 
3 h. The reaction mixture was then cooled (0-5.C) and 25 mL of a freshly prepared 
solution of saturated aqueous Na2S04 was cautiously added dropwise with continued 
stirring and cooling. The insoluble aluminum salts were removed by suction filtration 
through a 20 em x 12 em plug of Celite® and were washed with several portions of hot 
TI:IF. The collected flltrate was dried over anhydrous Na2S04 and concentrated in vacuo 
to yield 3.17 g (22.0 mmol, 90%) of 51 as a low melting white solid, mp 29-31 ·c, which 
was used without further purification. The spectral data for 51 were: IR (CHCl3) 3640-
3030, 1050 cm-1; 1H NMR (CDC13) S 4.32 (bs, 2 H), 3.58 (m, 2 H), 3.46 (m, 2 H), 1.70 
(m, 2 H), 1.58 (m, 2 H), 1.25 (m, 4 H), 1.00 (m, 2 H); 13C NMR (CDC13) S 67.7, 44.7, 
29.8, 26.1; MS (CI, isobutane): mle (%) 145 (M+ 1, 100), 127 (27), 109 (48), 95 (29), 
81 (17), 67 (14); HRMS, mle for C8H16o2: calcd, 144.1150; found, 144.1151. 
General Oxidation (Mn02) Procedure for the Preparation of Bicyclic 
Lactols from Diols 42 and 51 (43 and 52). The general procedure of Marner and 
· Jaenicke41 was followed. A slurry of 65 mmol of the diol (42 or 51) and 56.6 g (650 
mmol) of activated manganese dioxide (Mn02) in 200 mL of methylene chloride was 
stirred at 2s·c for 18 h. The resulting mixture was suction filtered through a 20 em x 12 
em plug of Celite® in a large frit and the collected solids were thoroughly washed with 
several 150 mL portions of methylene chloride. The collected filtrate was concentrated in 
vacuo to afford the lactol product as a clear thick colorless oil that was used directly. The 
physical and spectral properties of the products were the following: 
(1aS*,6aS*)-(±)-7-Hydroxy-8-oxabicyclo[4.3.0]nonane (43): 7.94 g 
(55.9 mmol, 86%); IR (thin film) 3560-3100,2660 (w), 1760 (m) cm-1; 1H NMR 
(CDCl3) S 5.16 (m, 1 H), 4.23 (bs, 1 H), 3.72 (m, 2 H), 2.53 (m, 1 H), 2.05 (m, 1 H), 
1.57-1.36 (complex, 8 H); 13C NMR (CDCl3) a 102.5, 70.5, 44.9, 35.1, 24.7, 24.2, 
23.3, 21.9; HRMS, mle for CgH140 2: calcd, 142.0994; found, 142.0989. 
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(laS* ,6aR*)·(±)-7-Hydroxy-8-oxabicyclo[4.3.0]nonane (52): 8.04 g 
(56.6 mmol, 87%); IR (thin film) 3550-3100, 1710 (m) cm-1; HRMS, mle for CgH1402: 
calcd, 142.0994; found, 142.0992. An examination of the lH NMR and 13C NMR spectra 
of 34 (both in CDC13) showed that all three of the expected open and closed isomeric 
forms of this lactol product were present 
General Wittig Olefination Procedure for the Preparation of 
Hydroxyesters 44 and 53 from Lactols 43 and 52. A 150-mL benzene solution 
of 57.0 mmol of the lactol (43 or 52) and 19.8 g (56.8 mmol) of ethyl (triphenylphos-
phoranylidene)acetate was refluxed for 16 h with stirring. The mixture was cooled to 
25oC and concentrated in vacuo to afford a thick yellow oil. The oil was subjected to flash 
vacuum chromatography62 through a 20 em x 12 em plug of silica gel in a large frit using 
75:25 hexane/ether. Concentration of the collected eluent afforded either a thick colorless 
or yellow oil which was purified by column chromatography on an 80 em x 2.5 em slurry 
packed silica gel column eluted with increasing the concentrations of ether in hexane. The 
physical and spectral properties .of the products were the following: 
(1S*,2S*)·(±)-l·((E)-2-Ethoxycarbonylethenyl)-2-(hydroxy-
methyl)cyclohexane (44): The third and largest band, eluted with 20% ether in 
hexane, afforded 5.81 g (27.4 mmol, 48%) of 44 as a clear colorless thick oil after 
concentration. The spectral data for 44 were: IR (thin film) 3600-3140, 1720, 1650 cm-1; 
lH NMR (CDCl3) o 7.15 (dd, 1 H, J = 15.6, 6.9 Hz), 5.87 (d, 1 H, J = 15.6 Hz), 4.19 
(q, 2 H, J = 7.2 Hz), 3.44 (d, 2 H), 2.68 (m, 1 H), 2.00 (bs, 1 H), 1.84 (m, 1 H), 1.75-
1.43 (complex, 7 H), 1.37 (m, 1 H), 1.29 (t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) o 
166.7, 149.7, 121.7, 64.7, 60.2, 42.5, 39.2, 30.2, 25.0, 24.6, 22.2, 14.2; MS (CI, 
isobutane): mle (%) 213 (M+1, 24), 182 (9), 167 (100), 149 (11), 121 (10), 81 (10); 
HRMS, m/e for C12H2o03: calcd, 212.1412; found, 212.1418. 
(lR * ,2S * )-(±)-1-( (E )-2-Ethoxycarbonylethenyl)-2- (by droxy-
methyl)cyclohexane (53): The third and largest band, eluted with 22% ether in 
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hexane, afforded 5.68 g (26.8 mmol, 47%) of 53 as a clear colorless thick oil after 
concentration. The spectral data for 53 were: IR (thin film) 3580-3140, 1715, 1650 cm-1; 
lH NMR (CDCl3) S 6.81 (dd, 1 H, J = 15.6, 7.2 Hz), 5.79 (d, 1 H, J = 15.6 Hz), 4.15 
(q, 2 H, J = 6.9 Hz), 3.54 (m, 1 H), 3.37 (m, 1 H), 2.02 (m, 1 H), 1.76 (m, 6 H), 1.30 
(m, 4 H), 1.26 (t, 3 H, J = 6.9 Hz); 13C NMR (CDCl3) o 166.8, 153.0, 120.8, 66.1, 
60.3, 43.9, 43.2, 32.4, 28.8, 25.6, 25.4, 14.3; MS (CI, isobutane): mle (%) 213 (M+1, 
26), 182 (23), 167 (100), 149 (8), 135 (8), 121 (12), 81 (9), 67 (7), 57 (71); HRMS, 
mle for C12H2o03: calcd, 212.1412; found, 212.1415. 
General Procedure for the Preparation of Methanesulfonate Esters 
45, 54, and 79 from Alcohols 44, 53, and 78. The general procedure of 
Crossland and Servis42 was followed. To a stirred and cooled (0-5°C) 30-mL methylene 
chloride solution of 8.7 mmol of the alcohol and 1.32 g (13 mmol) of triethylamine was 
added 1.20 g (10.4 mmol) of methanesulfonyl chloride dropwise over the course of 10 
min. The resulting mixture was stirred for 30 min with continued cooling. The mixture 
was poured into a 125 mL separatory funnel and extracted with ice water, 1.0 M HCl, 
saturated aqueous NaHC03 and saturated aqueous NaCl, dried over anhydrous Na2S04 
and concentrated in vacuo to afford the methanesulfonate ester as a light yellow to dark 
orange oil that was used directly. The physical and spectral properties of the products 
were the following: 
(1S*,2S*)-(±)-1-((E)-2-Ethoxycarbonylethenyl)-2-(methanesulfonyl-
oxymethyl)cyclohexane (45): 2.22 g (7.66 mmol, 88%); IR (thin film) 1720, 1655, 
1360, 1180 cm-1; 1H NMR (CDC13) o 7.11 (dd, 1 H, J = 15.6, 7.2 Hz), 5.89 (d, 1 H, 
J = 15.6 Hz), 4.20 (q, 2 H, J = 7.2 Hz), 4.00 (m, 2 H), 2.99 (s, 3 H), 2.71 (m, 1 H), 
2.10 (m, 1 H), 1.80-1.48 (complex, 6 H), 1.40 (m, 2 H), 1.30 (t, 3 H, J = 7.2 Hz); 13c 
NMR (CDCl3) o 166.2, 147.7, 122.8, 71.4, 60.3, 39.4, 38.8, 37.1, 29.9, 24.6, 24.2, 
21.7, 14.1; MS (CI, isobutane): mle (%) 293 (M+3, 3), 291 (M+1, 39), 245 (100), 195 
(41), 165 (19), 149 (17), 148 (18), 121 (71), 120 (42), 93 (22), 91 (16), 81 (23), 79 (35). 
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(lR* ,2S*)-(±)-1-((E)-2-Ethoxycarbonylethenyl)-2-(methanesulfonyl-
oxymethyl)cyclohexane (54): 2.30 g (7.92 mmol, 91%); IR (thin film) 1710, 1645, 
1365, 1175 cm-1; 1H NMR (CDCl3) o 6.75 (dd, 1 H, J = 15.6, 6.9 Hz), 5.82 (d, 1 H, 
J = 15.6 Hz), 4.16 (q, 2 H, J = 7.2 Hz), 4.09 (m, 1 H), 3.97 (m, 1 H), 2.95 (s, 3 H), 
2.04 (m, 1 H), 1.95 (m, 1 H), 1.70 (m, 4 H), 1.26 {t, 3 H, J = 7.2 Hz), 1.21 (m, 4 H); 
13C NMR (CDCl3) o 166.4, 151.0, 121.8, 72.7, 60.4, 42.9, 40.9, 37.1, 32.3, 28.5, 
25.2, 25.1, 14.2; MS (CI, isobutane): mle (%) 293 (M+3, 6), 291 (M+1, 100), 247 (4), 
245 (77), 194 (26), 165 (21), 148 (31), 121 (92), 107 (12), 93 (16), 79 (21), 67 (12). 
1-(2-Methanesulfonyloxyethyl)-1-vinylcyclohexane (79): 1.98 g (8.53 
mmol, 98%); IR (thin film) 3060, 1630, 1350, 1170 cm-1; 1H NMR (CDC13) o 5.60 (m, 
1 H), 5.08 (m, 1 H), 4.95 (m, 1 H), 4.18 (t, 2 H, J = 7.5 Hz), 2.95 (s, 3 H), 1.76 (t, 
2 H, J = 7.5 Hz), 1.56 (m, 2 H), 1.45 (m, 4 H), 1.35 (m, 4 H); 13C NMR (CDCl3) o 
144.7, 114.1, 67.4, 39.2, 38.8, 37.4, 35.7, 26.2, 21.9; HRMS, mle for C11H200 3S: 
calcd, 232.1133; found, 232.1128. 
General Procedure for the Preparation of Alkyl Bromides 46, 55, 
and 80 from Methanesulfonate Esters 45, 54, and 79. A modification of the 
procedure reported by Tufariello and coworkers43 was followed. To a stirred mixture of 
3.33 g (38.3 mmol) of anhydrous lithium bromide (LiBr) and 6.86 g (38.3 mmol, 
6.7 mL) ofhexamethylphosphoramide (HMPA) in 75 mL of dry ether was added 
dropwise a solution of 7.8 mmol of the methanesulfonate ester in 20 mL of dry ether and 
the resulting mixture was refluxed with stirring for 12 h. The mixture was cooled to 25°C 
and washed with 1.0 M HCl, water, saturated aqueous NaHC03 and saturated aqueous 
NaCl, dried over anhydrous MgS04 and concentrated in vacuo to afford the crude 
bromide product as a light yellow oil which was purified by either vacuum distillation 
using a Kugelrohr apparatus or by column chromatography on a 80 em x 2.5 em slurry 
packed silica gel column eluted with increasing the concentrations of ether in hexane. The 
physical and spectral properties of the products were the following: 
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(1S * ,2S *)- (±)-1-( (E )-2-Ethoxycar bony lethenyl )-2- (b romomethyl )-
cyclohexane (46): The first and largest band, eluted with 3% ether in hexane, afforded 
1.93 g (7 .02 mmol, 90%) of 46 as a clear colorless thin oil after concentration. The 
spectral data for 46 were: IR (thin film) 1730, 1660 cm-1; 1H NMR (CDC13) o 7.06 (dd, 
1 H, J = 15.6, 6.9 Hz), 5.95 (d, 1 H, J = 15.6 Hz), 4.20 (q, 2 H, J = 7.2 Hz), 3.25 (m, 
1 H), 3.15 (m, 1 H), 2.81 (m, 1 H), 1.97 (m, 1 H), 1.80-1.45 (complex, 6 H), 1.38 (m, 
2 H), 1.30 (t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) o 166.4, 147.5, 123.0, 60.3, 42.6, 
40.2, 36.7, 30.3, 27.2, 24.9, 21.6, 14.2; MS (CI, isobutane): mle (%) 277 (M+3, 96), 
275 (M+1, 100), 195 (21), 149 (13), 121 (20); HRMS, mle for C12H190279Br: calcd, 
274.0568; found, 274.0562; m/e for C12H190281Br: calcd, 276.0548; found, 276.0548. 
(1R* ,2S*)-(±)-1-((E)-2-Ethoxycarbonylethenyl)-2-(bromomethyl)-
cyclohexane (55): The first and largest band, eluted with 4% ether in hexane, afforded 
1.86 g (67 .9 mmol, 87%) of 55 as a clear colorless thin oil after concentration. The 
spectral data for 55 were: IR (thin film) 1715, 1645 cm-1; 1H NMR (CDC13) o 6.72 (dd, 
1 H, J = 15.6, 6.6 Hz), 5.89 (d, 1 H, J = 15.6 Hz), 4.18 (q, 2 H, J = 6.9 Hz), 3.42 (m, 
1 H), 3.28 (m, 1 H), 2.13 (m, 2 H), 1.65 (m, 4 H), 1.48 (m, 1 H), 1.29 (t, 3 H, J = 
6.9 Hz), 1.23 (m, 4 H); 13C NMR (CDC13) o 166.6, 151.2, 121.9, 60.3, 44.3, 42.3, 
39.8, 32.1, 30.2, 25.5, 25.2, 14.3; MS (CI, isobutane): mle (%) 277 (M+3, 97), 275 
(M+ 1, 100), 231 (15), 229 (17), 195 (39), 181 (26), 149 (35), 121 (37), 107 (16), 95 
(25); HRMS, mle for C12H19o279Br: calcd, 274.0568; found, 274.0568; mle for 
C12H190281Br: calcd, 276.0548; found, 276.0548. 
1-(2-Bromoethyl)-1-vinylcyclohexane (80): Vacuum distillation of the 
crude product oil yielded 1.27 g (58.5 mmol, 75%) of 80 as a clear colorless thin oil, bp 
60-63·c (1.0 mm Hg). The spectral data for 80 were: IR (thin film) 3060, 1635 cm-1; 
lH NMR (CDC13) o 5.59 (m, 1 H), 5.15 (m, 1 H), 4.97 (m, 1 H), 3.30 (m, 2 H), 1.91 
(m, 2 H), 1.54 (m, 2 H), 1.46 (m, 5 H), 1.36 (m, 3 H); 13C NMR (CDC13) o 144.8, 
113.9, 44.4, 41.0, 35.4, 29.2, 26.3, 22.0; HRMS, mle for C10H1779Br: calcd, 
216.0513; found, 216.0512; mle for C10H1781Br: calcd, 218.0493; found, 218.0486. 
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General Procedure for the Preparation of the Ethyl Esters 60 and 61 
of Acids 58 and 59. The general procedure of Munche-Peterson45 was followed. In 
a 500-mL round-bottomed flask equipped with a Dean-Stark trap and reflux condenser, a 
solution of 200 mmol of the carboxylic acid, 44 mL of absolute ethanol, and 1 mL of 
concentrated sulfuric acid in 100 mL of dry benzene were refluxed with stirring until the 
evolution of water had ceased (ca. 18 h). The mixture was cooled to 25oC and poured into 
50 mL of saturated aqueous NaHC03. The resulting organic layer was separated and 
washed with 50 mL of water, 50 mL of saturated aqueous NaHC03, 50 mL of water and 
saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in vacuo to afford 
the crude ester product as a clear light yellow oil which was purified by distillation at 
aspirator pressure. The physical and spectral properties of the products were the 
following: 
Ethyl Cyclopentanecarboxylate (60): 22.4 g (158 mmol, 79%); bp 68-
70oC (20 mm Hg); IR (thin film) 1730 cm-1; 1H NMR (CDCl3) S 4.12 (q, 2 H, J = 
7.2 Hz), 2.71 (m, 1 H), 1.95-1.55 (complex, 8 H), 1.25 (t, 3 H, J = 7.2 Hz); Be NMR 
(CDC13) S 176.8, 60.1, 43.8, 30.0, 25.8, 14.2; HRMS, mle for C8H140 2: calcd, 
142.0994; found, 142.0993. 
Ethyl Cyclohexanecarboxylate (61): 25.0 g (160 mmol, 80%); bp 76-78°C 
(20 mm Hg); IR (thin film) 1730 cm-1; 1H NMR (CDC13) S 4.12 (q, 2 H, J = 6.9 Hz), 
2.28 (m, 1 H), 1.90 (m, 2 H), 1.75 (m, 2 H), 1.66 (m, 1 H), 1.44 (m, 2 H), 1.28 (m, 
3 H), 1.25 (t, 3 H, J = 6.9 Hz); 13C NMR (CDCl3) S 176.1, 59.9, 43.2, 29.0, 25.7, 
25.4, 14.2; HRMS, mle for ~H16o2: calcd, 156.1150; found, 156.1153. 
General Procedure for the Alkylation of Esters 60 and 61 (62 and 
63). The general procedure of Williams and Sirvio46 was followed. To a stirred 25-mL 
THF solution of 15.6 mL of 1.6 M n-butyllithium (25 mmol) in hexanes at 0-5°C was 
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added 3.24 g (32 mmol, 4.49 mL) of dry diisopropylamine dropwise over the course of 5 
min. The resulting solution was stirred at O-s·c for 15 min. The solution was then cooled 
to -78·c and 22.0 mmol of the ester was added dropwise with continued stirring. 
Following 30 min of stirring at -78·c, a solution of 2.91 g (24 mmol) of allyl bromide in 
4 mL of HMPA was added drop wise. After 10 min of stirring at -78. C, the resulting 
mixture was warmed to 25·c and stirred for 9 h. The mixture was then cautiously treated 
with 5 mL of saturated aqueous NH4Cl and the TIIF was removed by rotary evaporation 
to yield a dark yellow residue. The isolated residue was treated with 50 mL of water and 
the resulting aqueous mixture was extracted twice with ether. The combined ether extracts 
were washed with water, 0.5 M aqueous HCl, water, saturated aqueous NaHC03 and 
saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in vacuo to yield 
a clear light yellow oil which was purified by distillation at aspirator pressure. The 
physical and spectral properties of the products were the following: 
Ethyl 1-(2-Propenyl)cyclopentanecarboxylate (62): 3.12 g (17.1 mmol, 
78%); bp 98-1oo·c (20 mmHg); IR (thin film) 1740, 1650 cm-1; lH NMR (CDC13) a 
5.71 (m, 1 H), 5.02 (m, 2 H), 4.12 (q, 2 H, J = 7.2 Hz), 2.36 (d, 2 H),2.08 (m, 2 H), 
1.70-1.46 (complex, 6 H), 1.24 (t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) a 177.3, 134.9, 
117.2, 60.3, 53.5, 42.9, 35.5, 25.0, 14.2; HRMS, mle for C11H 180 2: calcd, 182.1307; 
found, 182.1305. 
Ethyl 1-(2-Propenyl)cyclohexanecarboxylate (63): 3.67 g (18.7 mmol, 
85%); bp 108-110·c (20 mm Hg); IR (thin film) 1735, 1650 cm-1; lH NMR (CDCI3) a 
5.69 (m, 1 H), 5.00 (m, 2 H), 4.14 (q, 2 H, J = 6.9 Hz), 2.23 (d, 2 H), 2.05 (m, 2 H), 
1.55 (m, 3 H), 1.43-1.17 (complex, 5 H), 1.25 (t, 3 H, J = 6.9 Hz); 13C NMR (CDC13) 
a 176.2, 133.7, 117.4, 60.0, 47.0, 44.6, 33.7, 25.8, 23.1, 14.3; HRMS, mle for 
C12H2o02: calcd, 196.1463; found, 196.1461. 
General Procedure for the Reduction of Esters 62 and 63 (64 and 
65). To a stirred slurry of 2.5 g (66 mmol) of LiAIH4 in 150 mL of dry TIIF was added 
61 
a solution of 66 mmol of the ester in 50 rnL of dry THF drop wise over the course of 
5 min. The resulting mixture was refluxed with stirring for 2 h. The mixture was then 
cooled (0-5°C) and quenched cautiously with 3 rnL of water, 10 rnL of 5% aqueous NaOH 
and 5 rnL of water. The insoluble aluminum salts were removed by suction filtration 
through a 20 em x 12 em plug of Celite® in a large frit and washed with several portions 
of hot THF. The collected filtrate was dried over anhydrous Na2S04 and concentrated in 
vacuo to yield the crude alcohol product as a clear light yellow oil which was purified by 
vacuum distillation. The physical and spectral properties of the products were the 
following: 
1-(Hydroxymethyl)-1-(2-propenyl)cyclopentane (64): 7.40 g (52.9 
mmol, 80%); bp 68-69°C (1.0 mm Hg); IR (thin film) 3600-3140, 1645 cm-1; lH NMR 
(CDCI3) ~ 5.86 (m, 1 H), 5.07 (m, 2 H), 3.40 (s, 2 H), 2.16 (d, 2 H), 1.60 (m, 5 H), 
1.43 (m, 4 H); 13C NMR (CDC13) ~ 136.2, 116.9, 69.0, 47.2, 41.9, 34.1, 25.2; HRMS, 
mle for C9H160: calcd, 140.1201; found, 140.1204. 
1-(Hydroxymethyl)-1-(2-propenyl)cyclohexane (65): 7.58 g (49.2 
mmol, 73%); bp 76-78oC (1.0 mm Hg); IR (thin film) 3560-3120, 1635 cm-1; lH NMR 
(CDCl3) ~ 5.86 (m, 1 H), 5.07 (m, 2 H), 3.41 (s, 2 H), 2.12 (d, 2 H), 1.66 (bs, 1 H), 
1.44 (m, 6 H), 1.33 (m, 4 H); 13C NMR (CDCl3) ~ 135.3, 116.9, 68.6, 39.8, 37.7, 
32.2, 26.3, 21.4; HRMS, mle for C10H18o: calcd, 154.1358; found, 154.1355. 
General Procedure for the Conversion of Alcohols 64 and 65 to the 
Corresponding Chlorides (66 and 67). The general procedure of Lee and Nolen47 
was followed. An 80-rnL carbon tetrachloride solution of 43 mmol of the alcohol and 
12.4 g (47 mmol) of triphenylphosphine was refluxed with stirring for 12 h. The reaction 
mixture was cooled to 25°C and the carbon tetrachloride was removed by rotary 
evaporation under vacuum. The resulting white solid was subjected to flash vacuum 
chromatography through a 20 em x 12 em plug of silica gel in a large frit using 95:5 
hexane/ether. The collected eluent was concentrated to afford the crude chloride product 
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as a light yellow oil which was purified by distillation at aspirator pressure. The physical 
and spectral properties of the products were the following: 
1-(Chloromethyl)-1-(2-propenyl)cyclopentane (66): 4.91 g (31.0 mmol, 
72%); bp 75-78"C (20 mm Hg); IR (thin film) 1650 cm-1; 1H NMR (CDC13) ~ 5.73 (m, 
1 H), 5.09 (m, 2 H), 3.42 (s, 2 H), 2.23 (d, 2 H), 1.68 (m, 4 H), 1.51 (m, 4 H); 
13C NMR (CDC13) ~ 134.7, 117.9, 52.8, 42.0, 41.4, 35.4, 25.0; HRMS, mle for 
~H1535Cl: calcd, 158.0862; found, 158.0859; mle for ~H1537Cl: calcd, 160.0833; 
found, 160.0834. 
1-(Chloromethyl)-1-(2-propenyl)cyclohexane (67): 5.64 g (32.7 mmol, 
76%); bp 82-84"C (20 mm Hg); IR (thin film) 1645 cm-1; 1H NMR (CDC13) 5 5.76 (m, 
1 H), 5.10 (m, 2 H), 3.52 (s, 2 H), 2.13 (d, 2 H), 1.47 (m, 6 H), 1.32 (m, 4 H); 
13C NMR (CDCl3) ~ 134.7, 117.0, 43.9, 39.6, 37.3, 32.3, 26.5, 21.0; HRMS, m/e for 
Cu)fl1735Cl: calcd, 172.1019; found, 172.1018; mle for Cu)fi1737Cl: calcd, 174.0989; 
found, 174.0987. 
General Procedure for the Ozonolysis of Olefins 66, 67, and 80 to 
the Corresponding Aldehydes (68, 69, and 81). A 50-rnL methanol solution of 
24 mmol of the olefin at -78"C was treated with ozone for 30 min. The solution was then 
treated with 4 mL of dimethyl sulfide and 1 mL of glacial acetic acid with continued 
cooling. The mixture was concentrated in vacuo and the isolated residue was dissolved in 
100 mL of ether. The resulting ether solution was washed with 0.5 M aqueous HCl, 
saturated aqueous NaHC03 and saturated aqueous NaCl, dried over anhydrous MgS04 
and concentrated in vacuo to yield the crude aldehyde product as a clear liquid which was 
used directly. The physical and spectral properties of the products were the following: 
1-(Chloromethyl)-1-(formylmethyl)cyclopentane (68): 3.82 g (23.8 
rnmol, 99%); IR (thin film) 2740, 1730 cm-1; lH NMR (CDC13) ~ 9.78 (bs, 1 H), 3.56 
(s, 2 H), 2.42 (s, 2 H), 1.70 (m, 4 H), 1.52 (m, 4 H); 13C NMR (CDC13) o 201.7, 47.9, 
43.2, 42.6, 32.8, 26.5; HRMS, mle for CgH13035Cl: calcd, 160.0655; found, 
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160.0658; mle for C8H13037Cl: calcd, 162.0625; found, 162.0627. 
1-(Chloromethyl)-1-(formylmethyl)cyclohexane (69): 4.17 g (23.9 
mmol, 99%); IR (thin film) 2740, 1735 cm-1; 1H NMR (CDC13) o 9.75 (bs, 1 H), 3.59 
(s, 2 H), 2.41 (s, 2 H), 1.46 (m, 6 H), 1.35 (m, 4 H); Be NMR (CDC13) o 202.0, 46.3, 
39.7, 38.1, 31.8, 27.3, 21.1; HRMS, mle for C9H15o35Cl: calcd, 174.0811; found, 
174.0815; mle for ~H 15037Cl: calcd, 176.0782; found, 176.0786. 
1-(2-Bromoethyl)cyclohexanecarboxaldehyde (81): 4.31 g (19.7 mmol, 
82%); IR (thin film) 2725, 1715 cm-1; 1H NMR (CDCl3) o 9.87 (bs, 1 H), 3.46 (t, 2 H, 
J = 6.9 Hz), 2.27 (t, 2 H, J = 6.9 Hz), 1.43 (m, 6 H), 1.32 (m, 4 H); Be NMR (CDCl3) 
o 201.9, 44.8, 38.5, 34.7, 31.0, 27.5, 21.2; HRMS, mle for C9H 15o79Br: calcd, 
218.0306; found, 218.0312; mle for ~H15o81Br: calcd, 220.0286; found, 220.0283. 
General Wittig Olefination Procedure for the Conversion of 
Aldehydes 68, 69, and 81 to the Corresponding Ethyl Enoate Esters 
(70, 71, and 82). A 100-rnL benzene solution of 36.7 mmol of the aldehyde and 12.8 
g (36.7 mmol) of ethyl {triphenylphosphoranylidene)acetate was refluxed for 16 h with 
stirring. The mixture was cooled to 25oC and concentrated in vacuo to afford a light 
yellow solid residue. The residue was subjected to flash vacuum chromatography62 
through a 20 em x 12 em plug of silica gel in a large frit using 90: 10 hexane/ether. 
Concentration of the collected eluent afforded the crude enoate ester products as clear light 
yellow oils which were purified by column chromatography on a 80 em x 2.5 em slurry 
packed silica gel column eluted with increasing the concentrations of ether in hexane. 
The physical and spectral properties of the products were the following: 
1-(Chloromethyi)-1-((E)-3-ethoxycarbonyl-2-propenyl)cyclopentane 
(70): The first and largest band, eluted with 4% ether in hexane, afforded 6.08 g (26.4 
mmol, 72%) of 70 as a clear colorless thin oil after concentration. The spectral data for 
70 were: IR (thin film) 1730, 1660 cm-1; lH NMR (CDC13) o 6.91 (dt, 1 H, J = 15.6, 
7.8 Hz), 5.92 (d, 1 H, J = 15.6 Hz), 4.19 (q, 2 H, J = 6.9 Hz), 3.41 (s, 2 H), 2.37 (d, 
2 H, J = 7.8 Hz), 1.72-1.50 (complex, 8 H), 1.30 (t, 3 H, J = 6.9 Hz); 13C NMR 
(CDC13) li 166.3, 145.1, 124.3, 60.2, 52.4, 47.5, 39.7, 35.6, 24.9, 14.2; MS (CI, 
isobutane): mle (%) 232 (M+2, 15), 230 (44), 185 (11), 121 (17), 114 (100), 97 (15), 
95 (15), 86 (37), 81 (66), 67 (22). 
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1-( Chloromethyl )-1- ( (E)-3-ethoxycarbonyl-2-propenyl)cyclohexane 
(71): The first and largest band, eluted with 4% ether in hexane, yielded 6.65 g (27 .2 
mmol, 74%) of71 as a clear colorless oil after concentration. The spectral data for 71 
were: IR (thin film) 1725, 1650 cm-1; lH NMR (CDCl3) o 6.91 (dt, 1 H, J = 15.3, 8.1 
Hz), 5.91 (d, 1 H, J = 15.3 Hz), 4.19 (q, 2 H, J = 7.2 Hz), 3.43 (s, 2 H), 2.31 (d, 2 H, 
J = 8.1 Hz), 1.57-1.37 (complex, 10 H), 1.29 (t, 3 H, J = 7.2 Hz); 13 C NMR (CDCl3) 
li 166.2, 144.2, 124.4, 60.1, 51.9, 38.2, 37.8, 33.4, 25.8, 21.3, 14.2; MS (CI, 
isobutane): mle (%) 246 (M+2, 13), 244 (39), 114 (100), 95 (47), 86 (26). 
1-(2-Bromoethyi)-1-((E)-ethoxycarbonylethenyl)cyclohexane (82): 
The first and largest band, eluted with 4% ether in hexane, afforded 7.54 g (26.1 mmol, 
71%) of 82 as a clear colorless oil after concentration. The spectral data for 82 were: 
IR (thin film) 1715, 1640 cm-1; lH NMR (CDC13) o 6.77 (d, 1 H, J = 16.2 Hz), 5.76 (d, 
1 H, J = 16.2 Hz), 4.19 (q, 2 H, J = 7.2 Hz), 3.23 (m, 2 H), 1.98 (m, 2 H), 1.59 (m, 
2 H), 1.41 (m, 8 H), 1.29 (t, 3 H, J = 7.2 Hz); l3C NMR (CDC13) li 166.6, 154.8, 
120.8, 60.4, 43.9, 41.3, 35.2, 28.1, 26.0, 22.0, 14.3; MS (EI/DP): m/e (%) 290 (M+2, 
2), 288 (2), 245 (11), 243 (12), 209 (12), 182 (15), 181 (100), 163 (10), 135 (40), 121 
(10), 107 (37), 93 (15), 79 (27), 67 (30), 55 (15); HRMS, mle for C13H210 279Br: calcd, 
288.0725; found, 288.0728; mle for C 13H210z81Br: calcd, 290.0704; found, 290.0698. 
Methyl Cyclohexylideneacetate (75). The gener~ procedure of Wadsworth 
and Emmons49 was used. To a stirred and cooled (0-5°C) slurry of 2.4 g (100 mmol) 
of sodium hydride in 50 mL of dry benzene was added 18.2 g (100 mmol) of trimethyl 
phosphonoacetate in a dropwise manner over the course of 45 min and the resulting 
mixture was stirred at 25•c for 1 h. The mixture was cooled (0-5.C) and 9.8 g (100 
mmol) of cyclohexanone (74) was slowly added over 30 min with vigorous stirring. 
The resulting mixture was then refluxed for 12 h and cooled to 25·c. The mixture was 
concentrated in vacuo to yield a thick oily residue and 100 mL of water was added. 
The resulting aqueous mixture was extracted twice with ether. The combined ether 
extracts were washed with water and saturated aqueous NaCl, dried over anhydrous 
MgS04 and concentrated in vacuo to yield a clear light yellow oil which was purified by 
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vacuum distillation to afford 13.71 g (89 mmol, 89%) of 75 as a clear colorless thin oil, 
bp 53-56·c (0.5 mm Hg). The spectral data for 75 were: IR (thin film) 1725, 1655 cm-1; 
lH NMR (CDC13) S 5.58 (s, 1 H), 3.65 (s, 3 H), 2.81 (m, 2 H), 2.17 (m, 2 H), 1.60 (m, 
6 H); 13C NMR (CDC13) S 167.2, 163.9, 112.6, 50.8, 38.0, 29.8, 28.6, 27.8, 26.2; 
HRMS, mle for ~H1402: calcd, 154.0994; found, 154.0996. 
Cyclohexylidenemethanol (76). The general procedure of Angus and 
Johnson50 was followed. To a stirred and cooled (0-5.C) slurry of 3.79 g (100 mmol) of 
LiAlH4 in 250 mL of dry ether was added a solution of 15.4 g (100 mmol) of 75 in 100 
mL of dry ether dropwise over the course of 30 min. The resulting mixture was stirred 
with continued cooling for 2 h. The mixture was then quenched cautiously with 4 mL of 
water, 12 mL of 5% aqueous NaOH and 4 mL of water with vigorous stirring and 
continued cooling. The insoluble aluminum salts were removed by suction filtration 
through a 20 em x 12 em plug of Celite® in a large frit and washed with several portions 
of hot THF. The collected filtrate was dried over anhydrous Na2S04 and concentrated in 
vacuo to yield the crude alcohol as a clear colorless oil which was purified by vacuum 
distillation to afford 11.2 g (89 mmol, 89%) of 76 as a clear colorless liquid, bp 47-49·c 
(0.5 mm Hg). The spectral data for 76 were: IR (thin film) 3520-3100, 1660 cm-1; 
lH NMR (CDCl3) S 5.31 (t, 1 H, J = 6.6 Hz), 4.09 (d, 2 H, J = 6.6 Hz), 2.15 (m, 2 H), 
2.04 (m, 2 H), 1.98 (bs, 1 H), 1.54 (m, 6 H); 13C NMR (CDC13) S 144.1, 120.4, 58.4, 
37.0, 28.8, 28.4, 27.8, 26.7; MS (El/DP): mle (%) 126 (19), 108 (100), 93 (82), 83 
(82), 79 (94), 70 (30), 67 (96), 55 (40); HRMS, mle for CsH140: calcd, 126.1045; 
found, 126.1038. 
1-(Carboxymetbyl)-1-vinylcyclohexane (77). A solution of 5.04 g 
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(40.0 mmol) of 56, 19.5 g (120 mmol) of triethyl orthoacetate and 2 drops of propanoic 
acid were slowly heated to 140-15o·c with stirring in a 50-mL round-bottomed flask 
equipped with a short-path distillation apparatus until the evolution of ethanol had ceased 
(ca. 30 min). The resulting mixture was heated at this temperature range with stirring for 
an additional 2 h. The mixture was then cooled and the excess orthoester was removed by 
distillation at aspirator pressure. To the remaining oil was added a solution of 11.22 g 
(200 mmol) of KOH in 40 mL of water and the resulting mixture was refluxed with 
stirring for 16 h. The mixture was cooled to 25·c and extracted twice with ether. The 
isolated aqueous phase was then cooled (0-5.C) and carefully acidified with 6 M 
aqueous HCl to a pH of ca. 3. The acidified mixture was extracted twice with ether. 
The combined ether extracts were washed with water and saturated aqueous NaCl, dried 
over anhydrous Na2S04 and concentrated in vacuo to yield 4.86 g (28.9 mmol, 72%) of 
77 as a white solid, mp 52-54·c, which was used without further purification. The 
spectral data for 77 were: IR (CH03) 3515-2960, 1720, 1625 cm-1; lH NMR (CDC13) 
o 11.40 (bs, 1 H), 5.80 (m, 1 H), 5.08 (m, 2 H), 2.35 (s, 2 H), 1.67 (m, 2 H), 1.48 (m, 
8 H); 13C NMR (CDC13) o 178.4, 144.5, 113.6, 45.7, 39.1, 35.6, 26.1, 22.1; HRMS, 
m/e for CtoHt602: calcd, 168.1150; found, 168.1152. 
1-(2-Hydroxyetbyl)-1-vinylcyclohexane (78). To a stirred slurry of 
0.75 g (19.8 mmol) of LiAlH4 in 70 mL of dry THF at 23•c was added a solution of2.78 
g (16.5 mmol) of 77 in 25 mL of dry THF over the course of 15 min and the resulting 
mixture was heated at reflux for 3 h. The reaction mixture was then cooled (0-5.C) and 
10 mL of a freshly prepared solution of saturated aqueous Na2S04 was cautiously added 
dropwise with continued stirring and cooling. The insoluable aluminum salts were 
removed by suction filtration through a 20 em x 12 em plug of Celite® and were washed 
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with several portions of hot THF. The collected filtrate was dried over anhydrous Na2S04 
and concentrated in vacuo to yield a clear light yellow oil which was purified by vacuum 
distillation to afford 2.18 g (14.2 mmol, 86%) of78 as a colorless oil, bp 68-69"e 
(0.5 mm Hg). The spectral data for 78 were: IR (thin film) 3550-3120, 3060, 1630 cm-1; 
lH NMR (eDel3) o 5.68 (m, 1 H), 5.02 (m, 2 H), 3.61 (t, 2 H, J = 7.2 Hz), 1.75 (bs, 
1 H), 1.60 (t, 2 H, J = 7.2 Hz), 1.56 (m, 1 H), 1.44 (m, 6 H), 1.34 (m, 3 H); Be NMR 
(eDel3) o 146.6, 113.0, 59.3, 43.5, 38.8, 35.8, 26.4, 22.0; HRMS, mle for e 10H180: 
calcd, 154.1358; found, 154.1356. 
General Annulation Procedure for the Preparation of Dihydroiso-
indole Products 83, 84, and 85. A 20-mL methanol solution of 1.00 g (3.92 mmol) 
of 33, 3.92 mmol of the primary amine and 0.44 g ( 4.35 mmol) of triethylamine was 
stirred at 25"e for 24 h. The mixture was concentrated in vacuo to afford a thick golden 
residue which was treated with 50 mL of water and extracted twice with ether. The 
combined ether extracts were washed with water and saturated aqueous Nael, dried over 
anhydrous MgS04 and concentrated in vacuo to yield the crude dihydroisoindole product 
as a light yellow oil which was purified by column chromatography on an 80 em x 2.5 em 
slurry packed silica gel column eluted with increasing concentrations of ether in hexane. 
The physical and spectral properties of the products were the following: 
Methyl (±)-2-(2-Phenylethyl)-2,3-dihydro-lH -isoindole-1-acetate 
(83): The third and largest band, eluted with 9% ether in hexane, afforded 820 mg 
(2. 78 mmol, 71%) of 83 as a colorless oil after concentration. The spectral data for 83 
were: IR (thin film) 3020, 1735, 1630, 1600 cm-1; lH NMR (eDel3) o 7.22 (m, 9 H), 
4.37 (m, 2 H), 3.79 (m, 2 H), 3.69 (s, 3 H), 3.13 (m, 1 H), 2.85 (m, 2 H), 2.70 (m, 
2 H); Be NMR (eDel3) o 172.5, 142.4, 140.2, 139.2, 128.6, 128.3, 127.2, 126.9, 
126.0, 122.2, 122.1, 65.6, 58.1, 56.0, 51.6, 40.2, 35.3; MS (EI/DP): mle (%) 295 (2), 
223 (6), 222 (34), 205 (14), 204 (100), 162 (18), 115 (13), 105 (31), 104 (11), 91 (10), 
77 (9). 
Methyl (±)-2-(Phenylmethyl)-2,3-dihydro-lH -isoindole-1-acetate 
(84): The third and largest band, eluted with 9% ether in hexane, yielded 760 mg 
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(2.70 mmol, 69%) of 84 as a clear colorless oil after concentration. The spectral data for 
84 were: IR (thin film) 3020, 1740, 1600 cm-1; 1H NMR (CDCl3) ~ 7.39-7.10 (complex, 
9 H), 4.49 (t, 1 H, J = 5.4 Hz), 4.17 (d, 1 H, J = 13.2 Hz), 4.08 (d, 1 H, J = 13.2 Hz), 
3.70 (s, 3 H), 3.64 (m, 2 H), 2.81 (d, 2 H, J = 5.4 Hz); 13C NMR (CDCl3) ~ 172.5, 
142.2, 139.3, 128.6, 128.3, 127.2, 127.0, 126.9, 122.3, 122.2 (2), 65.5, 58.4, 58.0, 
51.6, 40.2; HRMS, mle for C1sH19N02: calcd, 281.1416; found, 281.1415. Anal. 
Calcd for C1gH19N02: C, 76.83; H, 6.81. Found: C, 76.51; H, 6.79. 
Methyl (±)-2-(Cyclohexyl)-2,3-dihydro-lH -isoindole-1-acetate (85): 
The third and largest band, eluted with 10% ether in hexane, afforded 660 mg (2.42 mmol, 
62%) of 85 as a colorless oil after concentration. The spectral data for 85 were: IR (thin 
film) 3020, 1740, 1630 cm-1; 1H NMR (CDC13) ~ 7.19 (m, 4 H), 4.73 (dd, 1 H, J = 8.1, 
5.1 Hz), 4.11 (d, 1 H, J = 13.5 Hz), 4.03 (d, 1 H, J = 13.5 Hz), 3.72 (s, 3 H), 2.78 
(dd, 1 H, J = 15.2, 5.1 Hz), 2.64 (m, 1 H), 2.58 (dd, 1 H, J = 15.2, 8.1 Hz), 1.83 (m, 
4 H), 1.65 (m, 1 H), 1.42-1.24 (complex, 5H); 13C NMR (CDCl3) 8 172.7, 142.9, 
139.6, 127.0, 126.7, 122.2 (2), 61.5, 58.8, 52.8, 51.5, 40.3, 32.4, 27.6, 26.2, 26.0, 
25.5; MS (EI/DP): mle (%) 273 (4), 230 (6), 200 (100), 190 (8), 158 (6), 144 (11), 130 
(14), 118 (46), 91 (11), 55 (11). 
Ethyl (E)-2-Vinylcinnamate (93). A 10-mL ethanol solution of 1.65 g 
(5.0 mmol) of 38, 536 mg (5.0 mmol) of benzylamine and 557 mg (5.5 mmol) of 
triethylamine were refluxed with stirring for 24 h. The mixture was cooled to 25oC and 
concentrated in vacuo to yield a light yellow residue which was treated with 50 mL of 
water. The resulting aqueous mixture was extracted twice with ether and the combined 
ether extracts were washed with water and saturated aqueous NaCl, dried over anhydrous 
MgS04 and concentrated in vacuo to afford a yellow oil that was purified by column 
chromatography on an 80 em x 2.5 em slurry packed silica gel column eluted with 
increasing concentrations of ether in hexane. The first and major band collected, eluted 
with 97:3 hexane/ether, yielded 900 mg (4.5 mmol, 90%) of93 as a colorless light oil 
after concentration. Further elutions with up to 50:50 hexane/ether yielded none of the 
desired annulation product The spectral data for 93 were: IR (thin film) 1710, 1635, 
1600 cm-1; lH NMR (eDel3) 5 8.04 (d, 1 H, J = 16.2 Hz), 7.50 (m, 2 H), 7.32 (m, 
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2 H), 7.07 (m, 1 H), 6.35 (d, 1 H, J = 16.2 Hz), 5.63 (m, 1 H), 5.42 (m, 1 H), 4.27 (q, 
2 H, J = 7.2 Hz), 1.34 (t, 3 H, J = 7.2 Hz); Be NMR (eDel3) 5 166.8, 142.3, 138.0, 
134.2, 132.5, 130.0, 127.9, 127.0 (2), 120.3, 118.0, 60.5, 14.4; MS (el, isobutane): 
mle (%) 203 (M+ 1, 64), 159 (18), 157 (69), 155 (16), 129 (100), 117 (10), 102 (14); 
HRMS, mle for e13H140 2: calcd, 202.0988; found, 202.0974. 
Ethyl (E)-2-(2-Phthalimidoethyl)cinnamate (94). The general procedure 
of Baker and Sifniades51 was followed. To a stirred solution of 1.41 g (5.0 mmol) of 37 
in 15 mL of dry dimethylformamide (DMF) was added 1.02 g (5.5 mmol) of neat 
potassium phthalimide in small portions while maintaining the reaction temperature below 
sooe. The resulting mixture was stirred at 25•e for 24 h. To the mixture was added 50 
mL of chloroform and the isolated organic layer was washed with two 75 mL portions of 
water and saturated aqueous Nael, dried over anhydrous Na2S04 and concentrated in 
vacuo to afford a light yellow solid residue which was recrystallized twice from methanol 
to yield 1.53 g (4.4 mmol, 88%) of 94 as a fine white solid, mp 112-113·c. The spectral 
datafor94were: IR(eHel3) 1775,1725,1710, 1635cm-1; 1HNMR(eDel3)o8.10 
(d, 1 H, J = 15.6 Hz), 7.79 (m, 2 H), 7.68 (m, 2 H), 7.54 (m, 1 H), 7.24 (m, 3 H), 6.29 
(d, 1 H, J = 15.6 Hz), 4.25 (q, 2 H, J = 7.2 Hz), 3.88 (t, 2 H, J = 7.8 Hz), 3.12 (t, 2 H, 
J = 7.8 Hz), 1.35 (t, 3 H, J = 7.2 Hz); Be NMR (eDel3) o 168.0, 166.6, 141.3, 137.6, 
133.9, 133.7, 132.0, 130.5, 130.2, 127.4, 126.7, 123.2, 120.3, 60.5, 38.8, 32.0, 14.3; 
MS(EI/DP): mle (%) 349 (2), 303 (30), 275 (3), 202 (8), 160 (100), 129 (37), 115 (13), 
104 (6); HRMS, mle for e21H19N04: calcd, 349.1314; found, 349.1319. 
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Ethyl (±)-1,2,3,4-Tetrahydroisoquinoline-1-acetate (96). The general 
procedure of Boeckman and co-workers19 was followed. A solution of 1.00 g (2.87 
mmol) of 94 and 129 mg ( 4.02 mmol) of hydrazine in 10 mL of absolute ethanol was 
refluxed with stirring for 6 h. The resulting mixture was cooled to 25°C and concentrated 
in vacuo to afford a solid yellow residue which was dissolved in ether. The organic layer 
was washed with 1 M aqueous NaOH and saturated aqueous NaCl, dried over anhydrous 
MgS04 and concentrated in vacuo to yield a yellow oil which was purified by column 
chromatography on an 80 em x 2.5 em slurry packed silica gel column eluted with 
increasing concentrations of ether in hexane. The frrst and major band collected, eluted 
with 70:30 hexane/ether, yielded 453 mg (2.07 mmol, 72%) of 96 as a clear colorless oil 
after concentration. The spectral data for 96 were: IR (thin film) 3340, 1725 cm-1; lH 
NMR (CDCl3) 8 7.12 (m, 4 H), 4.48 (m, 1 H), 4.18 (q, 2 H, J = 6.9 Hz), 3.21 (m, 1 H), 
3.03 (m, 1 H), 2.81 (m, 4 H), 2.64 (bs, 1 H), 1.26 (t, 3 H, J = 6.9 Hz); 13C NMR 
(CDC13) 8 172.3, 137.4, 135.4, 129.5, 126.4, 126.0, 125.9, 60.6 (CH2), 52.7 (CH), 
41.3 (CH2), 40.7 (CH2), 29.7 (CH2), 14.2 (CH3); MS (EI/DP): mle (%) 219 (9), 204 
(8), 190 (4), 172 (5), 133 (11), 132 (100), 130 (11), 117 (8), 77 (3). 
General Annulation Procedure for the Preparation of Monocyclic 
Nitrogen Products 86 and 87. A 15-mL methanol solution of 5.6 mmol of the 
iodoester (27 or 28), 600 mg (5.6 mmol) of benzylamine and 620 mg (6.2 mmol) of 
triethylamine was refluxed with stirring for 36 h. The mixture was cooled to 25oC and 
concentrated in vacuo to afford a light yellow oily residue which was treated with 20 mL 
of water and extracted twice with ether. The combined ether extracts were washed with 
water, 5% aqueous sodium thiosulfate and saturated aqueous NaCl, dried over anhydrous 
MgS04 and concentrated in vacuo to yield the crude annulation product as a clear yellow 
oil which was purified by column chromatography on an 80 em x 2.5 em slurry packed 
silica gel column eluted with increasing concentrations of ether in hexane. The physical 
and spectral properties of the products were the following: 
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Methyl (±)-1-(Phenylmethyl)-2-pyrrolidineacetate (86): The third and 
largest band, eluted with 15% ether in hexane, afforded 820 mg (3.53 mmol, 63%) of 86 
as a clear colorless oil after concentration. The spectral data for 86 were: IR (thin film) 
1740, 1600, 1580 cm-1; lH NMR (CDC13) o 7.26 (m, 5 H), 3.97 (d, 1 H, J = 12.9 Hz), 
3.67 (s, 3 H), 3.28 (d, 1 H, J = 12.9 Hz), 2.89 (m, 2 H), 2.67 (dd, 1 H, J = 14.7, 7.2 
Hz), 2.36 (dd, 1 H, J = 14.7, 7.8 Hz), 2.18 (m, 1 H), 2.05 (m, 1 H), 1.67 (m, 3 H); 
13C NMR (CDC13) o 172.7, 139.4, 128.7, 128.2, 126.8, 60.7, 58.6, 53.9, 51.4, 39.6, 
30.9, 22.1; MS (EIJDP): mle (%) 233 (5), 161 (11), 160 (100), 91 (94), 65 (10). 
Methyl (±)-1-(Phenylmethyl}-2-piperidineacetate (87): The third and 
largest band, eluted with 14% ether in hexane, afforded 810 mg (3.28 mmol, 59%) of 87 
as a clear colorless oil after concentration. The spectral data for 87 were: IR (thin film) 
1735, 1600 cm-1; lH NMR (CDC13) o 7.26 (m, 5 H), 3.80 (d, 1 H, J = 13.5 Hz), 3.67 
(s, 3 H), 3.35 (d, 1 H, J = 13.5 Hz), 2.97 (m, 1 H), 2.72 (dd, 1 H, J = 14.7, 8.1 Hz), 
2.62 (m, 1 H), 2.45 (dd, 1 H, J = 14.7, 7.5 Hz), 2.17 (m, 1 H), 1. 74 (m, 1 H), 1.61 
(m, 1 H), 1.47 (m, 4 H); 13C NMR (CDC13) o 173.3, 139.5, 128.7, 128.1, 126.7, 58.5, 
57.5, 51.5, 50.1, 36.0, 30.9, 25.1, 22.3; MS (EI/DP): mle (%) 247 (4), 175 (13), 174 
(100), 91 (47). 
Attempted Spiroannulation of Enoate Esters 70 and 71 Using the 
Conditions Established. A 15-mL methanol solution of 5.6 mmol of the chloro ester, 
600 mg (5.6 mmol) of benzylamine and 620 mg (6.2 mmol) of triethylamine was refluxed 
with stirring and periodic monitoring of the reaction mixture by TLC. At the end of 120 h 
of reflux, no annulation product was detected and the reaction was terminated. The 
bromide analog of 70 also showed a similar lack of reactivity with a >80% recovery of 
starting material at the end of the heterocyclization attempt using these reaction conditions. 
(±)-N -(Phenylmethyl)-1-(ethoxycarbonylmethyl)-2-azaspiro[ 4.5]-
decane (88). A 15-mL ethanol solution of 2.25 g (7.8 mmol) of 82, 840 mg (7.8 
mmol) of benzylamine and 870 mg (8.7 mmol) of triethylamine was refluxed with stirring 
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for 48 h. The mixture was cooled to 25oC and concentrated in vacuo to afford a dark 
yellow oily residue which was treated with 20 mL of water and extracted twice with ether 
The combined ether extracts were washed with water, 5% aqueous sodium thiosulfate and 
saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in vacuo to yield 
a clear yellow oil which was purified by column chromatography on an 80 em x 2.5 em 
slurry packed silica gel column eluted with increasing concentrations of ether in hexane. 
The third and largest band collected, eluted with 86:14 hexane/ether, afforded 1.68 g 
(5.34 mmol, 68%) of 88 as a clear light yellow oil after concentration. The spectral data 
for 88 were: IR (thin film) 1735 cm-1; lH NMR (CDCl3) o 7.27 (m, 5 H), 4.14 (q, 2 H, 
J = 7.2 Hz), 3.98 (d, 1 H, J = 13.2 Hz), 3.32 (d, 1 H, J = 13.2 Hz), 2.82 (m, 2 H), 2.49 
(dd, 1 H, J = 15.3, 5.1 Hz), 2.39 (dd, 1 H, J = 15.3, 9.3 Hz), 2.21 (dd, 1 H, J = 9.3, 
5.1 Hz), 1.53 (m, 5 H), 1.28 (m, 7 H), 1.26 {t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) o 
173.5, 140.2, 128.5, 128.1, 126.6, 70.4, 60.3, 59.9, 51.3, 44.5, 36.4 (2), 33.7, 33.1, 
26.4, 23.3, 22.9, 14.2; MS {EI/DP): mle (%) 315 (3), 251 (4), 229 (19), 228 (100), 223 
(8), 149 (4), 128 (11), 91 (30); HRMS, m/e for C2oH29N02: calcd, 315.2198; found, 
315.2196. Anal. Calcd for C2oH29N02: C, 76.14; H, 9.27. Found: C, 76.44; H, 
9.39. 
(1R * ,3aS*, 7aS*)-(±)-N -(Phenylmethyl)-1-( ethoxycarbonylmethyl)-
2, 3, 3a, 4, 5, 6, 7, 7a-octahydro-1H-isoindole (89) and (1S*,3aS*,7aS*)-
(±)-N -(Phenylmethyl)-1-(ethoxycarbonylmethyl)-2, 3, 3a, 4, 5, 6, 7, 7a-
octahydro-1H-isoindole (90). A 5-mL ethanol solution of 355 mg (1.29 mmol) of 
46, 138 mg (1.29 mmol) of benzylamine and 144 mg (1.42 mmol) of triethylamine was 
refluxed with stirring for 120 h. The mixture was cooled to 25oC and concentrated in 
vacuo to afford a light yellow residue which was treated with 20 mL of water and extracted 
twice with ether. The combined ether extracts were washed with water, 5% aqueous 
sodium thiosulfate and saturated aqueous NaCl, dried over anhydrous MgS04 and 
concentrated in vacuo to yield a clear yellow oil which was purified by PTLC on two 
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20 em x 20 em silica gel PTLC plates eluted with increasing concentrations of ether in 
hexane. The elution sequence used was: 99:1 hexane/ether (2x), 95:5 hexane/ether (2x), 
90:10 hexane/ether (2x) and 85:15 hexane/ether (1x). The third band afforded 19 mg 
(0.064 mmol, 5%) of 90 as a clear colorless oil after extraction and concentration. The 
spectral data for 90 were: IR (thin film) 1730 cm-1; 1H NMR (CDCl3) o 7.26 (m, 5 H), 
4.13 (q, 2 H, J = 7.6 Hz), 3.92 (d, 1 H, J = 13.8 Hz), 3.41 (d, 1 H, J = 13.8 Hz), 3.21 
(m, 1 H), 2.92 (m, 1 H), 2.49 (m, 2 H), 2.31 (m, 2 H), 2.02 (m, 1 H), 1.71 (m, 1 H), 
1.63-1.12 (complex, 7 H), 1.25 (t, 3 H, J = 7.6 Hz); 13C NMR (CDCl3) o 172.9, 140.7, 
128.3, 128.1, 126.6, 65.3 (CH), 60.2 (CH2), 58.7 (CH2), 54.8 (CH2), 41.0 (CH), 35.4 
(CH), 35.4 (CH2), 25.5 (CH2), 24.8 (CHz), 22.9 (CH2), 20.9 (CH2), 14.2 (CH3); 
HRMS, mle for C19H27NOz: calcd, 301.2036; found, 301.2036. The fourth and largest 
band yielded 268 mg (0.891 mmol, 69%) of 89 as a clear colorless oil after extraction and 
concentration. The spectral data for 89 were: IR (thin film) 1735 cm-1; lH NMR (CDC13) 
o 7.26 (m, 5 H), 4.12 (q, 2 H, J = 7.2 Hz), 4.02 (d, 1 H, J = 13.2 Hz), 3.59 (d, 1 H, 
J = 13.2 Hz), 2.98 (m, 1 H), 2.80 (m, 1 H), 2.45 (m, 2 H), 2.30 (m, 2 H), 1.82 (m, 
1 H), 1.58 (m, 4 H), 1.35 (m, 4 H), 1.25 (t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) ~ 
172.7, 140.2, 128.6, 128.1, 126.7, 66.7 (CH), 60.6 (CH2), 60.2 (CH2), 56.0 (CH2), 
43.7 (CH), 41.3 (CH2), 35.8 (CH), 28.4 (CH2), 25.7 (CH2), 24.6 (CH2), 22.5 (CH2), 
14.3 (CH3); HRMS, mle for C19H27N02: calcd, 301.2036; found, 301.2035. Anal. 
Calcd for C19H27N02: C, 75.70; H, 9.03. Found: C, 75.94; H, 9.18. 
(1R * ,3aS*, 7aR *)-(±)-N -(Phenylmethyl)-1-( ethoxycarbonylmethyl)-
2, 3, 3a, 4, 5, 6, 7, 7a-octahydro-1H-isoindole (91) and (1S*,3aS*,7aR*)-
(±)-N-(Phenylmethyl)-1·(ethoxycarbonylmethyl)·2, 3, 3a, 4, 5, 6, 7, 7a-
octahydro-1H-isoindole (92). A 5-mL ethanol solution of 355 mg (1.29 mmol) of 
55, 138 mg (1.29 mmol) of benzylamine and 144 mg (1.42 mmol) of triethylamine was 
refluxed with stirring for 96 h. The mixture was cooled to 25"C and concentrated in 
vacuo to afford a light yellow residue which was treated with 20 mL of water and 
extracted twice with ether. The combined ether extracts were washed with water, 5% 
aqueous sodium thiosulfate and saturated aqueous NaCl, dried over anhydrous MgS04 
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and concentrated in vacuo to yield a clear light yellow oil which was purified by PILC on 
two 20 em x 20 em silica gel PILC plates eluted with increasing concentrations of ether in 
hexane. The elution sequence used was: 99:1 hexane/ether (2x), 95:5 hexane/ether (2x), 
90:10 hexane/ether (4x) and 85:15 hexane/ether (lx). The third band afforded 49 mg 
(0.163 mmol, 13%) of92 as a clear light yellow oil after extraction and concentration. 
The spectral data for 92 were: IR (thin film) 1725 cm-1; lH NMR (CDC13) a 7.25 (m, 
5 H), 4.11 (q, 2 H, J = 7.2 Hz), 4.04 (d, 1 H, J = 12.9 Hz), 3.61 (d, 1 H, J = 12.9 Hz), 
3.45 (m, 1 H), 2.91 (m, 1 H), 2.32 (m, 2 H), 1.97 (m, 1 H), 1.87-1.46 (complex, 6 H), 
1.25 (t, 3 H, J = 7.2 Hz), 1.27-0.98 (complex, 4 H); 13C NMR (CDC13) a 173.0, 140.1, 
128.8, 128.1, 126.7, 62.5 (CH), 61.0 (CH2), 60.2 (CH2), 59.4 (CH2), 47.5 (CH), 42.1 
(CH), 39.0 (CH2), 29.5 (CH2), 26.6 (CH2), 26.2 (CH2), 25.7 (CH2), 14.2 (CH3); MS 
(EI/DP): mle (%) 3.01 (4), 215 (17), 214 (100), 91 (67), 65 (5); HRMS, mle for 
C19H27N02: calcd, 301.2036; found, 301.2033. The fourth and largest band yielded 
245 mg (0.815 mmol, 63%) of 91 as a clear colorless oil after extraction and 
concentration. The spectral data for 91 were: IR (thin film) 1730 cm-1; lH NMR (CDC13) 
a 7.27 (m, 5 H), 4.13 (q, 2 H, J = 7.2 Hz), 3.96 (d, 1 H, J = 13.8 Hz), 3.51 (d, 1 H, 
J = 13.8 Hz), 2.84 (m, 1 H), 2.60 (m, 2 H), 2.50 (m, 2 H), 1.84-1.72 (complex, 4 H), 
1.46 (m, 1 H), 1.29 (m, 1 H), 1.24 (t, 3 H, J = 7.2 Hz), 1.22 (m, 1 H), 1.08 (m, 3 H); 
13C NMR (CDCl3) o 172.8, 140.7, 128.5, 128.2, 126.6, 66.5 (CH), 60.2 (CH2), 59.8 
(CH2), 57.3 (CH2), 51.0 (CH), 43.0 (CH), 39.1 (CH2), 29.3 (CH2), 28.7 (CH2), 25.9 
(CH2), 25.8 (CH2), 14.2 (CH3); MS (EI/DP): mle, (%) 301 (11), 215 (17), 214 (100), 
213 (9), 91 (38), 65 (3); HRMS, m/e for C19H27N02: calcd, 301.2036; found, 
301.2034. Anal. Calcd for C19H27N02: C, 75.70; H, 9.03. Found: C, 75.50; H, 
9.05. 
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General Procedure for the Preparation of lsothiuronium Adducts 103 
and 109. The general procedure of Speziale58 was followed A 10-mL ethanol solution 
of 10 mmol of the bromide (33 or 37) and 760 mg (10 mmol) of thiourea was refluxed 
with stirring for 12 h. The solution was cooled to 25•c and then to 0-5·c without stirring 
for 3 h. The resulting adduct separated as a fme white solid which was collected by 
filtration, washed with several portions of ether and dried. The adduct was used without 
further purification in the subsequent hydrolysis step. The physical and spectral properties 
of the products were the following: 
Methyl ((E)-2-((Isothiuronium)methyl)cinnamate Bromide (103): 
2.95 g (8.90 mmol, 89%); mp 215-216·c; IR (CHC13) 3750-2920, 1715, 1640, 1635 
cm-1; 1H NMR (DMSO-~) 5 9.33 (bs, 2 H), 9.15 (bs, 2 H), 7.96 (d, 1 H, J = 15.6 Hz), 
7.86 (m, 1 H), 7.57 (m, 1 H), 7.44 (m, 2 H), 6.65 (d, 1 H, J = 15.6 Hz), 4.77 (s, 2 H), 
3.76 (s, 3 H); l3C NMR (DMSO-d6) 5 168.6, 166.4, 140.4, 133.4, 133.3, 130.9, 130.6, 
129.1, 127.5, 120.4, 51.7, 32.3; MS (FAB+, thioglycerol): 251 (M-Br). 
Ethyl ((E)-2-(2-(Isothiuronium)ethyl)cinnamate Bromide (109): 
3.30 g (9.20 mmol, 92%); mp 173-174.C; IR (CHC13) 3720-2910, 1715, 1645, 1630 
cm-1; 1H NMR (DMSO-~) o 9.11 (bs, 4 H), 7.86 (d, 1 H, J =15.6 Hz), 7.73 (m, 1 H), 
7.33 (m, 3 H), 6.51 (d, 1 H, J = 15.6 Hz), 4.18 (q, 2 H, J = 7.2 Hz), 3.43 (t, 2 H, 
J = 6.9 Hz), 3.07 (t, 2 H, J = 6.9 Hz), 1.24 (t, 3 H, J = 7.2 Hz); l3C NMR (DMSO-d6) 
5 169.6, 166.1, 140.9, 138.1, 132.8, 130.4, 130.3, 127.5, 127.0, 120.2, 60.2, 31.3, 
30.9, 14.3; MS (FAB+, thioglycerol): 279 (M-Br). 
General Procedure for the Preparation of Isothiuronium Adducts 
104, 105, and 106. A 5-mL ethanol solution of 5 mmol of the bromide (23, 24 or 
82) and 380 mg (5 mmol) of thiourea was refluxed with stirring for 24 h. The resulting 
mixture was cooled to 25•c and concentrated in vacuo to afford the adduct as a clear 
colorless glass that was used directly. The physical and spectral properties of the 
products were the following: 
Ethyl (E)-6-Isothiuronium-2-hexenoate Bromide (104): 1.47 g 
(4.95 mmol, 99%); IR (thin film) 3520-2800, 1720, 1660, 1640 cm-1; 1H NMR 
(DMSO-d6) o 9.17 (bs, 2 H), 9.05 (bs, 2 H), 6.92 (dt, 1 H, J = 15.6, 6.9 Hz), 5.93 (d, 
1 H, J = 15.6 Hz), 4.12 (q, 2 H, J = 7.2 Hz), 3.22 (m, 2 H), 2.33 (m, 2 H), 1.78 (m, 
2 H), 1.23 (t, 3 H, J = 7.2 Hz); 13C NMR (DMSO-~) o 169.8, 166.0, 148.1, 121.4, 
60.0, 30.2, 29.6, 26.9, 14.4; MS (FAB+, thioglycerol): 217 (M-Br). 
Ethyl (E)-7-Isothiuronium-2-heptenoate Bromide (105): 1.54 g 
(4.95 mmol, 99%); IR (thin film) 3450-2740, 1750, 1640, 1630 cm-1; 1H NMR 
(DMSO-d6) o 9.12 (bs, 2 H), 9.01 (bs, 2 H), 6.88 (dt, 1 H, J = 15.9, 7.2 Hz), 5.88 (d, 
1 H, J = 15.9 Hz), 4.11 (q, 2 H, J = 6.9 Hz), 3.20 (m, 2 H), 2.25 (m, 2 H), 1.57 (m, 
4 H), 1.21 (t, 3 H, J = 6.9 Hz); 13C NMR (DMSO-~) o 169.9, 165.6, 148.9, 121.3, 
59.7, 30.6, 29.8, 27.9, 26.1, 14.2; MS (FAB+, thioglycerol): 231 (M-Br). 
1-((E)-2-Ethoxycarbonylethenyl)-l-(2-(isothiuronium)ethyl)cyclo-
hexane Bromide (106): 1.75 g (4.80 mmol, 96%); IR (thin film) 3610-2820, 1740, 
1665, 1650 cm-1; 1H NMR (DMSO-~) o 9.08 (bs, 4 H), 6.74 (d, 1 H, J = 16.2 Hz), 
5.81 (d, 1 H, J = 16.2 Hz), 4.12 (q, 2 H, J = 7.2 Hz), 2.96 (m, 2 H), 1.66 (m, 3 H), 
1.39 (m, 9 H), 1.22 (t, 3 H, J = 7.2 Hz); 13C NMR (DMSO-~) o 169.7, 165.7, 154.6, 
120.7, 59.9, 55.9, 34.2, 25.7, 25.4, 21.6, 18.5, 14.1; MS (FAB+, thioglycerol): 285 
(M-Br). 
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General Procedure for the Preparation of lsothiuronium Adducts 107 
and 108. A 5-mL ethanol solution of 3.64 mmol of the bromide (46 or 55) and 277 mg 
(3.64 mmol) of thiourea was refluxed with stirring for 120 h. The resulting mixture was 
cooled to 25°C and concentrated in vacuo to yield the adduct as a white tacky solid that 
was used without further purification. The physical and spectral properties of the products 
were the following: 
(IS* ,2S *)-(±)-1-( (E) -2-Ethoxycar bonyletheny I) -2- ( (isoth i uroni um)-
methyl)cyclohexane Bromide (107): 1.26 g (3.59 mmol, 99%); IR (CHC13) 
77 
3540-2850, 1720, 1660, 1620 cm-1; 1H NMR (DMSO-~) o 9.07 (bs, 4 H), 7.02 (dd, 
1 H, J = 15.6, 7.2 Hz), 5.93 (d, 1 H, J = 15.6 Hz), 4.13 (q, 2 H, J = 7.2 Hz), 3.00 (m, 
2 H), 2.71 (m, 1 H), 1.84 (m, 1 H), 1.62 (m, 4 H), 1.37 (m, 4 H), 1.22 (t, 3 H, J = 7.2 
Hz); Be NMR (DMSO-d6) a 169.8, 165.5, 148.4, 122.5, 60.0, 40.1, 33.1, 29.1, 27.0 
(2), 23.7, 21.7, 14.2; MS (FAB+, thioglycerol): 271 (M-Br). 
(1R*,2S*)·(±)-1-((E)-2-Ethoxycarbonylethenyl)-2·((isothiuronium)-
methyl)cyclohexane Bromide (108): 1.24 g (3.53 mmol, 97%); IR (eHel3) 
3650-2720, 1730, 1655, 1645 cm-1; 1H NMR (DMSO-~) a 9.03 (bs, 4 H), 6.75 (dd, 
1 H, J = 15.6, 6.9 Hz), 5.89 (d, 1 H, J = 15.6 Hz), 4.11 (q, 2 H, J = 7.2 Hz), 3.19 (m, 
1 H), 2.94 (m, 1 H), 2.07 (m, 1 H), 1.85 (m, 1 H), 1.64 (m, 4 H), 1.22 (t, 3 H, J = 
7.2 Hz), 1.17 (m, 3 H), 1.10 (m, 1 H); Be NMR (DMSO-d6) a 170.0, 165.6, 151.5, 
121.6, 59.8, 45.0, 39.7, 35.5, 31.7, 29.8, 24.9, 24.7, 14.2; MS (FAB+, thioglycerol): 
271 (M-Br). 
General Annulation Procedure for the Preparation of Sulfur Products 
110, 111, 112, 113, 114, 115, and 116. The general procedure of Speziale58 was 
followed. A mixture of 3.64 mmol of the adduct and 2.63 g (46.9 mmol) of KOH in 10 
mL of water was refluxed with stirring for 8 h. The mixture was cooled to 25oe and 
acidified cautiously at 0-5°e by the dropwise addition of a solution of 2 mL of 
concentrated sulfuric acid in 4 mL of water to a pH of ca. 2. The resulting aqueous 
mixture was extracted twice with ether. The combined ether extracts were washed with 
water and saturated aqueous NaCl, dried over anhydrous Na2S04 and concentrated in 
vacuo to yield the crude acid product as either an oil or a solid which was purified by 
vacuum distillation or by recrystallization from hexane/ether. The physical and spectral 
properties of the products were the following: 
(±)-1,3-Dihydrobenzo[c]thiophene-1-acetic Acid (110): 487 mg 
(2.51 mmol, 69%); mp 103-104oe; IR (eHel3) 3300-2720, 1715 cm-1; 1H NMR 
(eDel3) a 10.50-9.00 (bs, 1 H), 7.22 (m, 4 H), 5.01 (dd, 1 H, J = 9.6, 4.4 Hz), 4.33 
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(d, 1 H, J = 14.0 Hz), 4.18 (d, 1 H, J = 14.0 Hz), 3.12 (dd, 1 H, J = 16.8, 4.4 Hz), 
2.86 (dd, 1 H, J = 16.8, 9.6 Hz); 13C NMR (CDCI3) o 177.5, 142.3, 140.3, 127.4, 
127.0, 125.0, 124.0, 48.9 (CH), 44.1 (CH2), 36.7 (CH2); HRMS, mle for C10H10S02: 
calcd, 194.0396; found, 194.0401. An analytical sample of 110 was obtained as 
colorless needles from hexane/ether, mp 107-108·c. Anal. Calcd for C10H 10S~: 
C, 61.84; H, 5.19. Found: C, 61.76; H, 5.28. 
(±)-3,4-Dihydro-1H-2-benzothiopyran-1-acetic Acid (116): 553 mg 
(2.66 mmol, 73%); mp 108-109.C; IR (CHC13) 3690-2885, 1725cm-1; 1H NMR (CDC13) 
o 10.80-9.90 (bs, 1 H), 7.20 (m, 4 H), 4.37 (m, 1 H), 3.05 (m, 2 H), 2.98 (m, 3 H), 
2.84 (m, 1 H); 13C NMR (CDCl3) o 177.3, 136.7, 136.4, 129.9, 127.3, 127.2, 126.6, 
43.4 (CH2), 37.0 (CH), 30.6 (CH2), 24.1 (CH2); MS (EI/DP): mle (%) 210 (M+2, 2), 
208 (22), 191 (6), 162 (17), 149 (100), 129 (9), 115 (28), 91 (6); HRMS, mle for 
C11H12S02: calcd, 208.0553; found, 208.0549. An analytical sample of 116 was 
obtained as colorless plates from hexane/ether, mp 110-111 • C. Anal. Calcd for 
CuH12S02: C, 62.44; H, 5.81. Found: C, 62.33; H, 5.80. 
(±)-2-Tetrahydrothiopheneacetic Acid (111): 314 mg (2.15 mmol, 59%); 
bp 72-76·c (0.5 mm Hg); IR (thin film) 3560-2480, 1715 cm-1; 1H NMR (CDC13) o 
10.40-9.80 (bs, 1 H), 3.72 (m, 1 H), 2.89 (m, 2 H), 2.67 (m, 2 H), 2.16 (m, 1 H), 2.01 
(m, 2 H), 1.65 (m, 1 H); 13C NMR (CDC13) o 178.0, 43.3, 42.0, 36.7, 32.5, 30.0; 
MS (EI/DP): mle (%) 148 (M+2, 2), 146 (34), 102 (1), 100 (21), 89 (5), 87 (100), 86 
(11), 85 (12), 60 (12), 59 (13); HRMS, mle for C6H10S02: calcd, 146.0396; found, 
146.0396. 
(±)-2H-Tetrahydrothiopyran-2-acetic Acid (112): 402 mg (2.51 mmol, 
69%); mp 73-74.C; IR (CHC13) 3400-2780, 1710 cm-1; 1H NMR (CDC13) o 9.73 (bs, 
1 H), 3.15 (m, 1 H), 2.69 (m, 2 H), 2.53 (m, 2 H), 2.07 (m, 1 H), 1.90 (m, 2 H), 1.62 
(m, 1 H), 1.46 (m, 2 H); 13C NMR (CDCI3) o 177.2, 40.5, 37.6, 33.8, 28.9, 26.7, 25.4; 
MS (EI/DP): mle (%) 162 (M+2, 2), 160 (34), 115 (12), 114 (18), 101 (100), 100 (16), 
----
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81 (13), 73 (11), 67 (32), 59 (18), 55 (17); HRMS, mle for C7H12S02: calcd, 160.0553; 
found, 160.0549. 
(±)-1-(Carboxymethyl)·2-thiaspiro[4.5]decane (113): 552 mg 
(2.58 mmol, 71 %); mp 99-1oo·c; IR (CHC13) 3520-2960, 1725 cm-1; 1H NMR (CDC13) 
o 12.40-11.60 (bs, 1 H), 3.36 (dd, 1 H, J = 11.4, 3.6 Hz), 2.81 (m, 2 H), 2.76 (dd, 1 H, 
J = 15.9, 3.6 Hz), 2.40 (dd, 1 H, J = 15.9, 11.4 Hz), 1.93 (m, 1 H), 1.77 (m, 1 H), 
1.57-1.25 (complex, 10 H); 13C NMR (CDC13) o 178.5, 64.0, 50.8, 47.8, 38.0, 34.9, 
30.6, 28.2, 26.4, 23.3, 23.1; MS (EI/DP): mle (%) 216 (M+2, 4), 214 (53), 157 (4), 
155 (48), 142 (19), 119 (13), 108 (100), 93 (21), 79 (28), 67 (30); HRMS, m/e for 
C11H1gS02: calcd, 214.1022; found, 214.1016. An analytical sample of 113 was 
obtained as colorless needles from hexane/ether, mp 102-103°C. Anal. Calcd for 
CuH1gS02: C, 61.65; H, 8.47. Found: C, 61.84; H, 8.35. 
(1R*,3aS*,7aS*)·(±)-1-(Carboxymethyl)-1, 3, 3a, 4, 5, 6, 7, 7a-
octahydrobenzo[c]thiophene (114): 538 mg (2.69 mmol, 74%); mp 78-8o·c; 
IR (CHC13) 3580-2~no, 1725 cm-1; 1H NMR (CDC13) o 11.20-10.40 (bs, 1 H), 3.48 
(m, 1 H), 2.90 (m, 1 H), 2.75 (m, 2 H), 2.56 (m, 1 H), 2.40 (m, 1 H), 1.92 (m, 1 H), 
1.57 (m, 6 H), 1.37 (m, 2 H); Be NMR (CDC13) o 177 .5, 48.2 (CH), 46.3 (CH), 42.2 
(CH2), 42.1 (CH), 34.8 (CH2), 26.5 (CHz), 26.1 (CH2), 23.2 (CH2), 23.0 (CH2); 
MS (EI/DP): m/e (%) 202 (M+2, 2), 200 (40), 166 (12), 154 (10), 141 (100), 135 (5), 
107 (48), 93 (25), 81 (30), 79 (29), 67 (30), 55 (19); HRMS, mle for CwH16S02: 
calcd, 200.0866; found, 200.0869. An analytical sample of 114 was obtained as 
colorless needles from hexane/ether, mp 81-82°C. Anal. Calcd for C1oH16S02: 
C, 59.97; H, 8.06. Found: C, 60.26; H, 8.15. 
(1R*,3aS*,7aR*)-(±)-1-(Carboxymethyl)-1, 3, 3a, 4, 5, 6, 7, 7a-
octahydrobenzo[c]thiophene (115): 554 mg (2.77 mmol, 76%); mp 129-130oC; 
IR (CHC13) 3590-2870, 1720 cm-1; 1H NMR (CDC13) o 10.40-9.60 (bs, 1 H), 3.29 (m, 
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1 H), 2.89 (m, 2 H), 2.52 (m, 2 H), 1.94 (m, 2 H), 1.79 (m, 2 H), 1.59 (m, 1 H), 1.17 
(m, 2 H), 1.06 (m, 3 H); 13C NMR (CDC13) 8 178.1, 53.0 (CH), 48.7 (CH), 48.3 (CH), 
40.0 (CHv, 36.7 (CH2), 31.8 (CH2), 30.1 (CHv, 25.6 (CHv, 25.5 (CH2); MS (EIIDP): 
mle (%) 202 (M+2, 4), 200 (60), 166 (18), 154 (21), 141 (100), 135 (12), 121 (6), 107 
(50), 93 (38), 79 (29), 67 (28); HRMS, mle for Ctoflt6S02: calcd, 200.0866; found, 
200.0865. An analytical sample of 115 was obtained as colorless plates from 
hexane/ether, mp 131-132°C. Anal. Calcd for C1oflt6S02: C, 59.97; H, 8.06. 
Found: C, 59.76; H, 8.01. 
Single Crystal X-ray Structure Determination of (lR*,3aS*,7aS*)· 
(±)-1-(Carboxymethyl)-1, 3, 3a, 4, 5, 6, 7, 7a-octahydrobenzo[c]thio-
phene (114). A crystal of C10H16~S, grown from aqueous ethanol, was mounted on 
a Syntex P3 automated diffractometer. Unit cell dimensions (see Table X) were determined 
by least squares refmement of the best angular positions for fifteen independent reflections 
(29>15°) during normal alignment procedures using molybdenum radiation (A-=0.71069 
A). Data (1331 independent points after removal of redundant data) were collected at room 
temperature using a variable scan rate, a e-29 scan mode and a scan width of 1.2° below 
Kcxt and 1.2° above Kcx2 to a maximum 29 value of 45°. Backgrounds were measured at 
each side of the scan for a combined time equal to the total scan time. The intensities of 
three standard reflections were remeasured after every 97 reflections. As the intensities of 
these reflections showed less than 5% variation, corrections for decomposition were were 
deemed unnecessary. Data were corrected for Lorentz, polarization and background 
effects. Observed reflections [ 943 ((1>3.0o(l))] were used for solution of non-hydrogen 
atom positions by direct methods using MULTAN.63 Refinement64 of scale factor, 
positional and anisotropic thermal parameters for all non-hydrogen atoms were carried out 
to convergence. The positions of hydrogen atoms were located from a difference Fourier 
synthesis. Hydrogen atom positions were included in the fmal cycles of refinement with 










































I.w(IFoi-1Fcl)2] led to a final agreement factor, R=4.7%. [R=(I.wiiFoi-IFcll/ I.wiFol) x 
100]. Scattering factors were taken from Cromer and Mann.65 In the fmal stages of 
refinement a weight factor of l/a(F}2 was used. Rw=6.2%. As is normal for solid state 
organic carboxylic acid groups, molecules exist in hydrogen bonded pairs, 01 H2' and 
H2 01', 1.643(4) A, '=1-x, -y, 1-z. Tables Xlll-XVI in Appendix A list bond angles 
and distances, dihedral angles, positional parameters, and final anisotropic thermal 
parameters for 114. 
1H-n.O.e. Determinations on Products 89, 90, 91, 92, and 115. 
Degassed and evacuated 0.024 M samples of products 89-92 (5 mg of the product in 
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0.7 mL of CDC13) were prepared using the freeze-thaw cycle as described by Neuhaus 
and Williamson. 55 In the case of 115,0.036 M samples (5 mg of 115 in CDC13) were 
used. In all 5 of these cases, 3 identical samples of each product were prepared. Each 
sample was then submitted to 3 separate lH-n.O.e. determinations (for a total of nine 
determinations for each compound) on a Varian XLA-400 superconducting FT instrument 
using the standard parameters for 1 H-n O.e. difference experiments as described by Kinns 
and Sanders. 56 In the data aquisition, a T -1 delay interval of 7 seconds was used in all 
cases studied. The standard FIDS data for the irradiated vs. nonirradiated spectra were 
collected in 16 transient blocks with interleave for a total of 48 total transients for each of 
the comparative spectra. The data as collected was then submitted to standard Fourier 
analysis and weighing and the % enhancements were determined by direct integral 
comparison of the irradiated vs. nonirradiated spectra for the assigned protons of interest 
in each compound. In all of the samples studied, the lH-n.O.e. results observed were 
reproducible to within ±0.1% enhancement. 
Reaction Chronology Study for the Formation of Nitrogen 
Heterocycles. A 5-mL ethanol solution of 0.57 g (0.62 mL, 5.0 mmol) of ethyl 
crotonate, 0.54 g (0.55 mL, 5.0 mmol) of benzylamine, 1.06 g (0.74 mL, 5.0 mmol) of 
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1-iodohexane and 0.56 g (0. 77 mL, 5.5 mmol) of triethylamine was heated at reflux 
according to the standard heterocyclization procedure. The reaction was monitored by 
GC analysis of 0.15 J,LL aliquots removed from the reaction at 30-min intervals during the 
first 3 hand at 1-h intervals thereafter. After 12 h, all of the benzylamine and 
1-iodohexane had been consumed. A significant amount (ca. 75%) of the ethyl crotonate 
remained after this time. 
Reaction Chronology Study for the Formation of Sulfur 
Heterocycles. A mixture of 1.24 g (5.0 mmol) of benzylisothiuronium bromide and 
0.88 g (5.0 mmol) of ethyl cinnamate was stirred at 23oC with 20% KOH in 4:1 
water/ethanol. The reaction was monitored by 1LC at 15-min intervals for disappearance 
of the reactants. After 40 min, the ethyl cinnamate had been completely consumed. 
Benzyl mercaptan and its cinnamate addition product were formed to only a minor extent 
during this period. 
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CHAPTER III 
A TANDEM NUCLEOPHILIC DECARBOXYXLATION-
MICHAEL ADDITION ROUTE TO 
FUNCTIONALIZED SPIRANES 
Introduction 
Spiro carbocyclic ring systems are an important structural subunit of many natural 
products66-69 and have received much attention in contemporary organic synthesis. 
Earlier work by Eilerman and Willis 70 illustrated an efficient method for the preparation 
of spirocyclic products 2 from the reaction of 2-methoxycarbonyl-2~( 4-chlorobutyl)cyclo-
alkanones 1 with catalytic lithium chloride in HMPA at 125-140°C. This approach is 
shown in Figure 24.- The reaction sequence was initiated by the reaction of (3-ketoester 1 
with chloride ion (see Figure 25) proceeding through an initial SN2-type dealkylation-
decarboxylation process to afford carbanion intermediate 3 which cyclized in a subsequent 
intramolecular alkylation reaction to afford 2. This method used a catalytic amount of 
lithium chloride (0.5 eq) due to the fact that the chloride ion initially consumed in the 














- C02 • 2 + CI 
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Figure 25. Mechanism for the Preparation of Spirane Product 2. 
In view of the above observations, it was envisioned that a similar approach involving 
a tandem nucleophilic decarboxylation-Michael reaction sequence resulting from the 
reaction of a 2-methoxycarbonyl-2-substituted. cycloalkanone 4 bearing a side chain 
incorporating a Michael acceptor with lithium chloride in HMP A could possibly be used to 
form spirocyclic ring systems 5 bearing differentiated.functionality (see Figure 26). In 




Figure 26. An Approach to Functionalized Spiranes Using a Tandem 
Decarboxylation-Michael Addition Route. 
this study, several goals were set, most notably the devisement of a set of viable reaction 
conditions that would allow for the process to proceed with the possibility of stereo-
chemical selectivity in the products formed. 
Results 
86 
Synthesis of the Starting Materials. The synthesis of the starting substrates 
lla-ffor the decarboxylation-Michael addition sequence is illustrated in Figure 27. Side 
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lla m=l, n=l 
llb m=l, n=2 
llc m=l, n=3 
lld m=l, n=l 
lle m=2, n=2 
llf m=l, n=3 
(Ph)JP=CHC02Et 
Figure 27. Synthesis of Starting Substrates lla-f. 
,.. 
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functionality were easily synthesized using a modification of the approach described by 
Cooke and Widener. 71 The buffered oxidation of 4-chlorobutanol (6a) with pyridinium 
chlorochromate37 to 4-chlorobutanal (7a) followed by Wittig olefination using ethyl 
(triphenylphosphoranylidene)acetate yielded ethyl (E)-6-chloro-2-hexenoate (Sa) in 57% 
overall yield Treatment of 8a with sodium iodide in refluxing acetone smoothly afforded 
ethyl (E)-6-iodo-2-hexenoate (9a). The alkylation of 2-methoxycarbonylcycloalkanones 
10a-c with 9a using potassium tert-butoxide in tert-butyl alcohol solvent then afforded 
the desired starting substrates lla-c in an average yield of 63%. The above sequence 
was also applied to the synthesis of ethyl (E)-7-iodo-2-heptenoate (9b) from 5-chloro-
pentanol (6b ). The alkylation of 10 a-c with 9b using tert-butoxide in tert-butyl alcohol 
yielded the 6-ring precursors 11d-f. 
Spirane Formation and Structure Elucidation of the Products. The results 
of this study on the tandem decarboxylation-Michael addition sequence for the series of 5-
ring and 6-ring starting substrates described in the previous section are shown in Table XI. 
The reaction was run in HMP A using 3 equivalents of anhydrous lithium chloride with the 
differences in reaction temperature and reaction time being dependent on whether the 
reaction sequence involved 5-ring or 6-ring closure. Formation of spiro[4.n]alkan-1-one 
products 12 a-c and 13 a-c (5-ring closure) proceeded smoothly at a reaction temperature 
of 95-100"C with a reaction time of 4 hand gave yields in the range of 55-65%. The 
stereochemical selectivities ranged from 3: 1 ~n the formation of the spiro[ 4.5]decan-1-one 
products (12b and 13b) to 30:1 for the spiro[4.6]undecan-l-ones (12c and 13c). In 
cases involving a 6-ring closure, it was found that higher reaction temperatures (125-
130"C) and a longer reaction time (6 h) were required for the reaction to proceed to 
completion. When these conditions were employed, yields in the range of 44-54% and 
stereochemical selectivities ranging from 21:1 to 26:1 were observed The lower yields 
from this series of substrates likely derives from the increased entropy required to bring 
the reactive centers together to close the 6-membered ring.72 
0 
TABLE XI 
THE PREPARATION OF FUNCTIONALIZED SPIRANES 
SPIRANES USING A TANDEM DECARBOXYLATION-
MICHAEL ADDIDON REACTION 
SEQUENCE. 
0 0 
~ A orB Cf.!m + GPm 0 >iii"VC02Et n -
'=-C02Et '=-C02Et 
11 a-f 12 a-r 13 a-r 
Starting Material m n 12 : 13 Yield(%) Reaction 
(12 + 13) Conditionsa 
lla 1 1 20: 1 62 A 
llb 1 2 3 : 1 56 A 
11c 1 3 30: 1 62 A 
lld 2 1 24: 1 50 B 
lle 2 2 21: 1 44 B 
llf 2 3 26: 1 54 B 
aA: 3 eq. LiCl, HMPA, 95-100°C, 4 h. B: 3 eq. LiCl, HMPA, 125-130°C, 6 h. 
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The procedure, as devised, differs from that used by Eilerman and Willis in requiring 
excess lithium chloride; this derives from the fact that chloride ion is not generated in the 
Michael addition step as it is in the alkylation where chloride was displaced from 3 in the 
cyclization step. The procedure was performed in HMPA, DMPU (1,3-dimethyl-3, 4, 5, 
6-tetrahydro-2(1H)-pyrimidinone) andN-methylpyrrolidine but it was found that HMPA 
was far superior in this current application. The use of HMP A as the solvent allowed for 
both lower reaction temperatures and shorter reaction times and is easily removed at the 
end of the reaction using an acidic workup. 
89 
The inherent reversibility of the Michael addition process leads to overall thermo-
dynamic control in the cyclization step. The elucidation of the stereochemistry of the 
major and minor products resulting from the 5-ring spiroannulation sequence (12a-c and 
13a-c) was accomplished by a combination of chemical degradation and single-crystal 
X-ray diffraction studies. The first degradative study attempted is outlined in Figure 28. 
It was expected that selective sodium borohydride reduction of the ketone functionality78 
followed by base hydrolysis, neutralization and mild acidification to pH 3-4 would result 
in lactonization (to give 17) for isomer 13 having the ketone and ethoxycarbonylmethyl 
functions cis. In the trans isomer 12, this sequence was expected to yield hydroxy acid 
15 since the trans oriented groups would not be expected to readily lactonize. 
0 OH 1.) OH -, H 20 OH 
Cp (R (R NaBH4 EUlH .. EtOH,. 2.) H +to 
-c~Et -c~Et pH 3·4 -c~H 
12 14 15 
n = 1-3 n = 1·3 n = 1-3 
0 
0 
!R 1.) OH -, HzO 
A 
tR NaBH4 ElQH ,.. (R EtOH ,... 2.) H +to 
-c~Et -c~Et pH 3-4 
13 16 17 
n = 1-3 n = 1-3 n = 1-3 
Figure 28. Chemical Degradation Proof Method 1. 
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The results of this chemical degradative scheme are summarized in Figure 29. 
Reduction of the trans major products 12a and 12b smoothly afforded hydroxy esters 
14a and 14b which, upon base hydrolysis and acidification, cleanly yielded the hydroxy 
acid products 15a and 15b thus implying that 12a and 12b had the trans stereochemistry. 
However, in the case of the cis minor products 13 a-c, it was not possible to avoid 
OH OH 0 1.) OH -, H20 
CR (jJ (jJ NaBH4 IHQH Jll EtOH Jll' 2.) H +to 
-c~Et -c~Et pH 3-4 
12a n=l 14a n=l 
12b n=2 14b n=2 
0 OH 
CRCOzEt 
NaBH4 CPu" EtOH Jll" 
13b 18a 
18b 
Figure 29. Results of Chemical Degradation Proof Method 1 




overreduction 73 and the diol products 18a and 18b were obtained as a pair of 
diastereomers from the reduction of 13b even when 0.25 equivalents of sodium boro-
hydride were used. To account for this observation, it would seem reasonable that the 
relative orientation of the ketone and ester groups in the cis products is such that initial 
reduction of the ketone places the oxygen-bound borohydride moiety directly over the ester 
group as in 20 (see Figure 31) facilitating the unexpected reduction of the ester. Literature 
--------
91 
precedent does exist for the activation of the borohydride moiety by heteroatom 
substitution.74 In cases derived from the 7-ring keto ester llc, overreduction occurred 
(see Figure 30) in both product isomers to afford the diol. This observation could result 
from the increased conformational flexibility in this ring system that would permit the 
oxygen-bound borohydride moiety to approach the ester functionality as in 21 (see Figure 





Figure 30. Results of Chemical Degradation Proof Method 1 
on Product 12c. 
20 21 
Figure 31. Structures 20 and 21. 
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In view of these observations, a second degradation scheme was devised in an attempt 
to avoid the possibility of overreduction of the ester functionality. In this approach, it was 
thought that the initial conversion of the ester group to the corresponding carboxylic acid, 
which would not be easily reduced by borohydride,75 followed by reduction (see Figure 
32) would avoid the problem of overreduction observed in the previous degradation 
scheme. It was envisioned that base hydrolysis of the ester functionality followed by 
sodium borohydride reduction of the ketone group76 and subsequent mild acidification to 
pH 3-4 would result in lactonization (to give 17) of the isomer 13 having the ketone and 
ethoxycarbonylmethyl groups cis. Conversely, as in the previous degradation scheme, 
the trans isomer 12 was expected to afford a hydroxy acid product (15) since the trans 
oriented groups would not be expected to lactonize. 
0 1.) OH -, H20 0 OH 
CR Cp 
1.) NaBH4, Cp ElQH,. ElQH,.. 2.) H + 2.) H +to 
-co.zEt -co.zH pH 3-4 "=-CQzH 
12 22 15 
n = 1-3 n = 1-3 n = 1-3 
0 
[p 1.) OH -. H20 
0 1.) NaBH4, ~ 
E!QH,. tR EtoH,.. CR 2.) H + 2.) H +to 
-cQzEt -co.zH pH 3-4 
13 23 17 
n = 1-3 n = 1-3 n = 1-3 
Figure 32. Chemical Degradation Proof Method 2. 
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The results of this second chemical degradative scheme are shown in Figure 33. Base 
hydrolysis of the trans major products 12a and 12b yielded keto acids 22a and 22b 
which, upon reduction and acidification, smoothly yielded the hydroxy acid products 15a 
and 15b. In the case of the cis minor products 13a and 13b, the employment of the same 
degradative scheme cleanly afforded the cis lactone products 17a and 17b. However, in 
the case of the trans major product 12c, the trans lactone 24 was isolated as the only 
degradation product after implementation of the base hydrolysis-reduction sequence. 
0 1.) OH -, H20 0 OH 
CR CR 
1.) NaBH4, 
CR EtQH,.. EtQH"' 2.) H + 2.) H +to 
-cQzEt -cOzH pH 3·4 -c<>zH 
lla n=1 22a n=1 1Sa n=1 
llb n=2 22b n=2 1Sb n=2 
0 
m 1.) OH -, H20 0 1.) NaBH4, ~ EtQH,... m EtoH,... (£? 2.) H + 2.) H +to n n pH 3-4 -cQzEt -cOzH 
13a n=1 23a n=1 17a n=1 
13b n=2 23b n=2 17b n=2 
0 
0 1.) OH -, H20 0 1.) NaBH4, ~ 
CRCO,Et 
EtOH• CR, EtoH,... ~ 2.) H + : 2.) H +to "=-C()zH pH 3·4 
llc 22c 24 
Figure 33. Results of Chemical Degradation Proof Method 2 
for 12a-c and 13a-b. 
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Apparently, the increased conformational flexibility in this ring system allows the carboxyl 
group to approach the hydroxyl functionality as in 25 (see Figure 34) such that the 
observed lactonization process can occur. 
25 
Figure 34. Structure 25. 
From the results of the chemical degradation sequences, the stereochemistry of major 
products 12a and 12b was assigned as being trans while the minor products 13a and 
13b were assigned the cis configuration. The trans stereochemistry of major product 12c 
was assigned formally based on a single crystal X-ray diffraction structure obtained on its 
2,4-dinitrophenylhydrazone derivative 26. The preparation 79 of derivative 26 is shown 
in Figure 35. The CHEM3D diagram for 26 as determined by single crystal X-ray 
diffraction techniques is illustrated in Figure 36. 
In an attempt to determine the stereochemistry of products 12d and 12f, the p-
bromoanilide derivatives, 29a and 29c, were prepared from the corresponding keto acids 
27 d and 27f. If these amides were solids, as expected, it was thought that single crystal 
X -ray diffraction techniques could be utilized to elucidate the stereochemistry of the 
spirocyclic framework. Despite several attempts using a number of different solvent 
combinations and recrystallization techniques, it proved impossible to obtain crystals 
suitable for a structure determination. The preparation of amides 29a and 29c is shown 










Figure 35. Preparation of 2,4-DNP Derivative 26. 
Figure 36. The CHEM3D Diagram for 26. (The Protons of the 
Spirocyclic Ring System and the Ethoxycarbonyl 
Portion of the Acetate Side Chain attached at C-1 





1.) OH -, H 20 
Etou,.. 







1.) (COCI)z , 
c,u, 
2.) 1 eq. 28, 




Figure 37. Preparation of Amides 29a and 29c. 
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The stereochemistry of products 12d, 12e, and 13d was tenatively assigned by using 
the same chemical degradation sequence and reasoning as outlined in Figure 32. Base 
hydrolysis of the major products 12d and 12e yielded ketoacids 27d and 27e which, 
upon reduction 76 and acidification, smoothly afforded hydroxy acid products 30d and 
30e. In the case of 13d, the employment of an identical sequence of reactions yielded 
lactone 32 as the only product The results of this chemical proof are shown in Figure 38. 
Reference to molecular models suggests a lack of appreciable ring strain difference in the 
lactone products derived form the cis and trans spirocyclic compounds in this series. Thus, 
the stereochemical assignments for these products are considered to be tentative at this time 
and merit further investigation. 
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1.) OH -. H20 1.) NaBH4, 
EUlH,.. 
2.) H + 
ElQH,.. 
2.) H +to 60 60 & 
--c~Et --c~H pH 3-4 0 ;_C~H 
12d o=1 27d o=1 30d o=1 
12e o=2 27e o=2 30e o=2 
0 
tp 1.) OH -. H20 ~ 
1.) NaBH4, ~ 
ElQH :Jill EtOH:JII CR 2.) H+ 2.) H +to 0 ::._C~Et 0 ;_C~H pH 3-4 0 
13d o=1 3ld o=l 32d o=1 
Figure 38. Results of Chemical Degradation Proof Method 2 
on 12d, 12e, and 13d. 
Experimental 
All solvents were purified by distillation or vacuum distillation prior to use. 
Anhydrous lithium chloride and 2-methoxycarbonylcyclopentanone were used as received 
from Aldrich Chemical Co. 2-Methoxycarbonylcyclohexanone and 2-methoxycarbonyl-
cycloheptanone were prepared and purified by adaptations of literature methods.77 All 
reactions were run under an atmosphere of dry nitrogen. Reactions were monitored by 
one of the following methods: 1) TLC on hard layer silica gel GF plates (Analtech No. 
21521) with UV or phosphomolybdic acid detection or 2) capillary GC (Varian 3400) 
with FI detection on a 0.1 mm x 6 m SE-30 column programmed between 100-300·c. 
Preparative separations were performed using one of the following methods: 1) PTLC on 
20 em x 20 em silica gel GF plates (Analtech No. 02015) or 2) flash chromatography61 on 
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silica gel (Grace, grade 62, 60-200 mesh) containing UV active phosphor (Sylvania 2282); 
in each case, band elution was monitored by a hand-held UV lamp. Melting points were 
obtained on a Fisher-Johns melting point apparatus and are uncorrected. IR spectra were 
recorded with a PE-681 instrument and are referenced to polystyrene. lH-NMR and 
13C-NMR spectra were measured as solutions in deuterated solvents at 300 MHz or 400 
MHz and 75 MHz or 100 MHz, respectively, on a Varian XL-300 or a Varian XLA-400 
superconducting Ff instrument; chemical shifts are reported in ~ units relative to internal 
Me4Si. Mass spectra (MS) were obtained using a VG TS-250 instrument; high resolution 
mass spectra (HRMS) were obtained using a VG ZAB-2SE. Elemental analyses were 
performed by Galbraith Laboratories, Knoxville, TN. 
Ethyl (E)-6-Iodo-2-hexenoate (9a) and Ethyl (E)-7-Iodo-2-hepten-
oate (9b). The preparations of 9a and 9b from 4-chlorobutanol (6a) and 5-chloro-
pentanol {6b) are described in an earlier portion of this thesis (see page 18). 
General Procedure for the Preparation of (±)-2-Methoxycarbonyi-2-
((E)-5-ethoxycarbonyl-4-pentenyl)cycloalkanones (lla, llb, and llc). A 
solution of potassium tert-butoxide was generated by dissolving 1.06 g (27.1 mg-atm) of 
potassium metal in 70 mL of tert-butyl alcohol at 40-50°C. The solution was cooled to 
20oC and 27.1 mmol of the 2-methoxycarbonylcycloalk:anone (lOa, lOb, or lOc) was 
added with stirring. After stirring for 1 hat 20°C, 7.26 g (27.1 mmol) of ethyl (E)-6-iodo-
2-hexenoate (9a) was added dropwise and the reaction was refluxed for 18 h. The 
reaction was cooled to 20°C and poured into 125 mL of 0.5 M HCl. The resulting 
solution was extracted twice with ether and the combined ether extracts were washed with 
0.5 M HCl, water, saturated aqueous NaHC03, 5% aqueous sodium thiosulfate and 
saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in vacuo to yield 
a yellow oil. The oil was purified by vacuum distillation using a Kugelrohr apparatus. 
The physical and spectral properties of the products were the following: 
(±)-2-Methoxycar bonyl-2- ( (E)-5 -ethoxycar bonyl-4-pen tenyl)-
cyclopentanone (lla): 5.40 g (19.1 mmol, 71.0%); bp 130~136"C (0.5 mm Hg); 
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IR (thin film) 1750, 1730, 1725, 1650 cm-1; 1H NMR (CDCl3) 5 6.95 (dt, 1 H, J = 15.9, 
7.0 Hz); 5.84 (d, 1 H, J = 15.9 Hz), 4.20 (q, 2 H, J = 7.2 Hz), 3.37 (s, 3 H), 2.48 (m, 
2 H), 2.26 (m, 2 H), 1.94 (m, 2 H), 1.50 (m, 2 H), 1.31 (t, 3 H, J = 7.2 Hz); 13C NMR 
(CDCl3) 5 214.4, 171.2, 166.3, 147.9, 121.7, 60.1, 60.0, 52.4, 37.7, 33.2, 32.7, 32.0, 
23.2, 19.4, 14.1; MS (CI, isobutane): mle (%) 283 (M+1, 88), 237 (85), 219 (36), 205 
(100), 177 (23). 
(±)-2-Methoxycarbonyi-2-((E)-5-ethoxycarbonyl-4-pentenyl)-
cyclohexanone (llb): 4.50 g (15.2 mmol, 59%); bp 140-145"C (0.5 mm Hg); 
IR (thin film) 1735, 1730, 1720, 1650 cm-1; 1H NMR (CDCl3) 5 6.94 (dt, 1 H, J = 15.6, 
7.0 Hz), 5.83 (d, 1 H, J = 15.6 Hz), 4.19 (q, 2 H, J = 6.9 Hz), 3.76 (s, 3 H), 2.46 (m, 
2 H), 2.22 (m, 2 H), 2.03 (m, 1 H), 1.97-1.36 (complex, 9 H), 1.30 (t, 3 H, J = 6.9 
Hz); 13C NMR (CDCl3) 5 207.5, 172.2, 166.4, 148.2, 121.5, 60.6, 59.9, 52.1, 40.9, 
36.0, 34.0, 32.2, 27.4, 22.7, 22.4, 14.1; MS (CI, isobutane): mle (%) 297 (M+1, 100), 
251 (19), 233 (27), 213 (14), 191 (23), 111 (20). 
(±)-2-Methoxycarbonyl-2- ( (E)-5-ethoxycar bonyl-4-pen tenyl)-
cycloheptanone (llc): 4.85 g ( 15.6 mmol, 60%); bp 158-162"C (0.5 mm Hg); 
IR (thin film) 1745, 1730, 1720, 1655 cm-1; 1H NMR (CDCl3) 5 6.92 (dt, 1 H, J = 15.6, 
6.8 Hz), 5.82 (d, 1 H, J = 15.6 Hz), 4.18 (q, 2 H, J = 7.2 Hz), 3.73 (s, 3 H), 2.63 (m, 
1 H), 2.46 (m, 1 H), 2.18 (m, 4 H), 1.95 (m, 1 H), 1.80-1.32 (complex, 9 H), 1.29 (t, 
3 H, J = 7.2 Hz); 13C NMR (CDCl3) 5 209.2, 172.7, 166.3, 148.1, 121.5, 62.5, 59.9, 
52.0, 41.9, 34.8, 32.7, 32.2, 29.7, 25.4, 24.7, 23.0, 14.1; MS (CI, isobutane): mle (%) 
311 (M+1, 100), 205 (12), 171 (50), 159 (18). 
General Decarboxylation-Michael Addition Procedure for the 
Formation of 5-Ring Spiranes (12a-c and 13a-c). A solution of 6.7 mmol of the 
(±)-2-methoxycarbonyl-2-((E)-5-ethoxycarbonyl-4-pentenyl)cycloalkanone (lla, llb, 
100 
or 11c) and 0.82 g (19.3 mmol) of anhydrous lithium chloride in 15-20 mL of anhydrous 
hexamethylphosphoramide (HMPA) was stirred at 95-1oo·c for 4 h. The resulting brown 
reaction mixture was cooled to 25·c, poured into 50 mL of 0.5 M HCl and extracted 3x 
with ether. The combined ether extracts were washed with 0.5 M HCl, water, saturated 
aqueous NaHC03 and saturated aqueous NaCl, dried over anhydrous MgS04 and 
concentrated in vacuo. The crude product was purified by PTLC using the following 
elution sequence: 99:1 hexane/ether (2x), 98:2 hexane/ether (2x), 96:4 hexane/ether (2x) 
and 95:5 hexane/ether (3x). This elution procedure afforded the major and minor 
diastereomeric products in relatively high purity. In all cases, the highest Rr band was the 
minor isomer, the middle band contained a small amount of a mixture and the low Rr band 
gave the major isomer. The following compounds were isolated: 
(5R * ,6R *)-(±)-6-(Ethoxycarbonylmethyl)spiro[ 4.4 ]nonan-1-one 
(12a): 850 mg (3.79 mmol, 59%); IR (thin film) 1745, 1735 cm-1; 1H NMR (CDCl3) 
o 4.09 (q, 2 H, J = 7.2 Hz), 2.60 (m, 1 H), 2.26 (d, 2 H, J = 8.1 Hz), 2.19, (m, 1 H), 
2.16-1.82 (complex, 5 H), 1.71 (m, 4 H), 1.59 (m, 1 H), 1.35 (m, 1 H), 1.25 (t, 3 H, 
J = 7.2 Hz); 13C NMR (CDC13) o 221.9, 172.2, 59.9, 58.1, 41.0, 37.4, 37.2, 35.5, 
31.7, 30.6, 22.3, 19.0, 13.8; MS (EI!DP): mle (%) 224 (M+, 35), 196 (29), 179 (35), 
150 (30), 137 (100), 136 (65), 128 (42), 122 (50), 108 (52), 97 (46), 94 (69), 79 (54). 
Anal. Calcd for C13H2o03: C, 69.60; H, 8.99. Found: C, 68.98; H, 8.69. 
(5R * ,6S *)· (±)-6-(Ethoxycarbonyl methyl)spiro[ 4.4 ]nonan-1-one 
(13a): 50 mg (0.22 mmol, 3%); IR (thin film) 1745, 1730 cm-1; 1H NMR (CDCl3) 
o 4.10 (q, 2 H, J = 7.2 Hz), 2.46 (m, 1 H), 2.27 (m, 4 H), 2.03 (m, 4 H), 1.81 (m, 3 H), 
1.55 (m, 3 H), 1.24 (t, 3 H, J = 7.2 Hz); 13C NMR (CDCl3) o 222.8, 173.3, 60.2, 57.7, 
44.2, 39.0, 38.2, 37.0, 35.7, 32.4, 23.3, 19.9, 14.2; MS (EI!DP): mle (%) 224 
(M+, 26), 198 (12), 196 (36), 179 (41), 150 (33), 137 (100), 136 (53), 122 (46), 
97 (52), 79 (54). 
(SR * ,6R *)-(±)-1-(Ethoxycarbonylmethyl)spiro[ 4.5] decan-6-one 
(12b): 640 mg (2.69 mmol, 42%); IR (thin film) 1730, 1720 cm-1; 1H NMR (eDel3) 
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o 4.14 (q, 2 H, J = 7.2 Hz), 2.44 (m, 2 H), 2.40 (m, 1 H), 2.10 (m, 1 H), 2.07-1.55 
(complex, 12 H), 1.40 (m, 1 H), 1.28 (t, 3 H, J = 7.2 Hz); Be NMR (eDel3) o 213.2, 
172.9, 60.0, 57 .9, 39.7, 39.2, 35.0, 34.9, 31.3, 29.6, 26.7, 21.5, 21.4, 14.0; MS 
(EI/DP): mle (%) 238 (M+, 16), 220 (41), 193 (38), 151 (100), 111 (60), 98 (86), 94 
(46), 93 (47), 81 (66), 79 (68), 67 (77), 55 (75). Anal. eaicd for e14H2203: e, 70.54; 
H, 9.31. Found: e, 69.90; H, 9.13. 
(SR*,6S*)-(±)-1-(Ethoxycarbonylmethyl)spiro[4.5]decan-6-one 
(13b): 210 mg (0.88 mmol, 14%); IR (thin film) 1735, 1715 cm-1; 1H NMR (eDel3) 
o 4.12 (q, 2 H, J = 7.2 Hz), 2.46 (m, 2 H), 2.25 (m, 1 H), 2.13 (m, 3 H), 2.04-1.36 
(complex, 11 H), 1.25 (t, 3 H, J = 7.2 Hz); Be NMR (eDel3) o 213.7, 173.5, 60.1, 
59.2, 44.1, 40.3, 38.0. 35.7, 35.1, 30.0 26.5, 22.4, 21.2, 14.1; MS (EI!DP): mle (%) 
238 (M+, 20), 220 (39), 191 (42), 151 (100), 98 (72), 93 (46), 81 (68), 67 (70), 55 (73). 
(SR *, 6R *)-(±)-1-(Ethoxycarbonylmethyl)spiro[ 4.6]undecan-6-one 
(12c): 980 mg (3.89 mmol, 60%); IR (thin film) 1730, 1700 cm-1; 1H NMR (eDel3) 
o 4.12 (q, 2 H, J = 7.0 Hz), 2.57 (m, 2 H), 2.52 (m, 1 H), 2.15 (m, 1 H), 2.08-1.40 
(complex, 14 H), 1.33 (t, 3 H, J = 7.0 Hz); Be NMR (eDel3) o 216.8, 172.8, 60.2, 
60.1, 42.9, 42.3, 36.7, 35.5, 30.9, 30.7, 30.5, 26.2, 25.3, 22.0, 14.1; MS (EI/DP): 
mle (%) 252 (M+, 19), 206 (44), 165 (77), 136 (82), 112 (70), 94 (60), 93 (62), 81 
(100), 79 (75), 67 (83), 55 (80). Anal. eaicd for e1sH2403: e, 71.38; H 9.59. 
Found: e, 70.57; H, 9.64. 
(SR * ,6S*)-(±)-1-(Ethoxycarbonylmethyl)spiro[ 4.6]undecan-6-one 
(13c): 30 mg (0.12 mmol, 2%); IR (thin film) 1735, 1700 cm-1; 1H NMR (eDel3) 
o 4.10 (q, 2 H, J = 7.0 Hz), 2.53 (m, 2 H), 2.37 (m, 1 H), 2.23 (m, 1 H), 2.05 (m, 1 H), 
1.95-1.51 (complex, 11 H), 1.48-1.33 (complex, 3 H), 1.17 (t, 3 H, J = 7.0 Hz); Be 
NMR (eDel3) o 217.7, 172.9, 61.3, 60.3, 47.8, 43.5, 37.7, 36.0, 34.9, 31.4, 30.6, 
26.7, 25.9, 22.5, 14.2; MS (EI/DP): mle (%) 252 (M+, 26), 206 (39), 165 (72), 137 
(59), 94 (63), 81 (100), 79 (78), 67 (72), 55 (80). 
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General Procedure for the Sodium Borohydride Reduction of 12a, 
12b, and 12c (14a, 14b, and 19). The procedure of Fieser and Ettorre78 was 
followed. A 5-mL ethanol solution of 2.00 mmol of the spiro compound was added to a 
slurry of 91 mg (2.40 mmol) of sodium borohydride in 10 mL of ethanol and the resulting 
mixture was stirred at room temperature for 8-10 h. The mixture was then cooled to 0 oc 
and 2 mL of 1.0 M HCl was slowly added dropwise over the course of 5 min. The 
ethanol was removed under vacuum, 15 mL of water was added and the resulting mixture 
was extracted twice with ether. The combined organic extracts were washed with water, 
saturated aqueous NaHC03 and saturated NaCl, dried over anhydrous Na2S04 and 
concentrated under vacuum. The products were isolated pure and used directly in the 
hydrolysis. The physical and spectral data were: 
(5R*,6R*)-(±)-6-(Ethoxycarbonylmethyl)-spiro[4.4]nonan-1-ol 
(14a): 384 mg (1.70 mmol, 85%); IR (thin film) 3580-3300, 1735 cm-1; 1H NMR 
(CDCl3) o 4.13 (q, 2 H, J = 7.2 Hz), 3.77 (m, 1 H), 2.86 (bs, 1 H), 2.30 (m, 1 H), 
2.10 (m, 2 H), 1.84 (m, 4 H), 1.72-1.60 (complex, 6 H), 1.32 (m, 2 H), 1.26 (t, 3 H, 
J = 7.2 Hz); 13C NMR (CDCl3) o 174.3, 75.6, 60.3, 54.8, 40.0, 35.3, 31.3, 30.0 (2), 
28.9, 21.6, 18.8, 14.1; HRMS, m/e for C13H2203: calcd, 226.1569; found, 226.1567. 
(5R * ,6R * )- (±)-1- (Ethoxycarbonylmethyl)spiro[ 4.5]decan-6-ol 
(14b): 418 mg (1.74 mmol, 87%); IR (thin .film) 3600-3200, 1730 cm-1; 1H NMR 
(CDCl3) o 4.14 (q, 2 H, J = 6.9 Hz), 3.33 (m, 1 H), 2.72 (bs, 1 H), 2.40 (m, 2 H), 
2.15 (m, 1 H), 1.92-1.44 (complex, 13 H), 1.31 (m, 1 H), 1.27 (t, 3 H, J = 6.9 Hz); 
13C NMR (CDCl3) o 174.6, 71.6, 60.4, 49.2, 39.3, 34.0, 32.1, 30.1, 28.9, 27.4, 24.8, 
21.5, 21.3, 14.1; HRMS, mle for C14H2403: calcd, 240.1725; found, 240.1726. 
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(SR * ,6R*)·(±)-1-(2-Hydroxyethyl)spiro[ 4.6]undecan-6-ol (19): 
352 mg (1.66 mmol, 83%); mp 90-91oC; IR (CHCl3) 3650-3200 cm-1; 1H NMR (CDCl3) 
o 3.72, (m, 1 H), 3.61 (m, 1 H), 2.70 (bs, 2 H), 2.07 (m, 2 H), 1.95 (m, 2 H), 1.80 (m, 
2 H), 1.68-1.32 (complex, 11 H), 1.21 (m, 2 H); 13C NMR (CDCl3) o 80.1, 62.6, 50.3, 
45.1, 36.1, 34.0, 33.8, 32.5, 28.0, 27.1, 22.3, 21.8, 21.3; HRMS, mle for C13H2402: 
calcd, 212.1776; found, 212.1770. 
General Procedure for the Hydrolysis of 14a and 14b (15a and 15b). 
A 5-mL ethanol solution of 1.00 mmol of the hydroxyester was added to 10 mL of 1.0 M 
NaOH and the resulting solution was heated with stirring at 40 oc for 2 h. The solution 
was cooled and carefully acidified to a pH of ca. 3 by dropwise addition of 6.0 M HCI. 
The resulting solution was stirred at 23 oc for 2 h, then extracted twice with ether. The 
combined organic extracts were washed with water and saturated NaCl, then dried over 
Na2S04 and concentrated in vacuo to give the following products. 
(5R*,6R*)·(±)-6-(Carboxymethyl)spiro[4.4]nonan-1-ol (15a): 
176 mg (0.88 mmol, 89%); IR (thin film) 3540-2500, 1710 cm-1; 1H NMR (CDCh) 
o 6.60 (bs, 2 H), 3.83 (m, 1 H), 2.36 (m, 1 H), 2.15 (m, 2 H), 1.98 (m, 2 H), 1.80 (m, 
1 H), 1.74-1.42 (complex, 5 H), 1.32 (m, 4 H); 13C NMR (CDCl3) o 179.2, 75.8, 54.9, 
39.7, 35.1, 31.5, 31.3, 30.1, 29.0, 21.7, 18.8; MS (CI, isobutane): mle (%) 198 (2), 
180 (8), 163 (11), 139 (13), 121 (100), 79 (30). 
(SR * ,6R *)-(±)-1-(Carboxymethyl)spiro[ 4.5]decan-6-ol (15b ): 
193 mg (0.91 mmol, 91 %); mp 123-124oC; IR (CHCl3) 3520-2540, 1710 cm-1; 1H NMR 
(CDCl3) o 7.00 (bs, 2 H), 3.40 (m, 1 H), 2.42 (m, 2 H), 2.16 (m, 1 H), 1.85 (m, 2 H), 
1.73-1.40 (complex, 5 H), 1.36-1.12 (complex, 6 H), 1.00-0.88 (m, 1 H); Be NMR 
(CDCh) o 179.3, 71.9, 49.1, 39.2, 33.9, 32.0, 30.1, 29.0, 27.4, 24.8, 21.6, 21.3; 
MS (CI, isobutane): mle (%) 212 (4), 195 (30), 194 (55), 152 (19), 135 (100), 93 (28), 
67 (32). 
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(SR* ,6S*)-(±)-1-(2-Hydroxyethyl)spiro[ 4.5]decan-6-ol (18a and 
18b). A 1-mL ethanol solution of 100 mg (0.42 mmol) of 13b was added to a slurry of 
19.1 mg (0.52 mmol) of sodium borohydride in 3 mL of ethanol and the resulting mixture 
was stirred at room temperature for 8 h. The mixture was then cooled to 0 oc and 0.5 mL 
of 1.0 M HCl was slowly added dropwise over the course of 5 min. The ethanol was 
removed under vacuum, 10 mL of water was added and the resulting mixture was 
extracted twice with ether. The combined organic extracts were washed with water, 
saturated aqueous NaHC03 and saturated NaCl, dried over anhydrous NazS04 and 
concentrated under vacuum. 1H and 13C-NMR analysis indicated that the crude reduction 
isolate was a mixture of two diastereomeric diol products. The mixture was passed 
through a 5.0 em silica gel plug with 50% ether in hexane to remove any polymeric 
material and then concentrated in vacuo. The resulting clear oil was purified by HPLC on 
a Waters 590 programmable HPLC, using a reverse phase Dynamax C-18 prep column 
eluted with 30:70 water:methanol. At a flow rate of 10 rnljmin, 250 J.1L injections 
containing 50 mg of the product mixture could be separated; a total of two injections were 
made. The first and major band (RT = 13.8 min) afforded 40 mg (0.20 mmol, 48%) of 
diastereomeric diol product 18a as a white solid after concentration of the collected eluent 
and extraction with ether, mp 49-50°C. The spectral data for 18a were: IR (CHCI3) 
3650-3060 cm-1; 1H NMR (CDCl3) B 3.72 (m, 1 H), 3.60 (m, 1 H), 3.45 (m, 1 H), 
1.80-1.52 (complex, 7 H), 1.48-1.03 (complex, 12 H); 13C NMR (CDCl3) B 73.9, 63.0, 
48.5 (2), 37.9, 33.4, 32.9, 32.7, 29.8, 24.4, 24.1, 23.3; HRMS, mle for C12H220z: 
calcd, 198.1620; found, 198.1623. The second band CRT= 19.8 min) afforded 26 mg 
(0.13 mmol, 31%) of diastereomeric diol product 18b as a white solid after concentration 
of the collected eluent and extraction with ether, mp 56-57°C. The spectral data for 18b 
were: IR (CHCI3) 3635-3060 cm-1; 1H NMR (CDCI3) B 3.70 (m, 2 H), 3.52 (m, 1 H), 
2.42 (bs, 2 H), 1.88 (m, 1 H), 1.74 (m, 1 H), 1.66 (m, 5 H), 1.64-1.22 (complex, 8 H), 
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1.12 (m, 2 H); 13C NMR (CDCl3) B 71.1, 62.0, 49.4, 44.5, 31.8, 30.7, 30.3, 30.0, 
28.7, 21.8, 21.2, 19.6; HRMS, mle for C12H2202: calcd, 198.1620; found, 198.1619. 
General Procedure for the Hydrolysis of Ketoesters 12a, 12b, and 
12c to Afford Ketoacids 22a, 22b, and 22c. A 5-mL ethanol solution of 1.00 
mmol of the ketoester was added to 10 mL of 1.0 M NaOH and the resulting solution was 
heated with stirring at 40 oc for 2 h. The solution was cooled and carefully acidified to a 
pH of ca. 3 by dropwise addition of 6.0 M HCI. The resulting solution was extracted 
twice with ether and the combined organic extracts were washed with water and saturated 
NaCl, dried over Na2S04 and concentrated in vacuo to afford the following ketoacid 
products. The products were isolated pure and used directly in the subsequent reduction 
step. The physical and spectral data were: 
(SR*,6R*)-(±)-6-(Carboxymethyl)spiro[4.4]nonan-1-one (22a): 
171 mg (0.87 mmol, 87%); IR (thin film) 3300-2500, 1740, 1730 cm-1; 1H NMR 
(CDCl3) a 10.60-9.80 (bs, 1 H), 2.60 (m, 1 H), 2.30 (m, 3 H), 2.06 (m, 2 H), 1.98 (m, 
1 H), 1.83 (m, 2 H), 1.70 (m, 4 H), 1.55 (m, 1 H), 1.31 (m, 1 H); 13C NMR (CDC13) a 
222.8, 178.6, 58.5, 40.8, 37.7, 37.4, 35.6, 32.0, 31.1, 22.7, 19.3; MS (CI, isobutane): 
mle (%) 196 (27), 179 (100), 155 (21), 137 (27), 97 (48), 80 (57). 
(SR * ,6R *)-(±)-1-(Carboxymethyl)spiro[ 4.5]decan-6-one (22b): 
179 mg (0.85 mmol, 85%); mp 78-79°C; IR (CHC13) 3420-2510, 1735, 1710 cm-1; 
1H NMR (CDCl3) a 11.00-9.80 (bs, 1 H), 2.90 (m, 1 H), 2.40 (m, 3 H), 2.14 (m, 1 H), 
1.98 (m, 2 H), 1.84 (m, 1 H), 1.80-1.45 (complex, 8 H), 1.25 (m, 1 H); 13c NMR 
(CDC13) a 213.8, 179.3, 58.1, 39.9, 39.1, 35.0, 34.9, 31.6, 29.6, 26.9, 21.7, 21.6; 
MS (CI, isobutane): mle (%) 210 (10), 193 (100), 169 (16), 151 (34), 111 (31), 80 (28), 
67 (32). 
(SR * ,6R *)-(±)-1-(Carboxymethyl)spiro[ 4.6]undecan-6-one (22c): 
197 mg (0.88 mmol, 88%); IR (thin film) 3560-2500, 1720, 1710 cm-1; 1H NMR 
(CDCl3) a 10.00-8.60 (bs, 1 H), 2.56 (m, 4 H), 2.16 (m, 1 H), 1.96 (m, 2 H), 1.88-
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1.46 (complex, 11 H), 1.35 (m, 1 H); Be NMR (eDel3) S 217.1, 179.0, 60.3, 42.5, 
42.3, 36.8, 35.3, 31.0, 30.7, 30.5, 26.2, 25.4, 22.1; MS (ei, isobutane): mle (%) 225 
(M+1, 24), 224 (18), 207 (68), 165 (28), 136 (63), 125 (53), 109 (100), 93 (47), 81 (69), 
67 (59). 
General Procedure for the Sodium Borobydride Reduction of 
Ketoacids 22a, 22b, and 22c to Afford Hydroxyacids 15a, 15b, and 
Lactone 24. The general procedure of House and co-workers 76 was followed. A 2-mL 
ethanol solution of 0.80 mmol of the ketoacid was slowly added to a stirred slurry of 61 
mg (1.60 mmol) of sodium borohydride in 3 mL of ethanol at o·e over the course of 2 
min so as to moderate the release of evolved hydrogen gas and the resulting mixture was 
stirred at room temperature for 6 h. The mixture was then cooled to 0 ·e and 2 mL of 1.0 
M Hel was slowly added dropwise over the course of 5 min, followed by 10 mL of water 
and enough additional 1.0 M Hel to reach a pH of ca. 3. The resulting solution was 
stirred at room temp~rature for 2 h and extracted twice with ether. The combined organic 
extracts were washed with water and saturated aqueous Nael, dried over anhydrous 
Na2S04 and concentrated in vacuo to yield the following reduction products. The physical 
and spectral data were: 
15a: 141 mg (0.71 mmol, 89%); the product isolated was identical spectro-
scopically to that described previously. 
15b: 155 mg (0.73 mmol, 91 %); the product isolated was identical spectro-
scopically to that described previously. 
(5R*,6R*)-(±)-1-(earboxymetbyl)spiro[4.6]undecan-6-ol Lactone 
(24): 141 mg (0.68 mmol, 85%); IR (thin film) 1735 cm-1; lHNMR (eDel3) S 4.29 (m, 
1 H), 2.69 (m, 1 H), 2.34 (m, 1 H), 2.11 (m, 1 H), 2.02-1.79 (complex, 6 H), 1.75-
1.42 (complex, 6 H), 1.34 (m, 2 H), 1.19 (m, 2 H); Be NMR (eDel3) S 171.9, 90.0, 
46.2, 45.7, 34.0, 32.9, 31.6, 26.9, 26.7, 21.8, 20.9, 20.7, 18.9; MS (EIIDP): mle (%) 
208 (12), 166 (50), 148 (100), 95 (32), 81 (46), 67 (65). 
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General Procedure for Hydrolysis of the Ketoesters 13a and 13b to 
Afford Ketoacids 23a and 23b. A 1-mL ethanol solution of 0.30 mmol of the 
ketoester was added to 5 mL of 1.0 M NaOH and the resulting solution was heated with 
stirring at 40 oc for 2 h. The solution was cooled and carefully acidified to a pH of ca. 3 
by dropwise addition of 6.0 M HCl. The resulting solution was extracted twice with ether 
and the combined organic extracts were washed with water and saturated NaCl, dried over 
anhydrous Na2S04 and concentrated in vacuo. The ketoacid products were isolated pure 
and used directly in the subsequent reduction step. The physical and spectral data were: 
(5R*,6S*)-(±)-6-(Carboxymethyl)spiro[4.4]nonan-1-one (23a): 
53 mg (0.27 mmol, 90%); IR (thin film) 3500-2700, 1735, 1715 cm-1; 1H NMR (CDC13) 
~ 10.00-8.60 (bs, 1 H), 2.46 (m, 1 H), 2.29 (m, 1 H), 2.16 (m, 3 H), 1.91 (m, 2 H), 
1.75 (m, 2 H), 1.58 (m, 5 H), 1.25 (m, 1 H); 13C NMR (CDCl3) ~ 223.0, 179.1, 57.8, 
43.9, 39.1, 38.1, 37.0, 35.4, 32.4, 23.3, 19.9; MS (CI, isobutane): mle (%) 196 (31), 
179 (100), 137 (30), 97 (65), 80 (70), 67 (30). 
(5R*,6R*)-(±)-1-(Carboxymethyl)spiro[4.5]decan-6-one (23b): 
53 mg (0.25 mmol, 83%); IR (thin film) 3480-2710, 1720, 1710 cm-1; 1H NMR (CDC13) 
~ 11.00-9.90 (bs, 1 H), 2.59 (m, 1 H), 2.45 (m, 1 H), 2.30 (m, 2 H), 2.12 (m, 3 H), 
2.02 (m, 1 H), 1.94-1.58 (complex, 8 H), 1.48 (m, 1 H); 13C NMR (CDC13) ~ 214.0, 
179.4, 59.3, 44.3, 40.3, 38.1, 36.2, 34.9, 30.3, 26.5, 22.6, 21.4; MS (CI, isobutane): 
mle (%) 210 (33), 193 (100), 151 (42), 111 (62), 102 (81), 67 (42). 
General Procedure for the Sodium Borohydride Reduction of 
Ketoacids 23a and 23b to Afford Lactones 17a and 17b. The general 
procedure of House and co-workers76 was followed. A 1-mL ethanol solution of 0.25 
mmol of the ketoacid was slowly added to a stirred slurry of 19 mg (0.50 mmol) of 
sodium borohydride in 1.5 mL of ethanol at ooc over the course of 2 min so as to 
moderate the release of evolved hydrogen gas and the resulting mixture was stirred at 
room temperature for 6 h. The mixture was then cooled to 0 oc and 0.75 mL of 1.0 M 
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Hel was slowly added dropwise over the course of 5 min, followed by 5 mL of water and 
enough additional 1.0 M Hel to reach a pH of ca. 3. The resulting solution was stirred at 
room temperature for 2 h and extracted twice with ether. The combined organic extracts 
were washed with water and saturated aqueous Nael, dried over anhydrous Na2S04 and 
concentrated in vacuo. In both cases, the lactone products were isolated as mixtures of cis 
diastereomers. The physical and spectral data were: 
(SR * ,6S*)·(±)-6-(Carboxymethyl)spiro[ 4.4]nonan-l-ol Lactone 
(17a): 33 mg (0.18 mmol, 72%); IR (thin film) 1740, 1730 cm-1; lH NMR (eDel3) 
o 4.32 (m, 0.5 H), 4.26 (m, 0.5 H), 2.71 (m, 0.5 H), 2.54 (m, 0.5 H), 2.28 (m, 0.5 H), 
2.18 (m, 0.5 H), 2.12 (m, 1 H), 2.00 (m, 2 H), 1.83 (m, 2 H), 1.67 (m, 3 H), 1.61 (m, 
4 H), 1.05 (m, 1 H); Be NMR (eDel3) o 176.1, 174.3, 87.6, 82.3, 54.0, 41.2, 39.2, 
38.1, 37.7, 36.9, 36.0, 34.6, 34.0, 33.9, 30.9, 29.7, 25.9, 25.0, 24.0, 21.3, 19.2; MS 
(EI/DP): mle (%) 180 (4), 152 (4), 138 (15), 120 (100), 112 (13), 94 (78), 79 (38), 67 
(30). 
(SR* ,6S*)-(±)-1-(Carboxymethyl)spiro[4.S]decan-6-ol Lactone 
(17b): 36 mg (0.19 mmol, 76%); IR (thin film) 1745, 1735 cm-1; lH NMR (eDel3) 
o 4.09 (m, 0.5 H), 3.96 (m, 0.5 H), 2.69 (m, 0.5 H), 2.61 (m, 0.5 H), 2.52 (m, 1 H), 
2.00 (m, 2 H), 1.82-1.26 (complex, 13 H); Be NMR (eDel3) o 174.2, 174.1, 81.9, 
79.7, 46.6, 44.7, 44.1, 42.5, 36.8, 35.7, 35.4, 35.1, 34.6, 34.2, 34.0, 29.4, 28.0, 
27.1, 25.4, 24.3, 24.1, 22.6, 22.1, 19.5; MS (EIIDP): mle (%) 194 (10), 152 (43), 134 
(100), 112 (93), 108 (69), 93 (33), 79 (36), 67 (67). 
2,4-DNP of (SR* ,6R*)-(±)-1-(Ethoxycarbonylmethyl)spiro[4.6]-
undecan-6-one (26). To a 5-mL ethanol solution of 2,4-dinitrophenylhydrazine 
reagent79 was added a 2-mL ethanol solution of 90 mg (0.36 mmol) of 12c in one 
portion and the resulting solution was allowed to stand at room temperature for 4 h until 
deposition of the adduct was complete. The crude adduct was isolated by filtration and 
recrystallized from absolute ethanol to afford 130 mg (0.30 mmol, 83 %) of 26 as a fine 
orange solid, mp 178-179°C. The spectral data were: IR (CHCl3) 3380, 1725, 1665, 
1525, 1350 cm-1; 1H NMR (CDC13) 8 11.29 (s, 1 H), 9.13 (d, 1 H, J = 2.7 Hz), 8.30 
(dd, 1 H, J = 9.6, 2.7 Hz), 8.04 (d, 1 H, J = 9.6 Hz), 4.18 (q, 2 H, J = 7.5 Hz), 3.72 
(m, 1 H), 2.78 (m, 2 H), 2.46 (m, 1 H), 2.06 (m, 2 H), 1.91-1.54 (complex, 10 H), 
1.42 (m, 3 H), 1.30 (t, 3 H, J = 7.5 Hz); 13C NMR (CDC13) 8 173.6, 165.3, 145.5, 
137.6, 130.1, 129.1, 123.5, 116.6, 60.4, 55.2, 42.0, 39.4, 36.0, 33.4, 31.0, 29.4, 
28.4, 25.0, 24.5, 20.8, 14.4; HRMS, mle for C21H2s06N4: calcd, 432.2009; found, 
432.2012. 
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General Procedure for the Preparation of (±)-2-Methoxycarbonyi-2-
((E)-6-ethoxycarbonyl-5-hexenyl)cycloalkanones (lld, lle, and llf). A 
solution of potassium tert-butoxide was generated by dissolving 1.06 g (27.1 mg-atm) of 
potassium metal in 70 mL of tert-butyl alcohol at 40-50°C. The solution was cooled to 
20oC and 27.1 mmol of the 2-methoxycarbonylcycloalkanone (lOa, lOb, or tOe) was 
added with stirring. After stirring for 1 h at 20°C, 7.64 g (27 .1 mmol) of ethyl (E)-7-
iodo-2-heptenoate (9b) was added dropwise and the reaction was refluxed for 18 h. The 
reaction was cooled to 20oC and poured into 125 mL of 0.5 M HCl. The resulting 
solution was extracted twice with ether and the combined ether extracts were washed with 
0.5 M HCl, water, saturated aqueous NaHC03, 5% aqueous sodium thiosulfate and 
saturated aqueous NaCl, dried over anhydrous MgS04 and concentrated in vacuo to yield a 
thick yellow oil. The oil was purified by vacuum distillation using a Kugelrohr apparatus. 
The physical and spectral properties of the products were the following: 
(±)-2-Methoxycarbonyi-2-((E)-6-ethoxycarbonyl-5-hexenyl)-
cyclopentanone (lld): 5.21 g (17.6 mmol, 65%); bp 140-146°C (0.5 mm Hg); 
IR (thin film) 1755, 1730, 1720, 1650 cm-1; 1H NMR (CDC13) 8 6.95 (dt, 1 H, J = 15.9, 
7.0 Hz), 5.83 (d, 1 H, J = 15.9 Hz), 4.20 (q, 2 H, J = 7.2 Hz), 3.73 (s, 3 H), 2.55 (m, 
1 H), 2.40 (m, 1 H), 2.27 (m, 3 H), 1.97 (m, 4 H), 1.53 (m, 3 H), 1.37 (m, 2 H), 1.31 
(t, 3 H, J = 7.2 Hz); 13C NMR (CDC13) 8 214.5, 171.2, 166.4, 148.5, 121.3, 60.2, 
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59.9, 52.3, 37.7, 33.4, 32.5, 31.6, 28.0, 24.2, 19.4, 14.1; MS (ei, is<?butane): m/e (%) 
297 (M+1, 87), 251 (79), 233 (37), 219 (100), 191 (36). 
(±)-2-Methoxycarbonyi-2-((E)-6-ethoxycarbonyl-5-hexenyl)-
cyclohexanone (lle): 5.21 g (16.8 mmol, 62%); bp 154-158oe (0.5 mm Hg); 
IR (thin film) 1730, 1720, 1715, 1660 cm-1; 1H NMR (eDel3) a 6.93 (dt, 1 H, J = 15.6, 
6.9 Hz), 5.80 (d, 1 H, J = 15.6 Hz), 4.17 (q, 2 H, J = 7.2 Hz), 3.73 (s, 3 H), 2.43 (m, 
3 H), 2.20 (m, 2 H), 2.02 (m, 1 H), 1.87 (m, 1 H), 1.81-1.40 (complex, 7 H), 1.29 (m, 
2 H), 1.28 (t, 3 H, J = 7.2 Hz); Be NMR (eDel3) a 207.3, 172.1, 166.2, 148.5, 
121.1, 60.5, 59.7, 51.9, 40.7, 35.8, 34.0, 31.5, 28.0, 27.3, 23.5, 22.2, 14.0; MS (ei, 
isobutane): mle (%) 311 (M+1, 100), 265 (26), 247 (32), 227 (15), 205 (27), 125 (31). 
(±)-2-Methoxycarbonyi-2-((E)-6-ethoxycarbonyl-5-hexenyl)-
cycloheptanone (llf): 6.15 g (19.0 mmol, 70%); bp 162-168oe (0.5 mm Hg); 
IR (thin film) 1740, 1730, 1715, 1655 cm-1; 1H NMR (eDel3) a 6.94 (dt, 1 H, J = 15.6, 
7.2 Hz), 5.82 (d, 1 H, J = 15.6 Hz), 4.18 (q, 2 H, J = 6.9 Hz), 3.72 (s, 3 H), 2.63 (m, 
1 H), 2.46 (m, 1 H), 2.17 (m,-3 H), 1.95 (m, 1 H), 1.80-1.36 (complex, 10 H), 1.28 (m, 
2 H), 1.27 (t, 3 H, J = 6.9 Hz); Be NMR (eDel3) a 209.2, 172.7, 166.3, 148.5, 121.2, 
62.6, 59.8, 51.9, 41.7, 34.8, 32.5, 31.6, 29.6, 28.0, 25.3, 24.6, 23.8, 14.0; MS (el, 
isobutane): m!e (%) 325 (M+1, 100), 219 (17), 185 (53), 173 (23). 
General Decarboxylation-Michael Addition Procedure for the 
Formation of 6-Ring Spiranes (12d-f and 13d-f). A solution of 5.00 mmol of 
the (±)-2-methoxycarbonyl-2-((E)-6-ethoxycarbonyl-5-hexenyl)cycloalkanone (lld, 
lle, or llf) and 0.64 g (15.0 mmol) of anhydrous lithium chloride in 15-20 mL of 
anhydrous HMPA was stirred at 125-130oe for 6 h. The resulting brown reaction 
mixture was cooled to 25°C, poured into 50 mL of 0.5 M HCl and extracted 3x with ether. 
The combined ether extracts were washed with 0.5 M Hel, water, saturated aqueous 
NaHC03 and saturated aqueous Nael, dried over anhydrous MgS04 and concentrated in 
vacuo. The crude product was purified by PTLC using the following elution sequence: 
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99:1 hexane/ether (2x), 98:2 hexane/ether (2x), 96:4 hexane/ether (3x) and 95:5 
hexane/ether (3x). This elution procedure pennitted separation of the major and minor 
diastereomeric products in relatively high purity. In all cases the third band was the minor 
isomer, the fourth band contained a small amount of a mixture and the fifth band gave the 
major isomer. The following compounds were isolated: 
(SR*,6R*)-(±)-6-(Ethoxycarbonylmethyl)spiro[4.5]decan-1-one 
(12d): 571mg (2.40 mmol, 48%); IR (thin film) 1740, 1730 cm-1; 1H NMR (eDC13) 
o 4.09 (q, 2 H, J = 6.9 Hz), 2.36 (m, 1 H), 2.22 (m, 1 H), 2.10 (m, 1 H), 1.98 (m, 2 H), 
1.96-1.78 (complex, 5 H), 1.68 (m, 4 H), 1.51 (m, 1 H), 1.30 (m, 2 H), 1.24 (t, 3 H, 
J = 6.9 Hz); Be NMR (eDel3) o 223.2, 172.4, 60.4, 53.2, 38.6, 37.9, 37.5, 33.3, 
28.7, 27.5, 25.5, 21.7, 18.9, 14.2; MS (EI/DP): mle (%) 238 (18), 220 (43), 193 (38), 
151 (100), 150 (63), 110 (57), 97 (41), 94 (42), 79 (70), 67 (78). Anal. eaicd for 
e14H2203: e, 70.54; H, 9.31. Found: e, 69.97; H, 9.31. 
(SR * ,6S *)-(±)-6-(Ethoxycarbonylmethyl)spiro[ 4.5]decan-1-one 
(13d): 24 mg (0.10 mmol, 2%); IR (thin film) 1745, 1730 cm-1; 1H NMR (eDel3) 
o 4.10 (q, 2 H, J = 7.2 Hz), 2.56 (m, 1 H), 2.19 (m, 4 H), 2.03 (m, 1 H), 1.87 (m, 2 H), 
1.74-1.46 (complex, 6 H), 1.34 (m, 2 H), 1.24 (t, 3 H, J = 7.2 Hz), 1.08 (m, 1 H); Be 
NMR (eoe13) o 222.1, 173.5, 60.3, 50.6, 38.9, 36.4, 36.2, 35.3, 31.8, 27.9, 23.2, 
21.6, 18.5, 14.2; MS (EI/DP): mle (%) 238 (23), 220 (38), 193 (32), 150 (100), 108 
(61), 97 (49), 79 (68). 
(6R*,7R*)-(±)-7-(Ethoxycarbonylmethyl)spiro[S.S]undecan-1-one 
(12e): 529 mg (2.10 mmol, 42%); IR (thin film) 1735, 1720 cm-1; 1H NMR (eDel3) 
o 4.13 (q, 2 H, J = 7.2 Hz), 2.56 (m, 1 H), 2.44 (m, 1 H), 2.28 (m, 2 H), 1.98 (m, 4 H), 
1.80-1.38 (complex, 11 H), 1.26 (t, 3 H, J = 7.2 Hz); Be NMR (eDel3) o 215.0, 173.1, 
60.1, 51.5, 38.4, 36.7, 36.3, 32.5, 26.9, 26.8, 26.1, 24.8, 20.7, 20.0, 14.2; MS 
(EI!DP): m/e (%) 252 (17), 234 (46), 207 (39), 165 (100), 111 (61), 98 (84), 97 (58), 
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79 (69), 67 (77). Anal. Calcd for C15H2403: C, 71.38; H 9.59. Found: C, 70.93; H, 
9.64. 
( 6R *, 7 S*)-(±)-7 -(Ethoxycarbonylmethyl)spiro[5.5]undecan-1-one 
(13e): 28 mg (0.11 mmol, 2%); IR (thin film) 1735, 1720 cm-1; 1H NMR (CDC13) 
5 4.13 (q, 2 H, J = 6.9 Hz), 2.49 (m, 2 H), 2.23 (m, 3 H), 2.01 (m, 2 H), 1.82 (m, 1 H), 
1.71-1.37 (complex, 7 H), 1.31 (m, 4 H), 1.21 (t, 3 H, J = 6.9 Hz); 13C NMR (CDC13) 
5 214.5, 173.1, 60.2, 52.3, 37.9, 37.0, 36.3, 35.9, 33.9, 31.2, 28.2, 23.6, 21.4, 19.1, 
14.1; MS (EIJDP): mle (%) 252 (19), 234 ( 48), 207 (38), 165 (100), 164 (73), 110 (59), 
97 (61), 79 (72), 67 (79). 
(lR * ,6S*)-(±)-1-(Ethoxycarbonylmethyl)spi ro[5.6] dodecan-7 -one 
(12f): 692 mg (2.60 mmol, 52%); IR (thin film) 1740, 1725 cm-1; lH NMR (CDC13) 
5 4.12 (q, 2 H, J = 7.2 Hz), 2.60 (m, 1 H), 2.46 (m, 2 H), 2.34 (m, 1 H), 2.00 (m, 1 H), 
1.82 (m, 1 H), 1.74-1.36 (complex, 14 H), 1.30 (m, 1 H), 1.25 (t, 3 H, J = 7.2 Hz); 
13C NMR (CDCl3) 5 217.2, 172.8, 60.1, 53.2, 42.4, 38.3, 36.6, 34.9, 31.0, 28.6, 27.2, 
25.9, 24.8, 24.6, 20.8, 14.1; MS (EI/DP): mle (%) 266 (21), 220 (45), 179 (79), 150 
(83), 112 (74), 96 (66), 81 (100), 79 (67), 67 (81). Anal. Calcd for C16H2603: C, 
72.13; H, 9.84. Found: C, 71.93; H, 9.64. 
(1S*,6S*)-(±)-1-(Ethoxycarbonylmethyl)spiro[5.6]dodecan-7-one 
(13f): 27 mg (0.10 mmol, 2%); IR (thin film) 1730, 1715 cm-1; lH NMR (CDC13) 
5 4.12 (q, 2 H, J = 7.1 Hz), 2.61 (m, 2 H), 2.34 (m, 2 H), 2.21 (m, 1 H), 2.06 (m, 1 H), 
1.94-1.48 (complex, 10 H), 1.35 (m, 5 H), 1.20 (t, 3 H, J = 7.1 Hz); 13C NMR (CDC13) 
5 217.3, 173.6, 62.0, 59.9, 45.7, 44.0, 38.1, 37.1, 36.2, 33.3, 30.2, 26.5, 24.9, 23.4, 
22.4, 14.2; MS (EI/DP): mle (%) 266 (17), 220 (44), 179 (78), 151 (81), 112 (72), 96 
(69), 81 (100), 79 (76), 67 (81). 
General Procedure for the Hydrolysis of 12d, 12e, 12f, and 13d to 
Afford Ketoacids 27d, 27e, 27f, and 3ld. A 1-mL ethanol solution of 0.30 mmol 
of the ketoester was added to 5 mL of 1.0 M NaOH and the resulting solution was heated 
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with stirring at 40 oc for 2 h. The solution was cooled and carefully acidified to a pH of 
ca. 3 by dropwise addition of 6.0 M HCl. The resulting solution was extracted twice with 
ether and the combined organic extracts were washed with water and saturated NaCl, dried 
over anhydrous Na2S04 and concentrated in vacuo to afford the following ketoacid 
products. The products were isolated pure and used directly in the subsequent reductions 
and amide formation steps. The physical and spectral data were: 
(SR*,6R*)-(±)-6-(Carboxymethyl)spiro[4.5]decan-1-one (27d): 53 
mg (0.25 mmol, 83%); IR (thin film) 3460-2700, 1740, 1715 cm-1; 1H NMR (CDCl3) a 
10.30-9.80 (bs, 1 H), 2.40 (m, 1 H), 2.22 (m, 1 H), 2.10 (m, 2 H), 1.98-1.80 (complex, 
8 H), 1.54 (m, 1 H), 1.31 (m, 3 H), 1.08 (m, 1 H); 13C NMR (CDCl3) a 223.4, 178.3, 
53.2, 38.4, 37.5, 37.1, 33.0, 28.6, 27.4, 25.4, 21.5, 18.8; MS (CI, isobutane): 
mle (%) 210 (25), 193 (100), 169 (36), 151 (42), 111 (55), 67 (38). 
(6R*, 7 R *)-(±)-7 -(Carboxymethyl)spiro[S.S]undecan-1-one (27e): 
57 mg (0.26 mmol, 87%); IR (thin film) 3500-2720, 1720, 1710 cm-1; 1H NMR (CDCl3) 
a 10.80-10.20 (bs, 1 H), 2.46 (m, 2 H), 2.24 (m, 2 H), 1.95 (m, 5 H), 1.76-1.24 
(complex, 9 H), 1.08 (m, 1 H); 13C NMR (CDCl3) a 215.5, 179.1, 51.5, 38.3, 36.7, 
36.2, 32.4, 27.3, 26.8, 24.9, 20.6, 20.0; MS (CI, isobutane): mle (%) 224 (18), 207 
(100), 183 (29), 164 (53), 125 (45), 67 (40). 
(lR * ,6S* )-(±)-1-(Carboxymethyl)spiro[5.6]dodecan-7 -one (27f): 
67 mg (0.28 mmol, 93%); IR (thin film) 3620-2870, 1725, 1710 cm-1; 1H NMR (CDCl3) 
a 10.30-9.85 (bs, 1 H), 2.54 (m, 1 H), 2.38 (m, 3 H), 1.97 (m, 1 H), 1.80 (m, 1 H), 
1.71-1.13 (complex, 15 H); 13C NMR (CDCl3) a 217.5, 179.1, 53.3, 42.2, 38.0, 36.5, 
35.3, 31.0, 28.7, 27.3, 25.9, 25.0, 24.6, 20.8; MS (CI, isobutane): mle (%) 238 (31), 
221 (76), 179 (33), 150 (65), 139 (51), 123 (100), 81 (67), 67 (62). 
(SR * ,6S*)-(±)-6-(Carboxymethyl)spiro[ 4.5]decan-1-one (31d): 55 
mg (0.26 mmol, 87%); IR (thin film) 3770-2810, 1745, 1715 cm-1; 1H NMR (CDC13) 
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o 10.21-9.62 (bs, 1 H), 2.63 (m, 1 H), 2.22 (m, 2 H), 2.01 (m, 1 H), 1.87 (m, 2 H), 
1.65 (m, 2 H), 1.45 (m, 2 H), 1.32-1.09 (complex, 6 H), 0.95 (m, 1 H); 13C NMR 
(CDC13) o 224.1, 178.6, 50.6, 38.9, 36.2 (2), 34.9, 31.7, 29.7, 27.9, 23.1, 21.6, 18.5; 
MS (CI, isobutane): mle (%) 210 (31), 193 (100), 171 (25), 169 (42), 151 (53), 111 
(55), 79 (37), 67 (42). 
General Procedure for the Preparation of Amides 29a and 29c. The 
general procedure ofMeinwald and co-workers80 was followed. A 5-mL benzene solution 
of 1.00 mmol of the ketoacid (27d or 27f) and 570 mg (4.50 mmol, 0.40 mL) of oxalyl 
chloride was refluxed with stirring for 2 h and the resulting solution was allowed to cool 
to room temperature. The benzene and excess oxalyl chloride were removed by rotory 
evaporation to afford a light yellow residue which was dissolved in 5 mL of dry benzene. 
The benzene solution was then added dropwise to a stirred 10-mL benzene solution of 120 
mg (1.5 mmol) of dry pyridine and 200 mg (1.2 mmol) of 4-bromoaniline at 0-5°C and the 
resulting mixture was stirred at room temperature for 6 h. The mixture was concentrated 
in vacuo to afford a yellow residue which was dissolved in water and extracted twice with 
ether. The combined organic extracts were washed with 1.0 M HCl, water, saturated 
aqueous NaHC03 and saturated aqueous NaCl, dried over anhydrous MgS04 and 
concentrated in vacuo to afford a light yellow solid that was recrystallized from ether I 
hexane to afford the amide product The physical and spectral properties were: 
(SR * ,6R *)-(±)-N-( 4-B romop henyl)-6-( carbamoylmethyl)spiro [ 4.5]-
decan-1-one (29a): 320 mg (0.88 mmol, 88%); mp 155-156oC; IR (CHCl3) 3320, 
1745, 1670 cm-1; lH NMR (CDCl3) o 7.62 (bs, 1 H), 7.36 (m, 4 H), 2.44 (m, 1 H), 
2.13 (m, 2 H), 2.06-1.83 (m, 7 H), 1.64 (m, 3 H), 1.24 (m, 4 H); 13C NMR (CDCl3) 
0 225.1, 170.6, 137.3, 131.9, 121.2, 116.5, 54.5, 41.8, 39.5, 38.2, 32.7, 29.0, 26.9, 
25.6, 21.4, 18.6; HRMS, mle for ClsHzzOzN79Br: calcd, 363.0834; found, 363.0832. 
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(1R*,6S*)-(±)-N-(4-Bromophenyl)-1-(carbamoylmethyl)spiro[S.6]-
dodecan-7-one (29c): 356 mg (0.91 mmol, 91 %); mp 183-184oe; IR (eHel3) 3325, 
1715, 1675 cm-1; 1H NMR (eDel3) o 8.24 (bs, 1 H), 7.50 (m, 2 H), 7.41 (m, 2 H), 
2.77 (m, 1 H), 2.42 (m, 2 H), 2.29 (m, 1 H), 2.04 (m, 1 H), 1.80 (m, 7 H), 1.61-1.14 
(complex, 9 H); Be NMR (eDel3) o 219.1, 171.7, 137.7, 131.8, 121.0, 116.1, 54.2, 
42.2, 41.7, 40.3, 37.5, 31.1, 28.4, 27.9, 26.1, 26.0, 25.4, 20.8; HRMS, mle for 
e2oH2602N79Br: calcd, 391.1147; found, 391.1148. 
General Procedure for the Sodium Borohydride Reduction of 
Ketoacids 27d, 27e, and 3ld to Afford Hydroxyacids 30d and 30e and 
Lactone 32d. The general procedure of House and co-workers76 was followed. A 
1-mL ethanol solution of 0.25 mmol of the ketoacid was slowly added to a stirred slurry 
of 19 mg (0.50 mmol) of sodium borohydride in 1.5 mL of ethanol at ooe over the course 
of 2 min so as to moderate the release of evolved hydrogen gas and the resulting mixture 
was stirred at room temperature for 6 h. The mixture was then cooled to 0 oe and 0.75 
mL of 1.0 M Hel was slowly added dropwise over the course of 5 min, followed by 5 mL 
of water and enough additional 1.0 M Hel to reach a pH of ca. 3. The resulting solution 
was stirred at room temperature for 2 h and extracted twice with ether. The combined 
organic extracts were washed with water and saturated aqueous NaCl, dried over 
anhydrous Na2S04 and concentrated in vacuo to yield the following reduction products. 
The physical and spectral data were: 
(SR*,6R*)-(±)-6-(Carboxymethyl)spiro[ 4.S]decan-1-ol (30d): 45 mg 
(0.21 mmol, 84%); IR (thin film) 3530-2710, 1720 cm-1; 1H NMR (eDel3) o 6.55-5.92 
(bs, 2 H), 3.51 (m, 1 H), 2.65 (m, 1 H), 2.27 (m, 2 H), 1.96 (m, 1 H), 1.79 (m, 5 H), 
1.53 (m, 2 H), 1.31 (m, 6 H); Be NMR (eDel3) o 179.3, 72.8, 45.6, 35.7, 34.2, 29.5, 
28.9, 26.1, 24.2, 23.9, 21.2, 20.6; HRMS, mle for e12H20o3: calcd, 212.1412; found, 
212.1416. 
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(6R*, 7 R*)-(±)-7 -(Carboxymethyl)spiro[S.S]undecan-1-ol (JOe): 
48 mg (0.21 mmol, 84%); mp 136-137"C; IR(CHC13) 3450-2700, 1715 cm-1; lH NMR 
(CDC13) ~ 6.40-5.80 (bs, 2 H), 3.48 (m, 1 H), 2.62 (m, 1 H), 2.19 (m, 1 H), 1.95 (m, 
1 H), 1.86 (m, 4 H), 1.55 (m, 2 H), 1.34 (m, 7 H), 0.95 (m, 1 H); 13C NMR (CDCl3) ~ 
179.6, 72.6, 40.8, 36.9, 35.0, 28.7, 28.6 (2), 26.3, 24.8, 24.7, 20.4, 19.9; HRMS, 
m/e for C13H2203: calcd, 226.1569; found, 226.1569. 
-
(5R*,6S*)-(±)-6-(Carboxymethyl)spiro[4.5]decan-1-ol Lactone 
(32d): 43 mg (0.22 mmol, 88%); IR (thin film) 1735 cm-1; lH NMR (CDC13) ~ 4.37 
(m, 1 H), 2.43 (m, 1 H), 2.19 (m, 1 H), 1.89 (m, 2 H), 1.80-1.42 (complex, 10 H), 
1.25 (m, 2 H), 1.04 (m, 1 H); 13C NMR (CDCI3) ~ 171.2, 93.0, 44.8, 36.5, 35.5, 33.2, 
31.5, 29.2, 25.8, 25.5, 22.2, 21.7; HRMS, m/e for C12H1s02: calcd, 194.1307; found, 
194.1313. 
Single Crystal X-ray Structure Determination of the 2,4-DNP of 
(SR * ,6R *)-(±)-1-.(Ethoxycarbonylmethyl)spiro[ 4.6]undecan-6-one (26). 
A crystal of C21H2sN406, grown from absolute ethanol, was mounted on a Syntex P3 
automated diffractometer. Unit cell dimensions (see Table XII) were determined by least 
squares refinement of the best angular positions for fifteen independent reflections 
(2e> 15 °) during normal alignment procedures using molybdenum radiation (1..=0. 71069 
A). Data (1493 independent points after removal of redundant data) were collected at 
room temperature using a variable scan rate, a e-2e scan mode and and a scan width of 
1.2° below Kat and 1.2° above Ka2 to a maximum 2e value of 45°. Backgrounds were 
measured at each side of the scan for a combined time equal to the total scan time. The 
intensities of three standard reflections were remeasured after every 97 reflections. As 
the intensities of these reflections showed less than 5% variation, corrections for 
decomposition were deemed unnecessary. Data were corrected for Lorentz, polarization 
and background effects. Observed reflections [780 ((l>3.0o(I))] were used for solution of 











































scale factor, positional and anisotropic thermal parameters for all non-hydrogen atoms 
were carried out to convergence. The atoms of the side chain attached at C1 showed 
disorder. The disorder was not entirely resolved by assignment of two partially occupied 
positions to atoms C13-C15 and 01 and 02 of the side chain ethyl ester group. The 
positions of 20 hydrogen atoms not associated with side chain atoms were located from a 
difference Fourier synthesis and were included in the final cycles of refmement with fixed, 
isotropic thermal parameters. The fmal cycle of refinement [function minimized. l:(IFoi-
1Fcl)2] led to a final agreement factor, R=7 .0%. [R=(l:IIFol- IFcll/ l:wiFol) x 100]. 
Scattering factors were taken from Cromer and Mann.65 In the final stages of refmement 
a weight factor of l/a(F)2 was used. Rw=8.9%. Tables XVTI-XIX in Appendix B list 
bond angles and distances, positional parameters, and final anisotropic thermal parameters 
for 26. 
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APPENDIX A 
TABLES OF CRYSTALLOGRAPHIC DATA FOR 
( 1R* ,3aS*, 7aS*)-( ± )-1-(CARBOXYMETHYL)-
1, 3, 3a, 4,5, 6, 7, 7a-OCTAHYDRO-
BENZO[ c]THIOPHENE (114) 
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TABLE XIII 
BOND ANGLES AND DISTANCES FOR (1R*,3aS*,7aS*)-( ± )-1-
(CARBOXYMETHYL)-1, 3, 3a, 4,5, 6, 7, 7a-OCTAHYDRO-
BENZO[c]THIOPHENE (114) 
Atoms Distance (A) Atoms Angle C) 
C1- S2 1.831(4) C7a- C1- S2 106.5(3) 
C1- C7a 1.544(7) C7a- C1- C8 110.9(4) 
S2- C3 1.824(6) S2- C1- C8 112.6(3) 
C3- C3a 1.518(6) Cl- S2- C3 93.8(2) 
C3a- C4 1.539(7) S2- C3- C3a 105.6(3) 
C3a- C7a 1.5_30(6) C3- C3a- C7a 104.8(9) 
C4- C5 1.517(7) C3- C3a- C4 113.1(4) 
C5- C6 1.522(7) C4- C3a- C7a 111.9(3) 
C6-C7 1.533(7) C3a- C4- C5 111.3(4) 
C7- C7a 1.530(6) C4- C5- C6 110.6(4) 
Cl- C8 1.511(7) C5- C6- C7 111.5(4) 
C8 -C9 1.503(8) C6- C7- C7a 113.0(3) 
C9-01 1.235(6) C7- C7a- C1 113.2(3) 
C9-02 1.293(6) C7- C7a- C3a 113.0(4) 
C1- C7a- C3a 108.9(3) 
C1- C8- C9 115.5(4) 
C8- C9- 01 122.9(5) 
C8- C9- 02 113.6(4) 




















POSmONAL PARAMETERS FOR (1R*,3aS*,7aS*)-( ± )-
1-(CARBOXYMETHYL)-1, 3, 3a, 4,5, 6, 7, 7a-OCfA-
HYDROBENZO[ c]THIOPHENE (114) 
Atoms X(SIG(X)) Y(SIG(Y)) Z(SIG(Z)) 
52 0.4599( 1) 0.0850( 3) 0.8050( 1) 
01 0.4377( 3) -0.0876( 7) 0.5774( 3) 
02 0.4330( 2) 0.2847( 7) 0.5010( 3 ) 
C1 0.3402( 3) 0.1201( 8) 0.7065( 3 ) 
C3 0.4264( 3) 0.2640( 10) 0.8999( 4) 
C3A 0.3176( 3) 0.2306( 8) 0.8712( 3) 
C4 0.2891( 3) -0.0290( 9) 0.9024( 3) 
C5 0.1801( 3) -0.0677( 9) 0.8604( 4) 
C6 0.1423( 3) -0.0467( 9) 0.7445( 4) 
C7 0.1690( 3) 0.2086( 10) 0.7089( 3) 
C7A 0.2772( 3) 0.2699( 8) 0.7556( 3) 
CB 0.3447( 3) 0.2535( 9) 0.6123( 3) 
C9 0.4102( 3) 0.1345( 9) 0.5625( 3) 
H1 0.3088 -0.0580 0.6871 
H2 0.4800 0.1906 0.4688 
H31 0.4421 0.4555 0.8960 
H32 0.4682 0.2134 0.9752 
H3A1 0.2884 0.3844 0.9078 
H41 0.3182 -0.0146 0.9857 
H42 0.3263 -0.1663 0.8798 
H51 0.1543 -0.2601 0.8766 
H52 0.1435 0.0725 0.8987 
H61 0.0618 -0.0945 0.7079 
H62 0.1753 -0.1975 0.7167 
H71 0.1488 0.2289 0.6295 
H72 0.1315 0.2505 0.7345 
H71>.1 0.2871 0.4642 0.7391 
H8l 0.2775 0.2784 0.5387 
H82 0.3675 0.4346 0.6179 
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TABLE XVI 
ANISOTROPIC THERMAL PARAMETERS FOR (1R*,3aS*,7aS*)-
(± )-1-(CARBOXYMETHYL)-1, 3, 3a, 4,5, 6, 7, 7a-OCTA-
HYDROBENZO[ c ]THIOPHENE (114) 
Atom Ull U22 U33 U12 U13 U23 
52 344( 7) 742( 10) 538( 8) 79( 6) 170( 6) 42( 8) 
01 79( 2) 45( 2) 67( 2) 13( 2) 52( 2) 7 ( 2) 
02 85( 2) 59( 2) 67( 2) 15( 2) 57( 2) 19( 2) 
C1 32( 2) 32( 2) 34( 2) 0 ( 2) 14( 2) 4 ( 2) 
C3 45( 2) 51( 3) 49( 3) -7( 2) 6 ( 2) -3( 2) 
C3A 46( 2) 33( 2) 38( 2) 2 ( 2) 18( 2) -4( 2) 
C4 55( 3) 50( 3) 37( 2) 5( 2) 20( 2) 2 ( 2) 
cs 55( 3) 46( 3) 57( 3) -7( 2) 33( 2) 7 ( 2) 
C6 39( 2) 41( 2) 53( 3) -6( 2) 18( 2) -4( 2) 
C7 36( 2) 53( 3) 43( 2) 9( 2) 20( 2) 7 ( 2) 
C7A 38( 2) 27( 2) 41( 2) 5( 2) 20( 2) 1 ( 2) 
C8 54( 2) 42( 3) 43( 2) 7 ( 2) 28( 2) 11( 2) 
C9 39( 2) 47( 3) 35( 2) 2( 2) 18( 2) 4( 2) 
Anisotropic thermal parameters in the format: 
e~p[ -21t2(Ullh2a*2 + U22k2b*2 + U3312c*2 + 2U12hka*b*+ 2U13hla*c*+ 2U23klb*c*)] 
x 103 for C, 0; x 104 for S 
APPENDIXB 
TABLES OF CRYSTALLOGRAPIDC DATA FOR THE 





BOND ANGLES AND DISTANCES FOR TiiE 2,4-DNP OF 
(5R*, 6R*)-( ± )-1-(ETHOXYCARBONYLMETHYL)-
SPIRO[ 4.6]UNDECAN-6-0NE (26) 
Atoms Distance (A) Atoms Anglen 
C1- C2 1.50(3) C2- C1- C5 100(1) 
C1- C5 1.56(2) C2- C1- C12 118(2) 
C1- C12 1.55(2) C5- C1- C12 115(2) 
C2- C3 1.48(3) C1- C2- C3 108(2) 
C3 -C4 1.48(3) C2- C3- C4 106(2) 
C4- C5 1.55(3) C3-C4-C5 106(2) 
C5- C6 1.53(2) C1- C5- C4 101(1) 
C5- Cll 1.53(2) C1- C5- C6 114(1) 
C6- c:T 1.49(2) C1- C5- Cll 112(2) 
C6- N1 1.30(2) C4-C5-C6 109(1) 
c:T- C8 1.49(3) C4-C5- Cll 114(1) 
C8-C9 1.56(3) C6- C5- Cll 108(2) 
C9- ClO 1.56(4) C5- C6- N1 116(2) 
C10- Cll 1.51(3) C5- C6- c:T 120(1) 
N1- N2 1.39(2) N1- C6- c:T 124(2) 
N2- C16 1.36(2) C6- c:T- C8 111(2) 
C16- C17 1.46(2) c:T- C8- C9 115(2) 
C16- C21 1.43(2) C8- C9- ClO 112(2) 
C17- C18 1.36(3) C9- ClO- Cll 115(2) 
C17- N3 1.43(3) ClO- Cll- C5 120(2) 
N3-03 1.24(2) C6- N1- N2 116(1) 
N3-04 1.23(2) Nl- N2- C16 117(1) 
C18- C19 1.36(2) N2- C16- C17 122(2) 
C19- C20 1.37(2) N2- C16- C21 123(2) 
C19- N4 1.45(2) C17- C16- C21 114(2) 
N4-05 1.24(2) C16- C17- N3 121(2) 
N4-06 1.18(2) C16- C17- C18 119(2) 




Atoms Distance (A) Atoms Anglen 
N'4- C19- C20 119(2) 
Cl9-N4-05 119(1) 
C19- N4- 06 119(2) 
05- N4- 06 123(1) 
Cl9- C20- C21 119(2) 
C20- C21 - CI6 124(2) 
Cl7- N3- 03 121(2) 
C17-N3-04 116(2) 
Cl7- CIS- Cl9 123(2) 
ClS - C19 - C20 121(2) 
CIS- Cl9- N4 I20(2) 
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TABLE XVIII 
POSIDONAL PARAMETERS FOR THE 2,4-DNP OF (5R*, 6R*)-
( ± )-1-(ETHOXYCARBONYLMETHYL)SPIRO-
[4.6]UNDECAN-6-0NE (26) 
Atom X(SIG(X)) Y(SIG(Y)) Z(SIG(Z)) 
03 0.0950( 8) 0.2665( 8) 0.2365( 20) 
04 0.2147( 8) 0.3145( 8) 0.1973( 25) 
05 0.4625( 8) 0.1969( 8) 0.3213( 20) 
06 0.4618( 8) 0.0890( 8) 0.4091( 17) 
N1 0.0462( 8) 0.0688( 8) 0.3749( 18) 
N2 0.0825( 8) 0.1345( 9) 0.3453( 21) 
N3 0.1709( 12) 0.2640( 10) 0.2422( 21) 
N4 0.4266( 8) 0.1411( 9) 0.3641( 24) 
C1 -0.0110( 12) -0.0666( 10) 0.4357( 26) 
C2 -0.0532( 12) -0.1320( 11) 0.3648( 30) 
C3 -0.0898( 12) -0.1158( 12) 0.1800( 27) 
C4 -0.0920( 11) -0.0375( 12) 0.1656( 28) 
cs -0.0714( 9) -0.0085( 9) 0.3636( 25) 
C6 -0.0320( 10) 0.0650( 10) 0.3432( 22) 
C7 -0.0832( 10) 0.1274( 11) 0.2889( 25) 
c8 -0.1099( 12) 0.1684( 12) 0.4569( 35) 
C9 -0.1754( 14) 0.1305( 15) 0.5810( 32) 
C10 -0.1476( 12) 0.0550( 13) 0.6437( 30) 
Cl1 -0.1463( 11) -0.0004( 13) 0.4902( 29) 
Cl2 0.0089( 10) -0.0623( 10) 0.6482( 24) 
Cl6 0.1660( 10) 0.1363( 10) 0.3465{ 21) 
C17 0.2121( 12) 0.2008( 10) 0.3009( 22) 
C18 0.2957( 11) 0.1989( 9) 0.3078( 24) 
C19 0.3378( 9) 0.1394( 10) 0.3560( 23) 
C20 0.2980( 9) 0.0786( 10) 0.4075( 20) 
C21 0.2160( 11) 0.0767( 10) 0.3985( 22) 
OlA 0.1269( 16) -0.1346( 15) 0.5700{ 37) 
01B 0.1378( 21) -0.0988( 21) 0.6256( 51) 
02A 0.0841( 16) -0.1215( 17) 0.8773( 42) 
02B .0.1031( 19) -0.0998{ 18) 0.8922{ 41) 
C13 0.0853( 12) -0.1057( 11) 0.7081( 46) 
Cl4A 0.1651( 16) -0.1418( 19) 0.9565( 49) 
Cl4B 0.1449( 36) -0.2010( 24) 0.9907( 84) 
C15 0.1542( 33) -0.2023( 29) 1. 0979 ( 52) 
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TABLE XVill (Continued) 
Atom X(SIG(X)) Y(SIG(Y)) Z(SIG(Z)) 
H1 0.0401 -0.0612 0.3686 
H21 -0.0960 -0.1479 0.4497 
H22 -0.0134 -0.1714 0.3511 
H31 -0.1447 -0.1389 0.1706 
H32 -0.0563 -0.1386 0.0791 
H41 -0.1477 -0.0196 0.1272 
H42 -0.0537 -0.0182 0.0722 
H71 -0.0539 0.1599 0.2021 
H72 -0.1340 0.1130 0.2232 
H81 -0.0598 0.1784 0.5354 
H82 -0.1300 0.2171 0.4209 
H91 -0.1821 0.1631 0.6904 
H92 -0.2231 0.1313 0.5075 
H101 -0.0901 0.0563 0.6920 
H102 -0.1823 0.0391 0.7441 
H111 -0.1578 -0.0466 0.5508 H112 -0.1945 0.0106 0.4113 
H18 0.3280 0.2421 0.2712 H20 0.3301 0.0363 0.4474 
H21 0.1871 0.0309 0.4313 
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TABLE XIX 
ANISOTROPIC THERMAL PARAMETERS FOR TIIE 2,4-DNP 
OF (5R*, 6R*)-( ± )-1-(ETIIOXYCARBONYLMETHYL)-
SPIRO[ 4.6]UNDECAN-6-0NE (26) 
Atom Ull U22 U33 U12 U13 U23 
03 56( 8) 61( 8) 109( 10) 12( 8) -13( 8) 15( 8) 
04 82( 10) 62( 9) 150( 14) -16( 8) -13( 10) 34( 10) 
05 59( 8) 93( 11) 145( 13) -8( 8) 0 ( 9) -14( ll) 
06 58( 8) 87( 10) 81( 9) -6( 7) 0( 7) -8( 9) 
N1 44( 8) 63( 10) 51( 9) -18( 8) -4( 7) -7( 9) 
N2 37( 8) 64( 10) 66( 10) -11( 8) 5( 8) -2( 9) 
N3 96( 13) 41( 9) 51( 9) 1 ( 11) -23( 9) 16( 8) 
N4 53( 9) 67( 9) 82( 10) 0( 9) -7( 9) -25( 9) 
C1 70( 14) 39( 10) 69( 13) -17( 11) 3 ( 11) -12( 10) 
C2 79( 14) 74( 16) 74( 16) -11( 12) 27( 12) 23( 13) 
C3 81( 14) 93( 18) 64( 14) -29( 12) 6( 12) 0( 13) 
C4 49( 13) 91( 15) 71( 15) -24( 11) -20( 11) 13( 13) 
cs 28( 9) 50( 11) 67( 12) -12( 9) 6( 9) 14( 11) 
C6 55( 11) 68( 11) 31( 9) 12( 11) 6( 9) 0( 9) 
C7 26( 9) 81( 14) 62( 12) 10( 9) 2( 9) -4( 11) 
CB 58( 13) 87( 16) 105( 19) 23( 14) -15( 14) 11( 15) 
C9 109( 17) 117( 19) 68( 16) 48( 16) -8( 13) -9( 15) 
C10 57( 12) 113( 19) 64( 14) 8( 13) 23( 11) -1( 15) 
C11 53( 10} 89( 15) 79( 16) -14( 11) -23( 12) 35( 14) 
C12 66( 11) 56( 11) 43( 10) 0( 9) -14( 9) 21( 9) 
C16 59( 11) 43( 9) 15( 8) 15( 10) -8( 9) 6( 7) 
C17 69( 12) 38( 11) '24( 10) -4( 11) -1( 9) 14( 8) 
C18 51( 13) 42( 10) 62( 13) -12( 10) -5( 11) 0( 9) 
C19 45( 9) 66( 10) 31( 9) -13( 9) 1( 9) -11( 9) 
C20 22( 10) 69( 13) 41( 10) 5( 9) -11( 7) -8( 9) 
C21 61( 13) 34( 12) 42( 11) -17( 10) 0( 9) -5( 10) 
C13 44( 15) 59( 14) 172( 26) -20( 11) -14( 17) 15( 17) 
01A 5( 0) 75( 18) 125( 24) 58( 16) 55( 18) -26( 14) 
01B 5( 0) 93( 21) 114( 30) 55( 25) -15( 21) -18( 19) 
02A 5( 0) 13( 17) 67( 23) 28( 16) -26( 15) -18( 15) 
02B 5( 0) 52( 21) 55( 21) 42( 19) -12( 17) -46( 18) 
C14A 121( 21) 140( 26) 192( 30) 7( 21) -25( 20) 63( 24) 
C14B 5( -0). 108( 37) 31( 25) 102( 45) 22( 24) -24( 41) 
C15 5( 0) 81( 30) 90( 33) 21( 23) -5( 24) -18( 26) 
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